Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the Health Information Technology for Economic and Clinical Health Act, 40868-40924 [2010-16718]
Download as PDF
40868
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
45 CFR Parts 160 and 164
RIN: 0991–AB57
Modifications to the HIPAA Privacy,
Security, and Enforcement Rules
Under the Health Information
Technology for Economic and Clinical
Health Act
srobinson on DSKHWCL6B1PROD with PROPOSALS2
AGENCY: Office for Civil Rights,
Department of Health and Human
Services.
ACTION: Notice of proposed rulemaking.
SUMMARY: The Department of Health and
Human Services (HHS or ‘‘the
Department’’) is issuing this notice of
proposed rulemaking to modify the
Standards for Privacy of Individually
Identifiable Health Information (Privacy
Rule), the Security Standards for the
Protection of Electronic Protected
Health Information (Security Rule), and
the rules pertaining to Compliance and
Investigations, Imposition of Civil
Money Penalties, and Procedures for
Hearings (Enforcement Rule) issued
under the Health Insurance Portability
and Accountability Act of 1996
(HIPAA). The purpose of these
modifications is to implement recent
statutory amendments under the Health
Information Technology for Economic
and Clinical Health Act (‘‘the HITECH
Act’’ or ‘‘the Act’’), to strengthen the
privacy and security protection of
health information, and to improve the
workability and effectiveness of these
HIPAA Rules.
DATES: Submit comments on or before
September 13, 2010.
ADDRESSES: You may submit comments,
identified by RIN 0991–AB57, by any of
the following methods (please do not
submit duplicate comments):
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Attachments should be in Microsoft
Word, WordPerfect, or Excel; however,
we prefer Microsoft Word.
• Regular, Express, or Overnight Mail:
U.S. Department of Health and Human
Services, Office for Civil Rights,
Attention: HITECH Privacy and Security
Rule Modifications, Hubert H.
Humphrey Building, Room 509F, 200
Independence Avenue, SW.,
Washington, DC 20201. Please submit
one original and two copies.
• Hand Delivery or Courier: Office for
Civil Rights, Attention: HITECH Privacy
and Security Rule Modifications, Hubert
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
H. Humphrey Building, Room 509F, 200
Independence Avenue, SW.,
Washington, DC 20201. Please submit
one original and two copies. (Because
access to the interior of the Hubert H.
Humphrey Building is not readily
available to persons without Federal
government identification, commenters
are encouraged to leave their comments
in the mail drop slots located in the
main lobby of the building.)
Inspection of Public Comments: All
comments received before the close of
the comment period will be available for
public inspection, including any
personally identifiable or confidential
business information that is included in
a comment. We will post all comments
received before the close of the
comment period at https://
www.regulations.gov. Because
comments will be made public, they
should not include any sensitive
personal information, such as a person’s
social security number; date of birth;
driver’s license number, State
identification number or foreign country
equivalent; passport number; financial
account number; or credit or debit card
number. Comments also should not
include any sensitive health
information, such as medical records or
other individually identifiable health
information, or any non-public
corporate or trade association
information, such as trade secrets or
other proprietary information.
FOR FURTHER INFORMATION CONTACT:
Andra Wicks, 202–205–2292.
SUPPLEMENTARY INFORMATION:
The discussion below includes a
description of the statutory and
regulatory background of the proposed
rules, a section-by-section description of
the proposed modifications, and the
impact statement and other required
regulatory analyses. We solicit public
comment on the proposed rules. Persons
interested in commenting on the
provisions of the proposed rules can
assist us by preceding discussion of any
particular provision or topic with a
citation to the section of the proposed
rule being discussed.
I. Statutory and Regulatory Background
The regulatory modifications
proposed below concern several sets of
rules that implement the Administrative
Simplification provisions of title II,
subtitle F, of the Health Insurance
Portability and Accountability Act of
1996 (HIPAA) (Pub. L. 104–191), which
added a new part C to title XI of the
Social Security Act (sections 1171–1179
of the Social Security Act, 42 U.S.C.
1320d–1320d–8). The Health
Information Technology for Economic
PO 00000
Frm 00002
Fmt 4701
Sfmt 4702
and Clinical Health (HITECH) Act,
which was enacted as title XIII of
division A and title IV of division B of
the American Recovery and
Reinvestment Act of 2009 (ARRA),
Public Law 111–5, modifies certain
provisions of the Social Security Act
pertaining to the Administrative
Simplification Rules (HIPAA Rules) and
requires certain modifications to the
HIPAA Rules themselves.
A. HIPAA Administrative
Simplification—Statutory Background
The Administrative Simplification
provisions of HIPAA provided for the
establishment of national standards for
the electronic transmission of certain
health information, such as standards
for certain health care transactions
conducted electronically and code sets
and unique health care identifiers for
health care providers and employers.
The Administrative Simplification
provisions of HIPAA also required the
establishment of national standards to
protect the privacy and security of
personal health information and
established civil money and criminal
penalties for violations of the
Administrative Simplification
provisions. The Administrative
Simplification provisions of HIPAA
apply to three types of entities, which
are known as ‘‘covered entities’’: health
care providers who conduct covered
health care transactions electronically,
health plans, and health care
clearinghouses.
B. HIPAA Administrative
Simplification—Regulatory Background
The rules proposed below concern the
privacy and security standards issued
pursuant to HIPAA, as well as the
enforcement rules that implement
HIPAA’s civil money penalty authority.
The Standards for Privacy of
Individually Identifiable Health
Information, known as the ‘‘Privacy
Rule,’’ were issued on December 28,
2000, and amended on August 14, 2002.
See 65 FR 82462, as amended at 67 FR
53182. The Security Standards for the
Protection of Electronic Protected
Health Information, known as the
‘‘Security Rule,’’ were issued on
February 20, 2003. See 68 FR 8334. The
Compliance and Investigations,
Imposition of Civil Money Penalties,
and Procedures for Hearings regulations,
collectively known as the ‘‘Enforcement
Rule,’’ were issued as an interim final
rule on April 17, 2003 (68 FR 18895),
and revised and issued as a final rule,
following rulemaking, on February 16,
2006 (71 FR 8390).
The Privacy Rule protects individuals’
medical records and other individually
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
identifiable health information created
or received by or on behalf of covered
entities, known as ‘‘protected health
information.’’ The Privacy Rule protects
individuals’ health information by
regulating the circumstances under
which covered entities may use and
disclose protected health information
and by requiring covered entities to
have safeguards in place to protect the
privacy of the information. As part of
these protections, covered entities are
required to have contracts or other
arrangements in place with business
associates that perform functions for or
provide services to the covered entity
and that require access to protected
health information to ensure that these
business associates likewise protect the
privacy of the health information. The
Privacy Rule also gives individuals
rights with respect to their protected
health information, including rights to
examine and obtain a copy of their
health records and to request
corrections.
The Security Rule, which applies only
to protected health information in
electronic form, requires covered
entities to implement certain
administrative, physical, and technical
safeguards to protect this electronic
information. As with the Privacy Rule,
the Security Rule requires covered
entities to have contracts or other
arrangements in place with their
business associates that provide
satisfactory assurances that the business
associates will appropriately safeguard
the electronic protected health
information they receive, create,
maintain, or transmit on behalf of the
covered entities.
The Enforcement Rule establishes
rules governing the compliance
responsibilities of covered entities with
respect to cooperation in the
enforcement process. It also provides
rules governing the investigation by the
Department of compliance by covered
entities, both through the investigation
of complaints and the conduct of
compliance reviews. It establishes rules
governing the process and grounds for
establishing the amount of a civil money
penalty where the Department has
determined a covered entity has
violated a requirement of a HIPAA Rule.
Finally, the Enforcement Rule
establishes rules governing the
procedures for hearings and appeals
where the covered entity challenges a
violation determination.
C. The HITECH Act—Statutory
Background
The HITECH Act, enacted on
February 17, 2009, is designed to
promote the widespread adoption and
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
standardization of health information
technology. Subtitle D of title XIII,
entitled ‘‘Privacy,’’ supports this goal by
adopting amendments designed to
strengthen the privacy and security
protections of health information
established by HIPAA. These provisions
include extending the applicability of
certain of the Privacy and Security
Rules’ requirements to the business
associates of covered entities; requiring
HIPAA covered entities and business
associates to provide for notification of
breaches of ‘‘unsecured protected health
information’’; establishing new
limitations on the use and disclosure of
protected health information for
marketing and fundraising purposes;
prohibiting the sale of protected health
information; requiring the consideration
of a limited data set as the minimum
necessary amount of information; and
expanding individuals’ rights to access
and receive an accounting of disclosures
of their protected health information,
and to obtain restrictions on certain
disclosures of protected health
information to health plans. In addition,
subtitle D adopts provisions designed to
strengthen and expand HIPAA’s
enforcement provisions. We provide a
brief overview of the relevant statutory
provisions below.
In the area of business associates, the
Act makes a number of changes. First,
section 13401 of the Act applies certain
provisions of the Security Rule that
apply to covered entities directly to
their business associates and makes
business associates liable for civil and
criminal penalties for the failure to
comply with these provisions.
Similarly, section 13404 makes business
associates of covered entities civilly and
criminally liable under the Privacy Rule
for making uses and disclosures of
protected health information that do not
comply with the terms of their business
associate contracts. The Act also
provides that the additional privacy and
security requirements of subtitle D of
the Act are applicable to business
associates and that such requirements
shall be incorporated into business
associate contracts. Finally, section
13408 of the Act requires that
organizations that provide data
transmission of protected health
information to a covered entity or
business associate and that require
routine access to such information, such
as Health Information Exchange
Organizations, Regional Health
Information Organizations, and Eprescribing Gateways, as well as
vendors that contract with covered
entities to offer personal health records
to patients as part of the covered
PO 00000
Frm 00003
Fmt 4701
Sfmt 4702
40869
entities’ electronic health records, shall
be treated as business associates for
purposes of the HITECH Act and the
HIPAA Privacy and Security Rules and
required to enter into business associate
contracts.
Section 13402 of the Act sets forth the
breach notification provisions, requiring
covered entities and business associates
to provide notification following
discovery of a breach of unsecured
protected health information.
Additionally, section 13407 of the Act,
enforced by the Federal Trade
Commission (FTC), applies similar
breach notification provisions to
vendors of personal health records and
their third party service providers.
Section 13405 of the Act requires the
Department to modify certain Privacy
Rule provisions. In particular, section
13405 sets forth certain circumstances
in which covered entities must comply
with an individual’s request for
restriction of disclosure of his or her
protected health information, provides
for covered entities to consider a limited
data set as the minimum necessary for
a particular use, disclosure, or request of
protected health information, and
requires the Secretary to issue guidance
to address what constitutes minimum
necessary under the Privacy Rule.
Section 13405 also requires the
Department to modify the Privacy Rule
to require covered entities that use or
maintain electronic health records to
provide individuals, upon request, with
an accounting of disclosures of
protected health information through an
electronic health record for treatment,
payment, or health care operations;
generally prohibits the sale of protected
health information without a valid
authorization from the individual; and
strengthens an individual’s right to an
electronic copy of their protected health
information, where a covered entity
uses or maintains an electronic health
record.
Section 13406 of the Act requires the
Department to modify the marketing
and fundraising provisions of the
Privacy Rule. With respect to marketing,
the Act requires authorizations for
certain health-related communications,
which are currently exempted from the
definition of marketing, if the covered
entity receives remuneration in
exchange for making the
communication. The Act also
strengthens an individual’s right under
the Privacy Rule to opt out of
fundraising communications by
requiring the Department to modify the
Privacy Rule so that covered entities
must provide individuals with a clear
and conspicuous opportunity to opt out
of receiving fundraising
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40870
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
communications and by requiring that
an opt out be treated as a revocation of
authorization under the Privacy Rule.
Section 13410 of the Act addresses
enforcement in a number of ways. First,
section 13410(a) provides that the
Secretary’s authority to impose a civil
money penalty will only be barred to
the extent a criminal penalty has been
imposed, rather than in cases in which
the offense in question merely
constitutes an offense criminally
punishable. In addition, section
13410(a) of the Act requires the
Secretary to formally investigate any
complaint where a preliminary
investigation of the facts indicates a
possible violation due to willful neglect
and to impose a penalty where a
violation is found in such cases. Section
13410(c) of the Act provides, for
purposes of enforcement, for the transfer
to the HHS Office for Civil Rights of any
civil money penalty or monetary
settlement collected under the Privacy
and Security Rules and also requires the
Department to establish by regulation a
methodology for distributing to harmed
individuals a percentage of the civil
money penalties and monetary
settlements collected under the Privacy
and Security Rules. Effective as of
February 18, 2009, section 13410(d) of
the Act also modified the civil money
penalty structure for violations of the
HIPAA Rules by implementing a tiered
increase in the amount of penalties
based on culpability. In addition, as of
February 18, 2009, section 13410(e) of
the Act also granted State Attorneys
General the authority to enforce the
HIPAA Rules by bringing civil actions
on behalf of State residents in court.
Section 13421 states that HIPAA’s
State preemption provisions at 42 U.S.C.
1320d–7 shall apply to the provisions of
subtitle D of the HITECH Act in the
same manner as they do to HIPAA’s
provisions.1 Section 13423 of the Act
provides a general effective date of
February 18, 2010, for most of its
provisions, except where a different
effective date is otherwise provided.
The Act also provides for the
development of guidance, reports, and
studies in a number of areas, including
guidance on appropriate technical
safeguards to implement the HIPAA
Security Rule (section 13401(c)); for
purposes of breach notification,
guidance on the methods and
technologies for rendering protected
1 We note that section 13421 of the HITECH Act
and HIPAA’s State preemption provisions do not
affect the applicability of other Federal law, such
as the Confidentiality of Alcohol and Drug Abuse
Patient Records Regulation at 42 CFR Part 2, to a
covered entity’s use or disclosure of health
information.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
health information unusable,
unreadable, or indecipherable to
unauthorized individuals (section
13402(h)); guidance on what constitutes
the minimum necessary amount of
information for purposes of the Privacy
Rule (section 13405(b)); a report by the
Government Accountability Office
(GAO) regarding recommendations for a
methodology under which harmed
individuals may receive a percentage of
civil money penalties and monetary
settlements under the HIPAA Privacy
and Security Rules (section 13410(c)); a
report to Congress on HIPAA Privacy
and Security enforcement (section
13424(a)); a study and report on the
application of privacy and security
requirements to non-HIPAA covered
entities (section 13424(b)); guidance on
de-identification (section 13424(c)); and
a study on the Privacy Rule’s definition
of ‘‘psychotherapy notes’’ at 45 CFR
164.501, with regard to including test
data that is related to direct responses,
scores, items, forms, protocols, manuals,
or other materials that are part of a
mental health evaluation (section
13424(f)).
Finally, the Act includes provisions
for education by HHS on health
information privacy and for periodic
audits by the Secretary. Section
13403(a) provides for the Secretary to
designate HHS regional office privacy
advisors to offer guidance and education
to covered entities, business associates,
and individuals on their rights and
responsibilities related to Federal
privacy and security requirements for
protected health information. Section
13403(b) requires the HHS Office for
Civil Rights, not later than 12 months
after enactment, to develop and
maintain a multi-faceted national
education initiative to enhance public
transparency regarding the uses of
protected health information, including
programs to educate individuals about
potential uses of their protected health
information, the effects of such uses,
and the rights of individuals with
respect to such uses. Section 13411
requires the Secretary to provide for
periodic audits to ensure covered
entities and business associates comply
with the applicable requirements of the
HIPAA Privacy and Security Rules.
We discuss many of the Act’s
statutory provisions in more detail
below where we describe section-bysection how these proposed regulations
would implement those provisions of
the Act. However, we do not discuss in
detail the breach notification provisions
in sections 13402 of the Act or the
modified civil money penalty structure
in section 13410(d) of the Act, which as
explained below, have been the subject
PO 00000
Frm 00004
Fmt 4701
Sfmt 4702
of previous rulemakings. In addition, we
do not address in this rulemaking the
accounting for disclosures requirement
in section 13405 of the Act, which is
tied to the adoption of a standard under
the HITECH Act at subtitle A of title XIII
of ARRA, or the penalty distribution
methodology requirement in section
13410(c) of the Act, which is to be based
on the recommendations noted above to
be developed at a later date by the GAO.
These provisions will be the subject of
future rulemakings. Further, we clarify
that we are not issuing regulations with
respect to the new authority of the State
Attorneys General to enforce the HIPAA
Rules. Finally, other than the guidance
required by section 13405(b) of the Act
with respect to what constitutes
minimum necessary, this proposed rule
does not address the studies, reports,
guidance, audits, or education efforts
required by the HITECH Act.
D. The HITECH Act—Regulatory
Background
As noted above, certain of the
HITECH Act’s privacy and security
provisions have already been the subject
of rulemakings and related actions. In
particular, the Department published
interim final regulations to implement
the breach notification provisions at
section 13402 of the Act for HIPAA
covered entities and business associates
in the Federal Register on August 24,
2009 (74 FR 42740), effective September
23, 2009. Similarly, the FTC published
final regulations implementing the
breach notification provisions at section
13407 for personal health record
vendors and their third party service
providers on August 25, 2009 (74 FR
42962), effective September 24, 2009.
For purposes of determining to what
information the HHS and FTC breach
notification regulations apply, the
Department also issued, first on April
17, 2009 (published in the Federal
Register on April 27, 2009, 74 FR
19006), and then later with its interim
final rule, the guidance required by the
HITECH Act under 13402(h) specifying
the technologies and methodologies that
render protected health information
unusable, unreadable, or indecipherable
to unauthorized individuals. In
addition, to conform the provisions of
the Enforcement Rule to the new tiered
and increased civil money penalty
structure made effective by the HITECH
Act on the day after enactment, or
February 18, 2009, the Department
published an interim final rule on
October 30, 2009 (74 FR 56123),
effective November 30, 2009.
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
II. General Issues
A. Effective and Compliance Dates
As noted above, section 13423 of the
Act provides that the provisions in
subtitle D took effect one year after
enactment, i.e., on February 18, 2010,
except as specified otherwise. There are
a number of exceptions to this general
rule. Some provisions were effective the
day after enactment, i.e., February 18,
2009. For example, the tiered and
increased civil money penalty
provisions of section 13410(d) were
effective for violations occurring after
the date of enactment. Sections 13402
and 13407 of the Act regarding breach
notification required interim final rules
within 180 days of enactment, with
effective dates 30 days after the
publication of such rules. Other
provisions of the Act have later effective
dates. For example, the provision at
section 13410(a)(1) of the Act providing
that the Secretary’s authority to impose
a civil money penalty will only be
barred to the extent a criminal penalty
has been imposed, rather than in cases
in which the offense in question merely
constitutes an offense that is criminally
punishable, becomes effective for
violations occurring on or after February
18, 2011. The rules proposed below
generally pertain to the statutory
provisions that became effective on
February 18, 2010, or, in a few cases, on
a later date.
We note that the final rule will not
take effect until after most of the
provisions of the HITECH Act became
effective on February 18, 2010. We
recognize that it will be difficult for
covered entities and business associates
to comply with the statutory provisions
until after we have finalized our
changes to the HIPAA Rules. In
addition, we recognize that covered
entities and business associates will
need some time beyond the effective
date of the final rule to come into
compliance with the final rule’s
provisions. In light of these
considerations, we intend to provide
covered entities and business associates
with 180 days beyond the effective date
of the final rule to come into
compliance with most of the rule’s
provisions. We believe that providing a
180-day compliance period best
comports with section 1175(b)(2) of the
Social Security Act, 42 U.S.C. 1320d–4,
and our implementing provision at 45
CFR 160.104(c)(1), which require the
Secretary to provide at least a 180-day
period for covered entities to comply
with modifications to standards and
implementation specifications in the
HIPAA Rules. While the Social Security
Act and the HIPAA Rules permit the
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Secretary to further delay the
compliance date for small health plans,
we do not believe that it is necessary to
do so for this rule both because most of
the changes being proposed are discrete
modifications to existing requirements
of the HIPAA Rules, as well as because
the Department is proposing an
additional one-year transition period to
modify certain business associate
agreements, which should provide
sufficient relief to all covered entities,
including small health plans. The
Department welcomes comment on the
assumption that it is not necessary to
extend the compliance date for small
health plans.
We also expect that for future
modifications to the HIPAA Rules, in
most cases, a 180-day compliance
period will suffice. Accordingly, we
propose to add a provision at § 160.105
to address the compliance date
generally for implementation of new or
modified standards in the HIPAA Rules.
Proposed § 160.105 would provide that
with respect to new standards or
implementation specifications or
modifications to standards or
implementation specifications in the
HIPAA Rules, except as otherwise
provided, covered entities and business
associates must comply with the
applicable new standards or
implementation specifications or
modifications to standards or
implementation specifications no later
than 180 days from the effective date of
any such change. Where future
modifications to the HIPAA Rules
necessitate a longer compliance period,
we would provide so accordingly in the
regulatory text. We propose to retain the
compliance date provisions at
§§ 164.534 and 164.318, which provide
the compliance dates of April 14, 2003,
and April 20, 2005, for initial
implementation of the HIPAA Privacy
and Security Rules, respectively, for
historical purposes only.
We note that proposed § 160.105
regarding the compliance date of new or
modified standards or implementation
specifications would not apply to
modifications to the provisions of the
HIPAA Enforcement Rule because such
provisions are not standards or
implementation specifications (as the
terms are defined at § 160.103). Such
provisions are in effect and apply at the
time the final rule becomes effective or
as otherwise specifically provided. We
also note that our proposed general rule
for a 180-day compliance period for new
or modified standards would not apply
where we expressly provide a different
compliance period in the regulation for
one or more provisions. For purposes of
this proposed rule, this would mean
PO 00000
Frm 00005
Fmt 4701
Sfmt 4702
40871
that the 180-day compliance period
would not govern the time period
required to modify those business
associate agreements that qualify for the
longer transition period proposed in
§ 164.532. We seek comments on any
potential unintended consequences of
establishing a 180-day compliance date
as a regulatory default, with the noted
exceptions.
B. Other Proposed Changes
While passage of the HITECH Act
necessitates much of the rulemaking
below, it does not account for all of the
proposed changes to the HIPAA Privacy,
Security, and Enforcement Rules
encompassed in this rulemaking. The
Department is taking this opportunity to
improve the workability and
effectiveness of all three sets of HIPAA
Rules. The Privacy Rule has not been
amended since 2002, and the Security
Rule has not been amended since 2003.
While the Enforcement Rule was
amended in the October 30, 2009,
interim final rule to incorporate the
enforcement-related HITECH statutory
changes that are already effective, it has
not been otherwise substantively
amended since 2006. In the intervening
years, HHS has accumulated a wealth of
experience with these rules, both from
public contact in various forums and
through the process of enforcing the
rules. In addition, we have identified a
number of needed technical corrections
to the rules. Accordingly, we propose a
number of modifications that we believe
will eliminate ambiguities in the rules
and/or make them more workable and
effective. Further, we propose a few
modifications to conform the HIPAA
Privacy Rule to provisions in the Patient
Safety and Quality Improvement Act of
2005 (PSQIA). We address the
substantive proposed changes in the
section-by-section description of the
proposed rule below. Technical
corrections are discussed at the end of
the section-by-section description of the
other proposed amendments to the
rules.
III. Section-by-Section Description of
the Proposed Amendments to Subparts
A and B of Part 160
Subpart A of part 160 of the HIPAA
Rules contains general provisions that
apply to all of the HIPAA Rules. Subpart
B of part 160 contains the regulatory
provisions implementing HIPAA’s
preemption provisions. We propose to
amend a number of these provisions.
Some of the proposed changes are
necessitated by the statutory changes
made by the HITECH Act, while others
are of a technical or conforming nature.
E:\FR\FM\14JYP2.SGM
14JYP2
40872
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
A. Subpart A—General Provisions,
Section 160.101—Statutory Basis and
Purpose
This section sets out the statutory
basis and purpose of the HIPAA Rules.
We propose a technical change to
include a reference to the provisions of
the HITECH Act upon which most of the
regulatory changes proposed below are
based.
B. Subpart A—General Provisions,
Section 160.102—Applicability
This section sets out to whom the
HIPAA Rules apply. We propose to add
a new paragraph (b) to make clear,
consistent with the provisions of the
HITECH Act that are discussed more
fully below, that the standards,
requirements, and implementation
specifications of the subchapter apply to
business associates, where so provided.
C. Subpart A—General Provisions,
Section 160.103—Definitions
Section 160.103 contains definitions
of terms that appear throughout the
HIPAA Rules. For ease of reference, we
propose to move several definitions
currently found at § 160.302 to
§ 160.103 without substantive change to
the definitions themselves. This
category includes definitions of the
following terms: ‘‘ALJ,’’ ‘‘civil money
penalty,’’ and ‘‘violation or violate.’’ As
the removal of these definitions, along
with the removal of other definitions
discussed below (e.g., ‘‘administrative
simplification provision’’ and
‘‘respondent’’), would leave § 160.302
unpopulated, we propose to reserve that
section. We also propose to remove a
comma from the definition of
‘‘disclosure’’ inadvertently inserted into
the definition in a prior rulemaking,
which is not intended as a substantive
change to the definition. In addition, we
propose to replace the term
‘‘individually identifiable health
information’’ with ‘‘protected health
information’’ in the definition of
‘‘standard’’ to better reflect the scope of
the Privacy and Security Rules. Further,
we propose the following definitional
changes:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
1. Definition of ‘‘Administrative
Simplification Provision’’
This definition is currently located in
the definitions section of subpart C of
part 160 of the HIPAA Enforcement
Rule. We propose to remove the
definition of this term from § 160.302
and move it to the definitions section
located at § 160.103 for clarity and
convenience, as the term is used
repeatedly throughout the entire part
160. We also propose to add to the
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
definition a reference to sections 13400–
13424 of the HITECH Act.
2. Definition of ‘‘Business Associate’’
Sections 164.308(b) of the Security
Rule and 164.502(e) of the Privacy Rule
require a covered entity to enter into a
contract or other written agreement or
arrangement with its business
associates. The purpose of these
contracts or other arrangements,
generally known as business associate
agreements, is to provide some legal
protection when protected health
information is being handled by another
person (a natural person or legal entity)
on behalf of a covered entity. The
HIPAA Rules define ‘‘business
associate’’ generally to mean a person
who performs functions or activities on
behalf of, or certain services for, a
covered entity that involve the use or
disclosure of protected health
information. Examples of business
associates include third party
administrators or pharmacy benefit
managers for health plans, claims
processing or billing companies,
transcription companies, and persons
who perform legal, actuarial,
accounting, management, or
administrative services for covered
entities and who require access to
protected health information. We
propose a number of modifications to
the definition of ‘‘business associate.’’ In
particular, we propose to modify the
definition to conform the term to the
statutory provisions of PSQIA, 42 U.S.C.
299b–21, et seq., and the HITECH Act.
Additional modifications are made for
the purpose of clarifying circumstances
when a business associate relationship
exists and for general clarification of the
definition.
a. Inclusion of Patient Safety
Organizations
We propose to add patient safety
activities to the list of functions and
activities a person may undertake on
behalf of a covered entity that give rise
to a business associate relationship.
PSQIA, at 42 U.S.C. 299b–22(i)(1),
provides that Patient Safety
Organizations (PSOs) must be treated as
business associates when applying the
Privacy Rule. PSQIA provides for the
establishment of PSOs to receive reports
of patient safety events or concerns from
providers and provide analyses of
events to reporting providers. A
reporting provider may be a HIPAA
covered entity and, thus, information
reported to a PSO may include
protected health information that the
PSO may analyze on behalf of the
covered provider. The analysis of such
information is a patient safety activity
PO 00000
Frm 00006
Fmt 4701
Sfmt 4702
for purposes of PSQIA and the Patient
Safety Rule, 42 CFR 3.10, et seq. While
the HIPAA Rules as written would
encompass a PSO as a business
associate when the PSO was performing
quality analyses and other activities on
behalf of a covered health care provider,
we propose this change to the definition
of business associate to more clearly
align the HIPAA and Patient Safety
Rules.
We note that in some cases a covered
health care provider, such as a public or
private hospital, may have a component
PSO that performs patient safety
activities on behalf of the health care
provider. See 42 CFR 3.20. In such
cases, the component PSO would not be
a business associate of the covered
entity but rather the persons performing
patient safety activities would be
workforce members of the covered
entity. However, if the component PSO
contracts out some of its patient safety
activities to a third party, the third party
would be a business associate of the
covered entity. In addition, if a
component PSO of one covered entity
performs patient safety activities for
another covered entity, such component
PSO would be a business associate of
the other covered entity.
b. Inclusion of Health Information
Organizations (HIO), E–Prescribing
Gateways, and Other Persons That
Facilitate Data Transmission; as Well as
Vendors of Personal Health Records
Section 13408 of the HITECH Act,
which became effective on February 18,
2010, provides that an organization,
such as a Health Information Exchange
Organization, E-prescribing Gateway, or
Regional Health Information
Organization, that provides data
transmission of protected health
information to a covered entity (or its
business associate) and that requires
access on a routine basis to such
protected health information must be
treated as a business associate for
purposes of the Act and the HIPAA
Privacy and Security Rules. Section
13408 also provides that a vendor that
contracts with a covered entity to allow
the covered entity to offer a personal
health record to patients as part of the
covered entity’s electronic health record
shall be treated as a business associate.
Section 13408 requires that such
organizations and vendors enter into a
written business associate contract or
other arrangement with the covered
entity in accordance with the HIPAA
Rules.
In accordance with the Act, we
propose to modify the definition of
‘‘business associate’’ to explicitly
designate these persons as business
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
associates. Under proposed paragraphs
(3)(i) and (ii) of the definition, the term
‘‘business associate’’ would include: (1)
A Health Information Organization, Eprescribing Gateway, or other person
that provides data transmission services
with respect to protected health
information to a covered entity and that
requires routine access to such
protected health information; and (2) a
person who offers a personal health
record to one or more individuals on
behalf of a covered entity.
Section 13408 of the Act makes
reference to Health Information
Exchange Organizations; however, we
instead include in the proposed
definition the term ‘‘Health Information
Organization’’ because it is our
understanding that ‘‘Health Information
Organization’’ is the more widely
recognized and accepted term to
describe an organization that oversees
and governs the exchange of healthrelated information among
organizations.2 Section 13408 of the Act
also specifically refers to Regional
Health Information Organizations.
However, we do not believe the
inclusion of the term in the definition
of ‘‘business associate’’ is necessary as a
Regional Health Information
Organization is simply a Health
Information Organization that governs
health information exchange among
organizations within a defined
geographic area.3 Further, the specific
terms of ‘‘Health Information
Organization’’ and ‘‘E-prescribing
Gateway’’ are merely illustrative of the
types of organizations that would fall
within this paragraph of the definition
of ‘‘business associate.’’ We request
comment on the use of these terms
within the definition and whether
additional clarifications or additions are
necessary.
Section 13408 also provides that the
data transmission organizations that the
Act requires to be treated as business
associates are those that require access
to protected health information on a
routine basis. Conversely, data
transmission organizations that do not
require access to protected health
information on a routine basis would
not be treated as business associates.
This is consistent with our prior
interpretation of the definition of
‘‘business associate,’’ through which we
have indicated that entities that act as
2 Department of Health and Human Services,
Office of the National Coordinator for Health
Information Technology, The National Alliance for
Health Information Technology Report to the Office
of the National Coordinator For Health Information
Technology: Defining Key Health Information
Terms, Pg. 24 (2008).
3 Id. at 25.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
mere conduits for the transport of
protected health information but do not
access the information other than on a
random or infrequent basis are not
business associates. See https://
www.hhs.gov/ocr/privacy/hipaa/faq/
providers/business/245.html. In
contrast, however, entities that manage
the exchange of protected health
information through a network,
including providing patient locator
services and performing various
oversight and governance functions for
electronic health information exchange,
have more than ‘‘random’’ access to
protected health information and thus,
would fall within the definition of
‘‘business associate.’’
c. Inclusion of Subcontractors
We propose to add language in
paragraph (3)(iii) of the definition of
‘‘business associate’’ to provide that
subcontractors of a covered entity—i.e.,
those persons that perform functions for
or provide services to a business
associate, other than in the capacity as
a member of the business associate’s
workforce, are also business associates
to the extent that they require access to
protected health information. We also
propose to include a definition of
‘‘subcontractor’’ in § 160.103 to make
clear that a subcontractor is a person
who acts on behalf of a business
associate, other than in the capacity of
a member of the workforce of such
business associate. Even though we use
the term ‘‘subcontractor,’’ which implies
there is a contract in place between the
parties, we note that the definition
would apply to an agent or other person
who acts on behalf of the business
associate, even if the business associate
has failed to enter into a business
associate contract with the person. We
request comment on the use of the term
‘‘subcontractor’’ and its proposed
definition.
The proposed modifications are
similar in structure and effect to the
Privacy Rule’s initial extension of
privacy protections from covered
entities to business associates through
contract requirements to protect
downstream protected health
information. The proposed provisions
avoid having privacy and security
protections for protected health
information lapse merely because a
function is performed by an entity that
is a subcontractor rather than an entity
with a direct relationship with a
covered entity. Allowing such a lapse in
privacy and security protections may
allow business associates to avoid
liability imposed upon them by sections
13401 and 13404 of the Act, thus
circumventing the congressional intent
PO 00000
Frm 00007
Fmt 4701
Sfmt 4702
40873
underlying these provisions. The
proposed definition of ‘‘subcontractor’’
also is consistent with Congress’ overall
concern that the privacy and security
protections of the HIPAA Rules extend
beyond covered entities to those entities
that create or receive protected health
information in order for the covered
entity to perform its health care
functions. For example, as discussed
above, section 13408 makes explicit that
certain types of entities providing
services to covered entities—e.g.,
vendors of personal health records—
shall be considered business associates.
Therefore, consistent with Congress’
intent in sections 13401 and 13404 of
the Act, as well as its overall concern
that the HIPAA Rules extent beyond
covered entities to those entities that
create or receive protected health
information, we propose that
downstream entities that work at the
direction of or on behalf of a business
associate and handle protected health
information would also be required to
comply with the applicable Privacy and
Security Rule provisions in the same
manner as the primary business
associate, and likewise would incur
liability for acts of noncompliance. We
note, and further explain below, that
this proposed modification would not
require the covered entity to have a
contract with the subcontractor; rather,
the obligation would remain on each
business associate to obtain satisfactory
assurances in the form of a written
contract or other arrangement that a
subcontractor will appropriately
safeguard protected health information.
For example, under this proposal, if a
business associate, such as a third party
administrator, hires a company to
handle document and media shredding
to securely dispose of paper and
electronic protected health information,
then the shredding company would be
directly required to comply with the
applicable requirements of the HIPAA
Security Rule (e.g., with respect to
proper disposal of electronic media) and
the Privacy Rule (e.g., with respect to
limiting its uses and disclosures of the
protected health information in
accordance with its contract with the
business associate).
d. Exceptions to Business Associate
We also propose to move the
provisions at §§ 164.308(b)(2) and
164.502(e)(1)(ii) to the definition of
business associate. These provisions
provide that in certain circumstances,
such as when a covered entity discloses
protected health information to a health
care provider concerning the treatment
of an individual, a covered entity is not
required to enter into a business
E:\FR\FM\14JYP2.SGM
14JYP2
40874
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
associate contract or other arrangement
with the recipient of the protected
health information. While we do not
change the meaning of these provisions,
we believe these limitations on the
scope of ‘‘business associate’’ are more
appropriately placed in the definition as
exceptions to the term to make clear that
the Department does not consider the
recipients of the protected health
information in these circumstances to be
business associates. The movement of
these exceptions and refinement of the
definition of ‘‘business associate’’ also
would help clarify that a person is a
business associate if it meets the
definition of ‘‘business associate,’’ even
if a covered entity, or business associate
with respect to a subcontractor, fails to
enter into the required contract with the
business associate.
e. Technical Changes to the Definition
For clarity and consistency, we also
propose to change the term
‘‘individually identifiable health
information’’ in the current definition of
‘‘business associate’’ to ‘‘protected health
information,’’ since a business associate
has no obligations under the HIPAA
Rules with respect to individually
identifiable health information that is
not protected health information.
3. Definition of ‘‘Compliance Date’’
The term ‘‘compliance date’’ currently
refers only to covered entities. We
propose a technical change to include
business associates in the term, in light
of the HITECH Act amendments, which
apply certain provisions of the HIPAA
Rules to business associates.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
4. Definition of ‘‘Electronic Media’’
The term ‘‘electronic media’’ was
originally defined in the Transactions
and Code Sets Rule issued on August
17, 2000 (65 FR 50312) and was
included in the definitions at § 162.103.
That definition was subsequently
revised and moved to § 160.103. The
purpose of the revision was to clarify
that—
the physical movement of electronic media
from place to place is not limited to magnetic
tape, disk, or compact disk. This clarification
removes a restriction as to what is considered
to be physical electronic media, thereby
allowing for future technological innovation.
We further clarified that transmission of
information not in electronic form before the
transmission, for example, paper or voice, is
not covered by this definition.
68 FR 8339, Feb. 20, 2003.
We propose to revise the definition of
‘‘electronic media’’ in the following
ways. First, we would revise paragraph
(1) of the definition to conform it to
current usage, as set forth in ‘‘Guidelines
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
for Media Sanitization’’ (Definition of
Medium, NIST SP 800–88, Glossary B,
p. 27 (2006)). The NIST definition,
which was updated subsequent to the
issuance of the Privacy and Security
Rules, was developed in recognition of
the likelihood that the evolution of
development of new technology would
make use of the term ‘‘electronic storage
media’’ obsolete in that there may be
‘‘storage material’’ other than ‘‘media’’
that house electronic data. Second, we
would add to paragraph (2) of the
definition of ‘‘electronic media’’ a
reference to intranets, to clarify that
intranets come within the definition.
Third, we propose to change the word
‘‘because’’ to ‘‘if’’ in the final sentence of
paragraph (2) of the definition of
‘‘electronic media.’’ The definition
assumed that no transmissions made by
voice via telephone existed in electronic
form before transmission; the evolution
of technology has made this assumption
obsolete. This modification would
extend the policy described in the
preamble discussion quoted above, but
correct its application to current
technology, where some voice
technology is digitally produced from
an information system and transmitted
by phone.
and the Northern Mariana Islands.’’ This
definition varies from paragraph (2) of
the HIPAA definition of ‘‘State’’ at
§ 160.103, which does not include
reference to American Samoa and the
Northern Mariana Islands. Thus, for
consistency with the definition applied
to the HIPAA Rules by the HITECH Act,
we propose to add reference to
American Samoa and the
Commonwealth of the Northern Mariana
Islands in paragraph (2) of the definition
of ‘‘State’’ at § 160.103.
5. Definition of ‘‘Protected Health
Information’’
We propose to modify the definition
of ‘‘protected health information’’ at
§ 160.103 to provide that the Privacy
and Security Rules do not protect the
individually identifiable health
information of persons who have been
deceased for more than 50 years. This
proposed modification is explained
more fully below in Section VI.E. of the
preamble where we discuss the
proposed changes to the Privacy Rule
related to the protected health
information of decedents.
D. Subpart B—Preemption of State Law,
Section 160.201—Statutory Basis
We propose to modify § 160.201
regarding the statutory basis for the
preemption of State law provisions to
add a reference to section 264(c) of
HIPAA, which contains the statutory
basis for the exception to preemption at
§ 160.203(b) for State laws that are more
stringent than the HIPAA Privacy Rule.
We also propose to add a reference to
section 13421(a) of the HITECH Act,
which applies HIPAA’s preemption
rules to the HITECH Act’s privacy and
security provisions. Finally, we propose
to re-title the provision to read
‘‘Statutory basis’’ instead of
‘‘Applicability.’’
We also take this opportunity to make
clear that section 264(c)(2) of HIPAA
and § 160.203(b) do not create a Federal
evidentiary privilege. Additionally, we
take this opportunity to make clear that
neither the HIPAA statute nor its
implementing regulations give effect to
State physician-patient privilege laws or
provisions of State law relating to the
privacy of individually identifiable
health information for use in Federal
court proceedings. Therefore, consistent
with the Supremacy Clause, any State
law that was preempted prior to HIPAA
because of conflicts with a Federal law
would continue to be preempted.
Nothing in HIPAA or its implementing
regulations is intended to expand the
6. Definition of ‘‘Respondent’’
The definition of the term
‘‘Respondent,’’ which is currently in
§ 160.302, would be moved to § 160.103.
A reference to ‘‘business associate’’
would be added following the reference
to ‘‘covered entity’’ in recognition of the
potential liability imposed on business
associates for violations of certain
provisions of the Privacy and Security
Rules by sections 13401 and 13404 of
the Act.
7. Definition of ‘‘State’’
The HITECH Act at section 13400,
which became effective February 18,
2010, includes a definition of ‘‘State’’ to
mean ‘‘each of the several States, the
District of Columbia, Puerto Rico, the
Virgin Islands, Guam, American Samoa,
PO 00000
Frm 00008
Fmt 4701
Sfmt 4702
8. Definition of ‘‘Workforce’’
The HITECH Act is directly
applicable to business associates and
has extended liability for compliance
with certain provisions of the Privacy
and Security Rules to business
associates. Because some provisions of
the Act and the Privacy and Security
Rules place obligations on the business
associate with respect to workforce
members, we propose to revise the
definition of ‘‘workforce member’’ in
§ 160.103 to make clear that such term
includes the employees, volunteers,
trainees, and other persons whose
conduct, in the performance of work for
a business associate, is under the direct
control of the business associate.
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
scope of State laws, regardless of
whether they are more or less stringent
than Federal law.
E. Subpart B—Preemption of State Law,
Section 160.202—Definitions.
1. Definition of ‘‘Contrary’’
The term ‘‘contrary’’ is currently
defined in § 160.202 to make clear when
the preemption provisions of HIPAA
apply to State law. Consistent with the
limited application of the HIPAA
provisions to covered entities only, the
current definition of the term ‘‘contrary’’
does not include reference to business
associates. However, section 13421(a) of
the HITECH Act provides that the
HIPAA preemption provision (section
1178 of the Social Security Act) applies
to the provisions and requirements
under the HITECH Act ‘‘in the same
manner’’ as it would apply under the
HIPAA provisions. Thus, the
preemption provisions would apply to
business associates, who are now, by
virtue of the HITECH Act, required to
comply with certain provisions of the
HIPAA Rules and are subject to
penalties for noncompliance, as
discussed elsewhere. Thus, we propose
to amend the definition of ‘‘contrary’’ by
inserting references to business
associates in paragraph (1) of the
definition. We also expand the reference
to the HITECH statutory provisions in
paragraph (2) of the definition to
encompass all of the sections of subtitle
D of the HITECH Act, rather than merely
to section 13402, which was added by
the breach notifications regulations.
These changes would give effect to
section 13421(a).
2. Definition of ‘‘More Stringent’’
srobinson on DSKHWCL6B1PROD with PROPOSALS2
The term ‘‘more stringent’’ is part of
the statutory preemption language
under HIPAA. HIPAA preempts State
law that is contrary to a HIPAA privacy
standard unless, among other
exceptions, the State law is more
stringent than the contrary HIPAA
privacy standard. The current regulatory
definition of ‘‘more stringent’’ does not
include business associates. We propose
to amend the definition to add a
reference to business associates, for the
reasons set out in the preceding
discussion.
IV. Section-by-Section Description of
the Proposed Amendments to the
Enforcement Rule—Subparts C and D of
Part 160
Section 13410 of the HITECH Act
made several amendments that directly
impact the Enforcement Rule, which
applies to the Secretary’s enforcement of
all of the HIPAA Administrative
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Simplification Rules, as well as the
recently promulgated Breach
Notification Rule. We issued an interim
final rule on October 30, 2009, 74 FR
56123, to address the HITECH Act
amendments impacting the Enforcement
Rule that became effective on February
18, 2009. For context, we describe those
modifications to the Enforcement Rule
briefly below. We then provide a
section-by-section description of the
other section 13410 amendments that
are part of this proposed rule.
In addition, sections 13401 and 13404
of the HITECH Act impose direct civil
money penalty liability on business
associates for violations of the HITECH
Act and certain Privacy and Security
Rule provisions. In doing so, sections
13401(b) and 13404(c) of the Act
provide that section 1176 of the Social
Security Act shall apply to a violation
by a business associate ‘‘in the same
manner’’ as it would apply to a covered
entity with respect to such a violation.
Both provisions are, by virtue of section
13423, effective February 18, 2010.
The provisions of subparts C and D of
part 160 currently apply by their terms
solely to covered entities. Accordingly,
to implement sections 13401(b) and
13404(c) of the Act, we propose to
revise a number of provisions in both
subparts to reflect this statutory change
by adding the term ‘‘business associate’’
where appropriate, following a reference
to ‘‘covered entity.’’ For ease, we list the
sections in which the term ‘‘business
associate’’ is added here rather than
repeat the change in each discussion of
the sections below: §§ 160.300; 160.304;
160.306(a) and (c); 160.308; 160.310;
160.312; 160.316; 160.401; 160.402;
160.404(b); 160.406; 160.408(c) and (d);
and 160.410(a) and (c).
In addition to these references, we
propose to add a paragraph in
§ 160.402(c)(2) to describe a business
associate’s liability for the actions of its
agents, in accordance with the Federal
common law of agency. This proposed
modification is discussed more fully
below in the discussion of § 160.402(c).
As noted above, the Department
issued an interim final rule (IFR) on
October 30, 2009, revising the
Enforcement Rule to incorporate the
provisions required by section 13410(d)
of the HITECH Act that immediately
took effect: Four categories of violations
that reflect increasing levels of
culpability, the corresponding tiers of
civil money penalty amounts, and the
revised limitations placed on the
Secretary’s authority to impose
penalties. More specifically, the IFR
revised subpart D of the Enforcement
Rule to transfer the definitions of
‘‘reasonable cause,’’ ‘‘reasonable
PO 00000
Frm 00009
Fmt 4701
Sfmt 4702
40875
diligence,’’ and ‘‘willful neglect’’ from
§ 160.410(a) to a new definitions section
at § 160.401. The IFR revised § 160.404
to incorporate, for violations occurring
on or after February 18, 2009, the new
penalty scheme required by section
13410(d), as follows: For violations in
which it is established that the covered
entity did not know and, by exercising
reasonable diligence, would not have
known that the covered entity violated
a provision, an amount not less than
$100 or more than $50,000 for each
violation; for a violation in which it is
established that the violation was due to
reasonable cause and not to willful
neglect, an amount not less than $1000
or more than $50,000 for each violation;
for a violation in which it is established
that the violation was due to willful
neglect and was timely corrected, an
amount not less than $10,000 or more
than $50,000 for each violation; and for
a violation in which it is established
that the violation was due to willful
neglect and was not timely corrected, an
amount not less than $50,000 for each
violation; except that a penalty for
violations of the same requirement or
prohibition under any of these
categories may not exceed $1,500,000 in
a calendar year. It also revised the
affirmative defenses in § 160.410 for
violations occurring on or after February
18, 2009, to remove a covered entity’s
lack of knowledge as an affirmative
defense and to provide an affirmative
defense when violations not due to
willful neglect are corrected within 30
days. Finally, the IFR added a
requirement that a notice of proposed
determination pursuant to § 160.420
also reference the applicable category of
violation. Readers are encouraged to
refer to the IFR for a more detailed
discussion of these topics as well as the
Enforcement Rule’s statutory and
regulatory background. See 74 FR
56123, 56124, Oct. 30, 2009.
The rules proposed below would
revise many provisions of subparts C
and D of part 160. However, the
Department’s current interpretations of
the regulatory provisions at subparts C
and D continue unchanged, except to
the extent they are inconsistent with the
changes to those provisions, as
indicated below.
A. Subpart C—Compliance and
Investigations, Section 160.304—
Principles for Achieving Compliance
Section 160.304 identifies cooperation
and assistance as two overarching
principles for achieving compliance.
The principle of cooperation, in
§ 160.304(a), states that ‘‘[t]he Secretary
will, to the extent practicable, seek the
cooperation of covered entities in
E:\FR\FM\14JYP2.SGM
14JYP2
40876
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
obtaining compliance with the
applicable administrative simplification
provisions.’’
Section 13410(a) of the HITECH Act
adds a new subsection (c) to section
1176 of the Social Security Act:
(c) NONCOMPLIANCE DUE TO WILLFUL
NEGLECT.—
(1) IN GENERAL.—A violation of a
provision of this part due to willful neglect
is a violation for which the Secretary is
required to impose a penalty under
subsection (a)(1).
(2) REQUIRED INVESTIGATION.—For
purposes of paragraph (1), the Secretary shall
formally investigate any complaint of a
violation of a provision of this part if a
preliminary investigation of the facts of the
complaint indicate such a possible violation
due to willful neglect.
Section 13410(b)(1) makes the
provisions of section 13410(a) effective
February 18, 2011.
Under section 1176(c), HHS is
required to impose a civil money
penalty for violations due to willful
neglect. Accordingly, although the
Secretary often will still seek to correct
indications of noncompliance through
voluntary corrective action, there may
be circumstances (such as
circumstances indicating willful
neglect), where the Secretary may seek
to proceed directly to formal
enforcement. As a conforming
amendment, HHS proposes to add the
phrase, ‘‘and consistent with the
provisions of this subpart,’’ to
§ 160.304(a) to recognize the statutory
revision.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
B. Subpart C—Compliance and
Investigations, Section 160.306(c)—
Complaints to the Secretary
Section 160.306(c) of the Enforcement
Rule currently provides the Secretary
with discretion to investigate HIPAA
complaints, through use of the word
‘‘may.’’ The new willful neglect
provisions, at section 1176(c)(2) of the
Social Security Act, will require HHS to
investigate ‘‘any complaint of a violation
of a provision of this part if a
preliminary investigation of the facts of
the complaint indicates * * * a
possible violation due to willful
neglect.’’
HHS proposes to implement section
1176(c)(2) by adding a new paragraph
(1) at § 160.306(c) to provide that the
Secretary will investigate any complaint
filed under this section when a
preliminary review of the facts indicates
a possible violation due to willful
neglect. As a practical matter, HHS
currently conducts a preliminary review
of every complaint received and
proceeds with the investigation in every
eligible case where its preliminary
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
review of the facts indicate a possible
violation of the HIPAA Rules.
Nevertheless, we propose this addition
to § 160.306 to make clear our intention
to pursue an investigation where a
preliminary review of the facts indicates
a possible violation due to willful
neglect.
HHS proposes to conform the
remainder of § 160.306(c) accordingly.
The new § 160.306(c)(2) (presently, the
initial sentence of § 160.306(c)) would
be revised by replacing ‘‘complaints’’
with ‘‘any other complaint’’ to
distinguish the Secretary’s discretion
with respect to complaints for which
HHS’s preliminary review of the facts
does not indicate a possible violation
due to willful neglect from the statutory
requirement to investigate all
complaints for which HHS’s
preliminary review of the facts indicates
a possible violation due to willful
neglect, as set out in the new
§ 160.306(c)(1). The current second
sentence of § 160.306(c), which
addresses the content of an
investigation, would be renumbered as
§ 160.306(c)(3) and amended by
changing the first word of the sentence
from ‘‘such’’ to ‘‘an,’’ to signal the
provision’s application to any
investigation, regardless of whether a
preliminary review of the facts indicates
a possible violation due to willful
neglect.
C. Subpart C—Compliance and
Investigations, Section 160.308—
Compliance Reviews
Section 160.308 provides that the
Secretary may conduct compliance
reviews. Use of the word ‘‘may’’ in this
section makes clear that this is a
discretionary activity. While complaints
and not compliance reviews are
specifically mentioned in the statutory
language of section 13410(a)(1)(B) of the
Act regarding willful neglect, HHS
proposes to also amend § 160.308 to
provide that the Secretary will conduct
a compliance review to determine
whether a covered entity or business
associate is complying with the
applicable administrative simplification
provision when a preliminary review of
the facts indicates a possible violation
due to willful neglect. This revision to
§ 160.308 furthers Congress’ intent to
strengthen enforcement with respect to
potential violations due to willful
neglect and ensures that investigations,
whether or not initiated by complaint,
are handled in a consistent manner.
Also, the current language of § 160.308
would be redesignated as paragraph (b),
and the words ‘‘in any other
circumstance’’ would be added to the
end of this paragraph to indicate that
PO 00000
Frm 00010
Fmt 4701
Sfmt 4702
the discretionary authority of this
paragraph applies to cases where the
preliminary review of the facts does not
indicate a possible violation due to
willful neglect. Note that if HHS
initiates an investigation of a complaint
because its preliminary review of the
facts indicates a possible violation due
to willful neglect, HHS would not also
be required to initiate a compliance
review under this section, since it
would be duplicative to do so.
D. Subpart C—Compliance and
Investigations, Section 160.310—
Responsibilities of Covered Entities
Section 160.310 explains a covered
entity’s responsibilities during
complaint investigations and
compliance reviews to make
information available to the Secretary
and to cooperate with the Secretary.
Section 160.310(c)(3) provides that any
protected health information obtained
by the Secretary in connection with an
investigation or compliance review will
not be disclosed by the Secretary, except
as necessary for determining and
enforcing compliance with the HIPAA
Rules or if otherwise required by law.
We propose to also allow the Secretary
to disclose protected health information
if permitted under the Privacy Act at 5
U.S.C. 552a(b)(7). Section 552a(b)(7)
permits the disclosure of a record on an
individual contained within a Privacy
Act protected system of records to
another agency or instrumentality of any
governmental jurisdiction within or
under the control of the United States
for a civil or criminal law enforcement
activity if the activity is authorized by
law and if the agency has made a
written request to the agency that
maintains the record. This proposed
change is necessary to permit the
Secretary to cooperate with other law
enforcement agencies, such as the State
Attorneys General pursuing HIPAA
actions on behalf of State residents
pursuant to section 13410(e) of the Act,
or the Federal Trade Commission,
pursuing remedies under other
consumer protection authorities.
E. Subpart C—Compliance and
Investigations, Section 160.312—
Secretarial Action Regarding
Complaints and Compliance Reviews
Where noncompliance is indicated,
§ 160.312 requires the Secretary to
attempt to resolve situations by informal
means. Section 1176(c)(2) of the Social
Security Act, as added by section
13410(a) of the HITECH Act, will
require formal investigation of a
complaint ‘‘if a preliminary
investigation of the facts of the
complaint indicate * * * a possible
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
violation due to willful neglect.’’
Further, section 1176(c)(1) of the Social
Security Act, as added by section
13410(a) of the HITECH Act, will
require the Secretary to impose a civil
money penalty where HHS makes a
finding of a violation involving willful
neglect. In addition to the proposed
modification to § 160.306(c)(1), in light
of the new provisions at section 1176(c),
we propose to make clear that HHS is
not required to attempt to resolve cases
of noncompliance due to willful neglect
by informal means. To do so, we
propose to replace the word ‘‘will’’ in
§ 160.312(a)(1) with ‘‘may.’’ While this
change would permit HHS to proceed
with a willful neglect determination as
appropriate, it would also permit HHS
to seek to resolve complaints and
compliance reviews that did not
indicate willful neglect by informal
means (e.g., where the covered entity or
business associate did not know and by
exercising reasonable diligence would
not have known of a violation, or where
the violation is due to reasonable cause).
It should be noted that this
amendment would not change the
substance of the response set forth in
the April 18, 2005, preamble to the
proposed Enforcement Rule, at 70 FR
20224, 20245–6, regarding objections to
the 60-day time limit for filing a request
for a hearing. In that response, HHS
indicated that it was not reasonable to
assume that a notice of proposed
determination would be served on a
respondent with no warning because the
covered entity would necessarily be
made aware of, and have the
opportunity to address, HHS’s
compliance concerns throughout the
investigative period preceding the
notice of proposed determination. This
proposed change to § 160.312 would
allow the Secretary to proceed directly
to a notice of proposed determination
without first attempting to resolve the
matter informally. This proposed
revision does not change the fact that
during the course of a complaint
investigation or a compliance review, a
covered entity or business associate
would be made aware of, and have the
opportunity to address, HHS’s
compliance concerns.
F. Subpart D—Imposition of Civil
Money Penalties, Section 160.401—
Definitions
Section 160.401 provides definitions
of the terms ‘‘reasonable cause,’’
‘‘reasonable diligence,’’ and ‘‘willful
neglect.’’ As discussed in the interim
final rule, at 74 FR 56123, 56126–7,
given section 13410(d) of the Act’s use
of these terms to describe the increasing
levels of culpability for which
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
increasing minimum levels of penalties
may be imposed, HHS transferred these
definitions from their prior placement at
§ 160.410(a) to signal the definitions’
broader application to the entirety of
subpart D of part 160. However, because
section 13410(d) of the Act referred to
these terms but did not amend these
definitions, the interim final rule did
not alter their content. HHS encourages
readers, as it did in the interim final
rule, to refer to prior preambles to the
Enforcement Rule for detailed
discussions of these terms at 70 FR
20224, 20237–9 and 71 FR 8390, 8409–
11.
While the provisions of section 13410
of the Act do not explicitly require
modification of these definitions, HHS
is concerned that the mens rea
demarcation between the categories of
culpability associated with the new tiers
of civil money penalty amounts is not
sufficiently clear based on the existing
definitions. As a result, certain
violations (i.e., those of which a covered
entity or business associate has or
should have knowledge, but does not
have the conscious intent or reckless
indifference associated with willful
neglect) might not fit squarely within
one of the established tiers. Therefore,
HHS proposes to amend the definition
of reasonable cause to clarify the scope
of violations fitting within that
definition.
HHS does not propose to otherwise
modify the definitions associated with
the categories of culpability of the
amended section 1176(a) of the Social
Security Act. However, we wish to
clarify how the Secretary intends to
apply these terms within this newly
established context, to assist covered
entities and business associates in
tailoring their compliance activities
appropriately. Accordingly, the
discussion below also addresses the
terms associated with the other
categories of culpability (i.e.,
knowledge, reasonable diligence, and
willful neglect).
1. Reasonable Cause
Reasonable cause is currently defined,
at § 160.401, to mean ‘‘circumstances
that would make it unreasonable for the
covered entity, despite the exercise of
ordinary business care and prudence, to
comply with the administrative
simplification provision violated.’’ This
definition is consistent with the
Supreme Court’s ruling in United States
v. Boyle, 469 U.S. 241, 245 (1985),
which focused on whether
circumstances were beyond the
regulated person’s control, thereby
making compliance unreasonable. See
70 FR 20224, 20238. Prior to the
PO 00000
Frm 00011
Fmt 4701
Sfmt 4702
40877
HITECH Act, section 1176 of the Social
Security Act treated reasonable cause as
a partial limitation on the Secretary’s
authority to impose a civil money
penalty. That is, by establishing that a
violation was due to reasonable cause
and not willful neglect and was either
corrected within a 30-day period or
such additional period as the Secretary
determined to be appropriate, a covered
entity or business associate would bar
the Secretary’s imposition of a civil
money penalty.
As described above, section 13410(d)
of the HITECH Act revised section 1176
of the Social Security Act to establish
four tiers of increasing penalty amounts
to correspond to the levels of culpability
associated with the violation. The first
category of violation (and lowest
penalty tier) covers situations where the
covered entity or business associate did
not know, and by exercising reasonable
diligence would not have known, of a
violation. The second category of
violation (and next highest penalty tier)
applies to violations due to reasonable
cause and not to willful neglect. The
third and fourth categories (and secondhighest and highest penalty tiers) apply
to circumstances where the violation
was due to willful neglect that is
corrected within a certain time period
and willful neglect that is not so
corrected, respectively. The importance
of mens rea, or state of mind, in
determining the degree of culpability is
clear with respect to the first, third, and
fourth categories, in that there is no
mens rea with respect to the lowest
category of violation, while the
existence of mens rea is presumed with
respect to the third and fourth categories
of violation.
However, the current definition of
reasonable cause does not address mens
rea with respect to the second category
of violations. HHS therefore proposes to
amend the definition of ‘‘reasonable
cause’’ in § 160.401 to clarify the full
scope of violations that will come
within the reasonable cause category of
violations, including those
circumstances that would make it
unreasonable for the covered entity or
business associate, despite the exercise
of ordinary business care and prudence,
to comply with the administrative
simplification provisions violated, as
well as those circumstances in which a
covered entity or business associate has
knowledge of a violation but lacks the
conscious intent or reckless indifference
associated with the willful neglect
category of violations. To that end, HHS
proposes to replace the current
definition of ‘‘reasonable cause’’ with the
following:
E:\FR\FM\14JYP2.SGM
14JYP2
40878
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
an act or omission in which a covered
entity or business associate knew, or by
exercising reasonable diligence would have
known, that the act or omission violated an
administrative simplification provision, but
in which the covered entity or business
associate did not act with willful neglect.
As modified, the definition of
‘‘reasonable cause’’ will continue to
recognize those circumstances that
would make it unreasonable for the
covered entity or business associate,
despite the exercise of ordinary business
care and prudence, to comply with the
administrative simplification provisions
violated. Consider the following
example:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
A covered entity received an individual’s
request for access but did not respond within
the time periods provided for in
§ 164.524(b)(2). HHS’s investigation reveals
that the covered entity had compliant access
policies and procedures in place, but that it
had received an unusually high volume of
requests for access within the time period in
question. While the covered entity had
responded to the majority of access requests
received in that time period in a timely
manner, it had failed to respond in a timely
manner to several requests for access. The
covered entity did respond in a timely
manner to all requests for access it received
subsequent to the time period in which the
violations occurred.
In this example, the covered entity
had knowledge of the violations but the
investigation revealed circumstances
that would make it unreasonable for the
covered entity, despite the exercise of
ordinary business care and prudence, to
comply with the administrative
simplification provisions violated. The
investigation also revealed that the
covered entity acted in a way that
demonstrated a good faith attempt to
comply with § 164.524(b)(2) by having
compliant policies and procedures in
place, responding to the majority of
access requests in a timely manner, and
otherwise responding to subsequent
requests as required. In contrast, had the
investigation revealed that the series of
access requests occurred over a longer
period of time, and that the covered
entity did not attempt to address the
backlog or communicate with the
individuals, in writing, regarding the
reasons for the delay or the date by
which the covered entity would
complete its action on the requests, the
notice of proposed determination might
alternatively categorize the violation as
being due to willful neglect.
The modified definition of reasonable
cause will also encompass those
circumstances in which a covered entity
or business associate has knowledge of
the violation but lacks the conscious
intent or reckless indifference
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
associated with willful neglect.
Consider the following example:
A covered entity presented an
authorization form to a patient for signature
to permit a disclosure for marketing purposes
that did not contain the core elements
required by § 164.508(c). HHS’s investigation
reveals that the covered entity was aware of
the requirement for an authorization for a use
or disclosure of protected health information
for marketing and had attempted to draft a
compliant authorization but had not
included in the authorization the core
elements required under § 164.508.
In this example, the covered entity
failed to act with the ordinary care and
business prudence of one seeking to
comply with the Privacy Rule.
Therefore, the violation cannot be
considered to come within the category
of violation that is associated with
violations where the covered entity did
not know (and by exercising reasonable
diligence would not have known) of the
violation. Yet, because the covered
entity had attempted to draft a
compliant authorization, it cannot be
established that the omission was due to
willful neglect involving either a
conscious, intentional failure or reckless
indifference to the obligation to comply
with § 164.508. Unless otherwise
resolved by informal means, HHS would
have grounds to find that the violation
was due to reasonable cause.
2. Knowledge and Reasonable Diligence
Prior rulemaking preambles
discussing the Enforcement Rule
explain the concept of knowledge, as it
applies to the limitations (i.e.,
affirmative defenses) that section
1176(b) of the Social Security Act places
on the Secretary’s authority to impose a
civil money penalty. As they explain,
‘‘the knowledge involved must be
knowledge that [a] violation has
occurred, not just knowledge of the facts
constituting the violation.’’ See 71 FR
8390, 8410, Feb. 16, 2006. Moreover, a
covered entity or business associate
cannot assert an affirmative defense
associated with its ‘‘lack of knowledge’’
if such lack of knowledge has resulted
from its failure to inform itself about
compliance obligations or to investigate
received complaints or other
information indicating likely
noncompliance. See 70 FR 20224,
20237–8, Apr. 18, 2005 and 71 FR 8390,
8410–11, Feb. 16, 2006.
Section 13410(d) of the Act
establishes the category of violations
where the covered entity or business
associate did not know (and by
exercising reasonable diligence would
not have known) of a violation as
warranting the lowest range of civil
money penalty amounts. The HITECH
PO 00000
Frm 00012
Fmt 4701
Sfmt 4702
Act incorporated the concepts of
knowledge and reasonable diligence
from HIPAA, and it did not revise their
substance. HHS therefore expects to
apply these existing concepts to the
newly established penalty structure
consistent with its prior interpretations.
Consider the following examples:
1. A covered health care provider with a
direct treatment relationship with an
individual patient failed to provide the
patient a complete notice of privacy practices
in compliance with § 164.520(c). HHS’s
investigation reveals that the covered entity
has a compliant notice of privacy practices,
policies and procedures for provision of the
notice, and appropriate training of its
workforce regarding the notice and its
distribution. The violation resulted from a
printing error that failed to print two pages
of the notice of privacy practices. The
printing error affected a small number of the
covered entity’s supply of notices and was an
isolated failure to provide an individual with
the covered entity’s notice of privacy
practices.
2. A business associate failed to terminate
a former employee’s access privileges to
electronic protected health information in
compliance with § 164.308(a)(3)(ii)(C). HHS’s
investigation reveals that the business
associate’s policies and procedures require
the termination of such access within a
reasonable time period. The HHS
investigation reveals that the business
associate attempted to terminate the former
employee’s access in accordance with its
policy, but that it instead terminated the
access of a current employee who had the
same name as the former employee.
In both examples, HHS’s investigations
reveal that the covered entity or
business associate has compliant
policies and procedures in place, as
well as some action by each covered
entity or business associate indicating
its intent to implement the respective
Privacy Rule requirements. The
investigations also reveal
noncompliance that the exercise of
reasonable diligence would not have
avoided.
HHS also notes that, in some
circumstances, we expect that the
knowledge of an employee or agent of
a covered entity or business associate
may determine whether a violation
implicates the ‘‘did not know’’ or
‘‘reasonable cause’’ categories of
violation. That is, absent an exception
under the Federal common law of
agency, the knowledge of an employee
or agent will generally be imputed to its
principal (i.e., the covered entity or
business associate). See 70 FR 20224,
20237 and 71 FR 8390, 8402–3
(discussing imputation of knowledge
under the Federal common law of
agency and violations attributed to a
covered entity, respectively). Consider
the following example:
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
A hospital employee accessed the paper
medical record of his ex-spouse while he was
on duty to discover her current address for
a personal reason, knowing that such access
is not permitted by the Privacy Rule and
contrary to the policies and procedures of the
hospital. HHS’s investigation reveals that the
covered entity had appropriate and
reasonable safeguards regarding employee
access to medical records, and that it had
delivered appropriate training to the
employee.
In this example, the ‘‘did not know’’
category of violation is implicated with
respect to the covered entity because the
mens rea element of knowledge cannot
be established. That is, while the
employee’s act is attributed to the
covered entity, the employee’s
knowledge of the violation cannot be
imputed to the covered entity because
the employee was acting adversely to
the covered entity. The Federal common
law of agency does not permit the
imputation of knowledge to the
principal where the agent consciously
acts in a manner that is adverse to the
principal.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
3. Willful Neglect
Willful neglect is defined, at
§ 160.401, to mean the ‘‘conscious,
intentional failure or reckless
indifference to the obligation to comply
with the administrative simplification
provision violated.’’ The term not only
presumes actual or constructive
knowledge on the part of the covered
entity that a violation is virtually certain
to occur but also encompasses a
conscious intent or degree of
recklessness with regard to its
compliance obligations.
While the HITECH Act references
willful neglect in several provisions, it
does not revise the term’s definition.
HHS therefore expects to apply the
current definition of willful neglect to
all newly established contexts in the
same manner as previously discussed.
Consider the following examples:
1. A covered entity disposed of several
hard drives containing electronic protected
health information in an unsecured
dumpster, in violation of § 164.530(c) and
§ 164.310(d)(2)(i). HHS’s investigation reveals
that the covered entity had failed to
implement any policies and procedures to
reasonably and appropriately safeguard
protected health information during the
disposal process.
2. A covered entity failed to respond to an
individual’s request that it restrict its uses
and disclosures of protected health
information about the individual. HHS’s
investigation reveals that the covered entity
does not have any policies and procedures in
place for consideration of the restriction
requests it receives and refuses to accept any
requests for restrictions from individual
patients who inquire.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
3. A covered entity’s employee lost an
unencrypted laptop that contained unsecured
protected health information. HHS’s
investigation reveals the covered entity
feared its reputation would be harmed if
information about the incident became
public and, therefore, decided not to provide
notification as required by § 164.400 et seq.
The facts in these examples demonstrate
that the covered entities had actual or
constructive knowledge of their various
violations. In addition, the covered
entities’ failures to develop or
implement compliant policies and
procedures or to respond to incidents as
required by § 164.400 et seq.
demonstrate either conscious intent or
reckless disregard with respect to their
compliance obligations. In the second
example, the covered entity’s refusal to
accept any requests for restrictions from
individual patients who inquire would
be grounds for a separate finding of a
violation due to willful neglect.
4. Correction of Willful Neglect
Violations
We also note that while a covered
entity’s or business associate’s
correction of a willful neglect violation
will not bar the imposition of a civil
money penalty, such correction may
foreclose the Secretary’s authority to
impose a penalty from the highest
penalty tier prescribed by section
1176(a)(1) of the Social Security Act.
While not all violations can be
corrected, in the sense of being fully
undone or remediated, HHS has
previously set forth a broad
interpretation of ‘‘corrected,’’ in light of
the statute’s association of the term with
‘‘failure to comply.’’ See 71 FR 8390,
8411 (recognizing that the term
‘‘corrected’’ could include correction of
a covered entity’s noncompliant
procedure by making the procedure
compliant). For example, in the event a
covered entity’s or business associate’s
inadequate safeguards policies and
procedures result in an impermissible
disclosure, the disclosure violation itself
could not be fully undone or corrected.
The safeguards violation, however,
could be ‘‘corrected’’ in the sense that
the noncompliant policies and
procedures could be brought into
compliance. In any event, corrective
action will always be required of a
covered entity or business associate.
G. Subpart D—Imposition of Civil
Money Penalties, Section 160.402—
Basis for a Civil Money Penalty
Section 160.402(a) provides the
general rule that the Secretary will
impose a civil money penalty upon a
covered entity if the Secretary
determines that the covered entity
PO 00000
Frm 00013
Fmt 4701
Sfmt 4702
40879
violated an administrative
simplification provision. Paragraphs (b)
and (c) of this section explain the basis
for a civil money penalty against a
covered entity where more than one
covered entity is responsible for a
violation, where an affiliated covered
entity is responsible for a violation, and
where an agent of a covered entity is
responsible for a violation. As explained
above, this proposed rule would add
references to ‘‘business associate’’ where
appropriate in this section to effectuate
the HITECH Act’s imposition of liability
on business associates for violations of
the HITECH Act and certain Privacy and
Security Rule provisions.
Further, in paragraph (c), which
provides the basis for the imposition of
a civil money penalty against a covered
entity for the acts of its agent, in
accordance with the Federal common
law of agency, we propose to add a
parallel provision providing for civil
money penalty liability against a
business associate for the acts of its
agent. Thus, we propose to add a new
paragraph (2) to § 160.402(c) to provide
that a business associate is liable, in
accordance with the Federal common
law of agency, for a civil money penalty
for a violation based on the act or
omission of any agent of the business
associate, including a workforce
member or subcontractor, acting within
the scope of the agency.
The existing language of § 160.402(c)
regarding the liability of covered entities
for the acts of their agents would be
redesignated as paragraph (1), with one
substantive change. This section
currently provides an exception for
covered entity liability for the acts of its
agent in cases where the agent is a
business associate, the relevant contract
requirements have been met, the
covered entity did not know of a pattern
or practice of the business associate in
violation of the contract, and the
covered entity did not fail to act as
required by the Privacy or Security Rule
with respect to such violations. We
propose to remove this exception to
principal liability for the covered entity
so that the covered entity remains liable
for the acts of its business associate
agents, regardless of whether the
covered entity has a compliant business
associate agreement in place. This
change is necessary to ensure, where the
covered entity has contracted out a
particular obligation under the HIPAA
Rules, such as the requirement to
provide individuals with a notice of
privacy practices, that the covered
entity remains liable for the failure of its
business associate to perform that
obligation on the covered entity’s
behalf.
E:\FR\FM\14JYP2.SGM
14JYP2
40880
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
We do not believe this proposed
change would place any undue burden
on covered entities, since covered
entities are customarily liable for the
acts of their agents under agency
common law. We note that this
proposed regulatory change does not
create liability for covered entities with
respect to business associates that are
not agents, e.g., independent
contractors. The determination of
whether a business associate is an agent
of a covered entity, or whether a
subcontractor is an agent of a business
associate, will be based on the facts of
the relationship, such as the level of
control over the business associate’s or
subcontractor’s conduct.
H. Subpart D—Imposition of Civil
Money Penalties, Section 160.408—
Factors Considered in Determining the
Amount of a Civil Money Penalty
1. Determination of Penalty Amounts
Prior to the HITECH Act
Section 160.408 implements section
1176(a)(2) of the Social Security Act,
which requires the Secretary, when
imposing a civil money penalty, to
apply the provisions of section 1128A of
the Social Security Act ‘‘in the same
manner as such provisions apply to the
imposition of a civil money penalty
under section 1128A.’’ As currently
written, Section 1128A requires the
Secretary to take into account—
srobinson on DSKHWCL6B1PROD with PROPOSALS2
(1) The nature of the claims and the
circumstances under which they were
presented,
(2) The degree of culpability, history of
prior offenses and financial condition of the
person presenting the claims, and
(3) Such other matters as justice may
require.
Like other regulations that implement
section 1128A, HHS tailored these
factors by breaking them down into
their component elements and
providing a more specific list of
circumstances, within each component,
that apply to the context of HIPAA Rule
violations. Because the Enforcement
Rule applies to a number of rules, which
apply to an enormous number of entities
and circumstances, HHS left to the
Secretary’s discretion the decisions of
whether and how (i.e., as either
aggravating or mitigating) to consider
the following factors in determining the
amount of a civil money penalty:
(a) The nature of the violation, in light of
the purpose of the rule violated.
(b) The circumstances, including the
consequences, of the violation, including but
not limited to * * * [specific circumstances]
(c) The degree of culpability of the covered
entity, including but not limited to * * *
[specific circumstances]
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
(d) Any history of prior compliance with
the administrative simplification provisions,
including violations, by the covered entity,
including but not limited to * * * [specific
circumstances]
(e) The financial condition of the covered
entity, including but not limited to * * *
[specific circumstances]
(f) Such other matters as justice may
require.
See 70 FR 20224, 20235–6 and 71 FR
8390, 8407–9 for a discussion of HHS’s
interpretation of the factors currently
enumerated in § 160.408.
2. Determination of Penalty Amounts
After the HITECH Act
As discussed in more detail in the
IFR, section 13410(d) of the HITECH Act
modified section 1176(a)(1) of the Social
Security Act in several ways, including
the establishment of tiers of penalty
amounts that are associated with
increasing levels of culpability. It also
added a provision to section 1176(a)(1)
of the Social Security Act directing HHS
to ‘‘base such determination [of the
appropriate penalty amount] on the
nature and extent of the violation and
the nature and extent of the harm
resulting from such violation.’’ The
HITECH Act did not modify section
1176(a)(2) (requiring application of
section 1128A). In addition, many of the
factors currently identified by § 160.408
already pertain to the nature of the
violation and the resulting harm.
Section 160.408(a), for example,
identifies the nature of the violation for
consideration; paragraph (b) addresses
the circumstances, including the
consequences, of the violation (e.g.,
physical harm, financial harm and
whether the violation hindered or
facilitated an individual’s ability to
obtain health care); and paragraph (f)
addresses such other matters as justice
may require. Thus, HHS did not modify
§ 160.408 in the IFR.
Upon further consideration of the
statutory mandates and the significantly
broader range of penalty amounts
available, HHS believes it is appropriate
to amend the structure of § 160.408, to
make explicit the new statutory
requirement that the Secretary consider
the nature and extent of the violation
and the nature and extent of the harm
resulting from the violation, in addition
to those factors enumerated in section
1128A. Thus, HHS proposes to revise
§ 160.408(a) and (b), as discussed below,
to require the Secretary’s consideration
of the nature and extent of the violation,
as well as the nature and extent of the
harm resulting from violation, in
addition to those factors referenced by
section 1128A. We would exclude,
however, the factor presently identified
PO 00000
Frm 00014
Fmt 4701
Sfmt 4702
as § 160.408(c) (the degree of culpability
of covered entity), which originated in
section 1128A. Congress’ revision of
section 1176(a)(1) of the Social Security
Act to establish increasing tiers of
penalty amounts that reflect increasing
degrees of culpability renders
consideration of the degree of
culpability as an aggravating or
mitigating factor redundant. In contrast,
HHS is not proposing to amend the
Secretary’s discretion with respect to
the non-exhaustive list of specific
circumstances that may be considered.
In addition, HHS proposes to
reorganize the remaining, specific
circumstances under § 160.408(a) and
(b) to better reflect the categories to
which they are now attributed, to add
another circumstance for consideration
under each, as described below, to
explicitly provide that the Secretary’s
consideration of all specific
circumstances is optional, and to
modify the phrase ‘‘prior violations’’ in
subsections (c)(1) and (2) to read
‘‘indications of noncompliance.’’
a. The Nature and Extent of the
Violation
HHS proposes to revise subsection (a)
to identify ‘‘[t]he nature and extent of
the violation,’’ as the first factor the
Secretary must consider in determining
a civil money penalty amount. While
the ‘‘the nature of the violation’’ was
previously identified for consideration,
as it is grounded in section 1128A, the
current list of factors in § 160.408 does
not specifically reference ‘‘the extent of
the violation,’’ which section 1176(a)
now requires. We also propose to
transfer ‘‘the time period during which
the violation(s) occurred,’’ to this factor
and to add, ‘‘the number of individuals
affected,’’ since both circumstances
might be indicative measures of ‘‘the
nature and extent of the violation.’’ Our
compliance and enforcement experience
to date further supports the addition of
the latter, particularly with respect to
potential violations that negatively
affect numerous individuals (e.g., where
disclosure of protected health
information in multiple explanation of
benefits statements that were mailed to
the wrong individuals resulted from one
inadequate safeguard but affected a large
number of beneficiaries). We recognize
these specific circumstances might also
be considered under § 160.406, with
respect to counting violations. In this
regard, we direct readers’ attention to 71
FR 8390, 8409 (responding to a
comment expressing concern that the
overlap of certain variables proposed in
§ 160.406 with factors proposed in
§ 160.408 might result in compound
liability by asserting that since
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
consideration of such circumstances
may be relevant to each separable
element of the penalty calculation, their
consideration will be different in
nature).
b. The Nature and Extent of the Harm
Resulting From the Violations
HHS proposes to revise subsection (a)
to identify ‘‘[t]he nature and extent of
the harm resulting from the violation’’ as
the second factor the Secretary must
consider. This minor amendment
merely conforms the factor’s language to
the amended statutory language and
continues to include the optional
consideration of several specific
circumstances which might be
indicative of harm. In addition to these
specific circumstances, HHS proposes to
add reputational harm to make clear
that reputational harm is as cognizable
a form of harm as physical or financial
harm.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
c. The History of Prior Compliance With
the Administrative Simplification
Provisions
HHS proposes to modify the phrase
‘‘prior violations’’ in § 160.408(c)(1) and
(2) to read ‘‘indications of
noncompliance.’’ As defined in
§ 160.302, ‘‘violation’’ or ‘‘violate’’
means, ‘‘as the context may require,
failure to comply with an administrative
simplification provision.’’ Use of the
term is generally reserved, however, to
circumstances in which the Department
has made a formal finding of a violation
through a notice of proposed
determination. As explained in 71 FR
8390, 8408, a covered entity’s general
history of HIPAA compliance is relevant
in determining the amount of a civil
money penalty within the penalty range.
When we reviewed this language of
§ 160.408(c)(1) and (2) for the purposes
of this rulemaking, we noticed that the
regulatory text uses the term ‘‘violation’’
which is generally reserved for use in a
notice of proposed determination. We
are proposing to change this
terminology to ‘‘indications of
noncompliance’’ to make the regulatory
language consistent with HHS’ policy of
considering a covered entity’s general
history of HIPAA compliance.
I. Section 160.410—Affirmative
Defenses
Section 160.410 currently implements
the limitations placed on the Secretary’s
authority to impose a civil money
penalty under section 1176(b) of the
Act. As amended by the IFR, § 160.410
is organized to implement section
13410(d) of the HITECH Act in a way
that distinguishes the affirmative
defenses available to covered entities
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
40881
and business associates prior to, on, or
after February 18, 2009, the day after
section 13410(d) of the HITECH Act
became effective. See 74 FR 56123, Oct.
30, 2009, for a detailed discussion of the
IFR’s recent amendments.
Section 13410(a)(1) revises section
1176(b) to replace the phrase, ‘‘if the act
constitutes an offense punishable under
section 1177’’ with ‘‘a penalty has been
imposed under section 1177 with
respect to such act.’’ This statutory
change is effective February 18, 2011.
HHS proposes to amend § 160.410 to
implement the revision of section
1176(b)(1) of the Social Security Act by
providing in a new paragraph (a)(1) that
the affirmative defense of criminally
‘‘punishable’’ is applicable to penalties
imposed prior to February 18, 2011. A
new paragraph (a)(2) in that section
would make clear that, on or after
February 18, 2011, the Secretary’s
authority to impose a civil money
penalty will only be barred to the extent
a covered entity or business associate
can demonstrate that a penalty has been
imposed under 42 U.S.C. 1320d–6 with
respect to such act. As a conforming
change, current paragraphs (a)(2) and
(a)(3) are renumbered as paragraphs
(b)(1) and (b)(2), respectively, and
current paragraph (b) is renumbered as
paragraph (c).
As an additional conforming change,
HHS also proposes to amend
§ 160.410(a)(3)(i) (which has been
redesignated as § 160.410(b)(2)(i)) to
replace the term ‘‘reasonable cause’’ with
the unrevised text of its current
definition. This will ensure that the
current definition is applied to
violations occurring prior to February
18, 2009, thereby avoiding any potential
issues regarding a retroactive
application of the revised term.
V. Section-by-Section Description of the
Proposed Amendments to Subpart A of
Part 164 and the Security Rule in
Subpart C of Part 164
The HITECH Act made several
amendments that directly impact
current provisions of the HIPAA
Security Rule. We discuss the proposed
changes to the Security Rule as a result
of the HITECH Act in our section-bysection description below. We also
discuss various technical and
conforming proposed changes to the
Security Rule, as well as proposed
changes to provisions in subpart A of
part 164, which applies to both the
Security and Privacy Rules.
J. Section 160.412—Waiver
3. Section 164.105—Organizational
Requirements
We propose conforming changes to
this section, to align the cross-references
to § 160.410 with the proposed revisions
to that section discussed above.
K. Subpart D—Imposition of Civil
Money Penalties, Section 160.418—
Penalty Not Exclusive
We propose to revise this section to
incorporate a reference to the provision
of the Patient Safety and Quality
Improvement Act of 2005 at 42 U.S.C.
299b–22 that provides that penalties are
not to be imposed under both that act
and the Privacy Rule for the same
violation.
PO 00000
Frm 00015
Fmt 4701
Sfmt 4702
A. Technical Changes to Subpart A—
General Provisions
1. Section 164.102—Statutory Basis
This section sets out the statutory
basis of part 164. We propose a
technical change to include a reference
to the provisions of sections 13400
through 13424 of the HITECH Act upon
which the regulatory changes proposed
below are based.
2. Section 164.104—Applicability
This section sets out to whom part
164 applies. We propose to replace the
existing paragraph (b) with an
applicability statement for business
associates, consistent with the
provisions of the HITECH Act that are
discussed more fully below. Proposed
paragraph (b) would make clear that,
where provided, the standards,
requirements, and implementation
specifications of the HIPAA Privacy,
Security, and Breach Notification Rules
apply to business associates. We
propose to remove as unnecessary the
existing language in § 164.104(b)
regarding the obligation of a health care
clearinghouse to comply with § 164.105
relating to organizational requirements
of covered entities.
a. Section 164.105
Section 164.105 outlines the
organizational requirements and
implementation specifications for health
care components of covered entities and
for affiliated covered entities. As
§ 164.105 now also applies to subpart D
of part 164 regarding breach notification
for unsecured protected health
information, we propose to remove
several references to subparts C and E
throughout this section to make clear
that the provisions of this section also
apply to the new subpart D of this part.
In addition, we propose the following
modifications to this section.
E:\FR\FM\14JYP2.SGM
14JYP2
40882
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
b. Section 164.105(a)(2)(ii)(C)–(E)
We propose to modify this section to
remove as unnecessary paragraphs (C)
and (D), which pertain to the obligation
of a covered entity to ensure that any
component that performs business
associate-like activities and is included
in the health care component complies
with the requirements of the Privacy
and Security Rules, and to re-designate
paragraph (E) as (C). A covered entity’s
obligation to ensure that a health care
component complies with the Privacy
and Security Rules is already set out at
§ 164.105(a)(2)(ii). In addition, in light
of a business associate’s new direct
liability for compliance with certain of
the Security and Privacy Rule
provisions, we request comment on
whether we should require, rather than
permit as is currently the case under
§ 164.105(a)(2)(iii)(C), a covered entity
that is a hybrid entity to include a
component that performs business
associate-like activities within its health
care component so that such
components are directly subject to the
Rules.
c. Section 164.105(a)(2)(iii)(C)
We propose to modify this section to
re-designate § 164.105(a)(2)(iii)(C) as
(D), and to include a new paragraph (C),
which makes clear that, with respect to
a hybrid entity, the covered entity itself,
and not merely the health care
component, remains responsible for
complying with §§ 164.314 and 164.504
regarding business associate
arrangements and other organizational
requirements. This proposed
modification is intended to recognize
that hybrid entities may need to execute
legal contracts and conduct other
organizational matters at the level of the
legal entity rather than at the level of the
health care component.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
d. Section 164.105(b)(1)
We propose to fix a minor
typographical error in this paragraph by
redesignating the second paragraph (1)
as paragraph (2).
e. Section 164.105(b)(2)(ii)
We propose to simplify this paragraph
by collapsing subparagraphs (A), (B),
and (C) regarding the obligations of an
affiliated entity to comply with the
Privacy and Security Rules into one
provision, and to expand the reference
to compliance with the ‘‘part’’ so that the
breach notification obligations in
subpart D are also included.
4. Section 164.106—Relationship to
Other Parts
We propose to add a reference to
business associates, consistent with
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
their inclusion elsewhere throughout
the other HIPAA Rules.
B. Modifications to the HIPAA Security
Rule in Subpart C
1. References to Business Associates
The Security Rule, as it presently
stands, does not directly apply to
business associates of covered entities.
However, section 13401 of the HITECH
Act, which became effective on
February 18, 2010, provides that the
Security Rule’s administrative, physical,
and technical safeguards requirements
in §§ 164.308, 164.310, and 164.312, as
well as its policies and procedures and
documentation requirements in
§ 164.316, shall apply to business
associates in the same manner as these
requirements apply to covered entities,
and that business associates shall be
civilly and criminally liable for
penalties for violations of these
provisions.
Accordingly, to implement section
13401 of the HITECH Act, we propose
to insert references to ‘‘business
associate’’ in subpart C, as appropriate,
following references to ‘‘covered entity’’
to make clear that these provisions of
the Security Rule also apply to business
associates. In particular, we propose to
modify the following sections by adding
references to business associates:
§§ 164.302 (applicability), 164.304
(definitions of ‘‘administrative
safeguard’’ and ‘‘physical safeguard’’),
164.308, 164.310, 164.312, and 164.316.
In addition, we propose the changes
below to the Security Rule.
2. Section 164.306—Security Standards:
General Rules
Section 13401 of the HITECH Act
pertaining to requirements on business
associates does not specifically make
reference to § 164.306 of the Security
Rule. However, § 164.306 sets out the
general rules that apply to all of the
security standards and implementation
specifications that follow. Thus, for
example, § 164.306(b)(2) sets out the
particular factors that covered entities
must take into account in deciding
which security measures to use, and
§ 164.306(d) sets out the general rule
that required implementation
specifications must be implemented and
the process and basis for implementing
addressable implementation
specifications. Accordingly, §§ 164.308,
164.310, and 164.312 provide that the
administrative, physical, and technical
safeguards of the Security Rule must be
implemented ‘‘in accordance with
§ 164.306.’’ We do not believe that
Congress intended to apply enumerated
Security Rule sections to business
PO 00000
Frm 00016
Fmt 4701
Sfmt 4702
associates in a different manner than to
covered entities, as evidenced by the
statutory language that these sections
should be applied to business associates
‘‘in the same manner that such sections
apply to the covered entity.’’ For these
reasons, we also propose to revise
§ 164.306 to insert the word ‘‘business
associate,’’ as appropriate, so that the
general rules found at § 164.306 apply to
business associates in the same manner
as covered entities.
In addition, we propose technical
revisions to § 164.306(e) to more clearly
indicate that to maintain security
measures that continue to meet the
requirements of §§ 164.308, 164.310,
and 164.312, covered entities and
business associates must review and
modify such security measures and
update documentation accordingly
under § 164.316(b)(2)(iii).
3. Section 164.308—Administrative
Safeguards
First, as noted above, we propose to
modify § 164.308 to include throughout
appropriate references to business
associates. Second, we propose a
technical change to § 164.308(a)(3)(ii)(C)
regarding security termination
procedures for workforce members, to
add the words ‘‘or other arrangement
with’’ after ‘‘employment of’’ in
recognition of the fact that not all
workforce members are employees (e.g.,
some may be volunteers) of a covered
entity or business associate. Third, we
propose to remove the reference to
§ 164.306 in paragraph (b)(1) as
unnecessary. Fourth, as discussed
below, we propose a number of
modifications to the provisions in this
section regarding business associate
contracts and other arrangements to
conform to and address modifications
proposed in the definition of ‘‘business
associate,’’ including the proposed
inclusion of subcontractors within the
scope of ‘‘business associate.’’
Section 164.308(b) provides that a
covered entity may permit a business
associate to create, receive, maintain, or
transmit electronic protected health
information only if the covered entity
has a contract or other arrangement in
place to ensure the business associate
will appropriately safeguard the
protected health information. Section
164.308(b)(2) contains several
exceptions to this general rule for
certain situations that do not give rise to
a business associate relationship, such
as where a covered entity discloses
electronic protected health information
to a health care provider concerning the
treatment of an individual. We propose
to remove these exceptions from
§ 164.308(b)(2), since as discussed
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
above, we propose to include these as
exceptions to the definition of ‘‘business
associate.’’
In addition, we propose to modify
§ 164.308(b)(1) and (2) to clarify the new
proposed requirements on business
associates with regard to subcontractors.
As described above with respect to the
definition of ‘‘business associate’’ in
§ 160.103, we propose to include in the
definition subcontractors that create,
receive, maintain, or transmit protected
health information on behalf of a
business associate. However, we do not
intend this proposed modification to
mean that a covered entity is required
to have a contract with the
subcontractor. Rather, such obligation is
to remain with the business associate
who contracts with the subcontractor.
Accordingly, in § 164.308(b)(1), we
propose to clarify that covered entities
are not required to obtain satisfactory
assurances in the form of a contract or
other arrangement with a business
associate that is a subcontractor. In
§ 164.308(b)(2), we then propose to
make clear that it is the business
associate that must obtain the required
satisfactory assurances from the
subcontractor to protect the security of
electronic protected health information.
We propose to remove the provision
at § 164.308(b)(3), which provides that a
covered entity that violates the
satisfactory assurances it provided as a
business associate of another covered
entity will be in noncompliance with
the Security Rule’s business associate
provisions, as a covered entity’s actions
as a business associate of another
covered entity are now directly
regulated by the Security Rule’s
provisions that apply to business
associates.
Finally, in § 164.308(b)(4)
(renumbered as § 164.308(b)(3)), which
requires documentation of the required
satisfactory assurances through a
written contract or other arrangement,
we propose to add a reference to the
new paragraph at § 164.308(b)(2)
regarding business associates and
subcontractors.
4. Section 164.314—Organizational
Requirements
Section 13401 of the HITECH Act
does not include § 164.314 among the
provisions for which business associates
are directly liable. However, section
13401 does state that § 164.308 applies
to business associates ‘‘in the same
manner’’ that the provision applies to
covered entities. Section 164.308(b)
requires a covered entity’s business
associate agreements to conform to the
requirements of § 164.314. Accordingly,
in order for § 164.308(b) to apply to
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
business associates in the same manner
as it applies to covered entities, we have
revised § 164.314 to reflect that it is also
applicable to agreements between
business associates and subcontractors
that create, receive, maintain, or
transmit electronic protected health
information.
We also propose a number of
modifications to the business associate
contract requirements in § 164.314 to
streamline the provisions. First, we
propose to remove § 164.314(a)(1)(ii)
regarding the steps a covered entity
must take if it knows of a material
breach or violation by the business
associate of the contract. A parallel
provision exists in the Privacy Rule’s
business associate contract provisions at
§ 164.504 and, since a business associate
for purposes of the Security Rule is also
always a business associate for purposes
of the Privacy Rule, the inclusion of a
duplicate provision in the Security Rule
is unnecessary. For the same reason, we
also propose to remove the contract
provision at § 164.314(a)(2)(i)(D)
authorizing the termination of the
contract by the covered entity if it is
determined the business associate has
violated a material term of the contract.
A parallel provision exists in the
Privacy Rule at § 164.504(e)(2)(iii). Also,
because the Privacy Rule has a parallel
provision, we remove the specific
requirements under § 164.314(a)(2)(ii)
for other arrangements, such as a
memorandum of understanding when
both a covered entity and business
associate are governmental entities, and
instead simply refer to the requirements
of § 164.504(e)(3).
Second, we propose the following
modifications to the remaining contract
provision requirements: (1) In
§ 164.314(a)(2)(i)(A), we streamline the
provision to simply indicate a business
associate’s obligation to comply with
the Security Rule; (2) in
§ 164.314(a)(2)(i)(B), we revise the
language with respect to ensuring
subcontractors implement reasonable
and appropriate safeguards to refer to
the proposed requirement at
§ 164.308(b)(4) that would require a
business associate to enter into a
contract or other arrangement with a
subcontractor to protect the security of
electronic protected health information;
and (3) in § 164.314(a)(2)(i)(C), with
respect to the reporting of security
incidents by business associates to
covered entities, we make clear that the
business associate contract must
provide that the business associate will
report to the covered entity breaches of
unsecured protected health information
as required by § 164.410 of the breach
notification rules.
PO 00000
Frm 00017
Fmt 4701
Sfmt 4702
40883
Third, we add a provision at
§ 164.314(a)(2)(iii) that provides that the
requirements of this section for
contracts or other arrangements between
a covered entity and business associate
would apply in the same manner to
contracts or other arrangements between
business associates and subcontractors
required by the proposed requirements
of § 164.308(b)(4). For example, to
comply with proposed
§ 164.314(a)(2)(i)(C), a business
associate contract between a business
associate and a business associate
subcontractor must provide that the
subcontractor report any security
incident of which it becomes aware,
including breaches of unsecured
protected health information as required
by § 164.410, to the business associate.
Thus, if a breach of unsecured protected
health information occurs at or by a
subcontractor, the subcontractor must
notify the business associate of the
breach, which then must notify the
covered entity of the breach. The
covered entity then notifies the affected
individuals, the Secretary, and, if
applicable, the media, of the breach,
unless it has delegated such
responsibilities to a business associate.
Finally, we propose to remove the
reference to subcontractors in
§ 164.314(b)(2)(iii) regarding
amendment of group health plan
documents as a condition of disclosure
of protected health information to a plan
sponsor, to avoid confusion with the use
of the term subcontractor when referring
to subcontractors that are business
associates. This modification does not
constitute a substantive change to
§ 164.314(b).
VI. Section-by-Section Description of
the Proposed Amendments to the
Privacy Rule
The HITECH Act made a number of
amendments that affect current
provisions of the Privacy Rule. In the
section-by-section description of the
proposed regulatory changes below, we
discuss the HITECH Act requirements
and the regulatory provisions affected
by them, as well as certain other
substantive proposed changes to the
Privacy Rule intended to improve the
workability and effectiveness of the
Rule and to conform the Privacy Rule to
PSQIA. At the end of this discussion,
we also briefly list a number of
proposed technical corrections and
conforming changes to the Privacy Rule
that are not otherwise addressed
elsewhere.
A. Section 164.500—Applicability
We propose to revise § 164.500 to
include new § 164.500(c) and to
E:\FR\FM\14JYP2.SGM
14JYP2
40884
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
redesignate the current § 164.500(c) as
(d). In accordance with section 13404 of
the HITECH Act, which applies certain
of the Privacy Rule requirements to
business associates, as discussed more
fully below, § 164.500(c) would now
clarify that, where provided, the
standards, requirements, and
implementation specifications of the
Privacy Rule apply to business
associates.
B. Section 164.501—Definitions
srobinson on DSKHWCL6B1PROD with PROPOSALS2
1. Definition of ‘‘Health Care
Operations’’
PSQIA, 42 U.S.C. 299b–21 et seq.,
provides, among other things, that PSOs
are to be treated as business associates
of covered health care providers.
Further, PSQIA provides that the patient
safety activities of PSOs in relation to
HIPAA covered health care providers
are deemed to be health care operations
under the Privacy Rule. See 42 U.S.C.
299b–22(i).
We propose to amend paragraph (1) of
the definition of ‘‘health care
operations’’ to include a reference to
patient safety activities, as defined in
the PSQIA implementing regulation at
42 CFR 3.20. Many health care
providers participating in the voluntary
patient safety program authorized by
PSQIA are HIPAA covered entities;
PSQIA acknowledges that such
providers must also comply with the
Privacy Rule and deems patient safety
activities to be health care operations
under the Privacy Rule. While such
activities are already encompassed
within paragraph (1) of the definition,
which addresses various quality
activities, we propose to expressly
include patient safety activities within
paragraph (1) of the definition of health
care operations to expressly conform the
definition to PSQIA and to eliminate the
potential for any confusion. This
modification would also address public
comments the Department received
during the rulemaking period for the
PSQIA implementing regulations, which
urged the Department to modify the
definition of ‘‘health care operations’’ in
the Privacy Rule to expressly reference
patient safety activities so that the
intersection of the Privacy and PSQIA
Rules would be clear. See 73 FR 70732,
70780, November 21, 2008.
2. Definition of ‘‘Marketing’’
The Privacy Rule requires covered
entities to obtain a valid authorization
from individuals before using or
disclosing protected health information
to market a product or service to them.
See § 164.508(a)(3). Section 164.501
defines ‘‘marketing’’ as making a
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
communication about a product or
service that encourages recipients of the
communication to purchase or use the
product or service. Paragraph (1) of the
definition includes a number of
exceptions to marketing for certain
health-related communications. In
particular, the Privacy Rule does not
consider the following communications
to be marketing: (1) Communications
made to describe a health-related
product or service (or payment for such
product or service) that is provided by,
or included in a plan of benefits of, the
covered entity making the
communications, including
communications about: the entities
participating in a healthcare provider
network or health plan network;
replacement of, or enhancements to, a
health plan; and health-related products
or services available only to a health
plan enrollee that add value to, but are
not part of, a plan of benefits; (2)
communications made for the treatment
of the individual; and (3)
communications for case management
or care coordination for the individual,
or to direct or recommend alternative
treatments, therapies, health care
providers, or settings of care to the
individual. Thus, a covered entity is
permitted to make these excepted
communications without an
individual’s authorization as either
treatment or health care operations
communications, as appropriate, under
the Privacy Rule. In addition, the
Privacy Rule does not require a covered
entity to obtain individual authorization
to communicate face-to-face or to
provide only promotional gifts of
nominal value to the individual. See
§ 164.508(a)(3)(i). However, a covered
entity must obtain prior written
authorization from an individual to
send communications to the individual
about non-health related products or
services or to give or sell the
individual’s protected health
information to a third party for
marketing. See the current paragraph (2)
of the definition of ‘‘marketing’’ in the
Privacy Rule. Still, concerns have
remained about the ability under these
provisions for a third party to pay a
covered entity in exchange for the
covered entity to send health-related
communications to an individual about
the third party’s products or services.
Section 13406(a) of the HITECH Act,
which became effective on February 18,
2010, addresses these marketing
provisions. In particular, section
13406(a) of the HITECH Act limits the
health-related communications that may
be considered health care operations
and thus, that are excepted from the
PO 00000
Frm 00018
Fmt 4701
Sfmt 4702
definition of ‘‘marketing’’ under the
Privacy Rule to the extent a covered
entity receives or has received direct or
indirect payment in exchange for
making the communication. In cases
where the covered entity would receive
such payment, the HITECH Act at
section 13406(a)(2)(B) requires that the
covered entity obtain the individual’s
valid authorization prior to making the
communication, or, if applicable, prior
to its business associate making the
communication on its behalf in
accordance with its written contract.
Section 13406(a)(2)(A) of the HITECH
Act includes an exception to the
payment limitation for communications
that describe only a drug or biologic that
is currently being prescribed to the
individual as long as any payment
received by the covered entity in
exchange for making the
communication is reasonable in
amount. Section 13406(a)(3) of the Act
provides that the term ‘‘reasonable in
amount’’ shall have the meaning given
such term by the Secretary in regulation.
Finally, section 13406(a)(4) of the Act
clarifies that ‘‘direct or indirect
payment’’ does not include any payment
for treatment of the individual. We
believe Congress intended with these
provisions to curtail a covered entity’s
ability to use the exceptions to the
definition of ‘‘marketing’’ in the Privacy
Rule to send communications to the
individual that were motivated more by
commercial gain or other commercial
purpose rather than for the purpose of
the individual’s health care, despite the
communication’s being about a healthrelated product or service.
To implement the marketing
limitations of the HITECH Act, we
propose a number of modifications to
the definition of ‘‘marketing’’ in the
Privacy Rule at § 164.501. In particular,
we propose to: (1) Revise the exceptions
to marketing to better distinguish the
exceptions for treatment
communications from those
communications made for health care
operations; (2) add a definition of
‘‘financial remuneration;’’ (3) provide
that health care operations
communications for which financial
remuneration is received are marketing
and require individual authorization; (4)
provide that written treatment
communications for which financial
remuneration is received are subject to
certain notice and opt out conditions set
out at § 164.514(f)(2); (5) provide a
limited exception from the
remuneration prohibition for refill
reminders; and (6) remove the
paragraph regarding an arrangement
between a covered entity and another
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
entity in which the covered entity
receives remuneration in exchange for
protected health information. We
propose to revise §§ 164.514(f)(2) and
164.520(b)(1)(iii)(A) to include the
notice and opt out conditions that
would attach to written treatment
communications about products or
services sent by a health care provider
to an individual in exchange for
financial remuneration by the third
party whose product or service is being
described. We also propose to make a
conforming change to the authorization
requirements for marketing at
§ 164.508(a)(3)(ii). We describe these
proposed modifications in more detail
below.
In paragraph (1) of the definition of
‘‘marketing,’’ we propose to maintain the
general concept that ‘‘marketing’’ means
‘‘to make a communication about a
product or service that encourages
recipients of the communication to
purchase or use the product or service.’’
In paragraph (2) of the definition, we
propose to include three exceptions to
this definition to encompass certain
treatment and health care operations
communications about health-related
products or services. First, at proposed
paragraph (2)(iii), we would exclude
from the definition of ‘‘marketing’’
certain health care operations
communications, except where, as
provided by section 13406(a)(2) of the
HITECH Act, the covered entity receives
financial remuneration in exchange for
making the communication. This
provision would encompass the health
care operations activities currently
described in paragraph (1)(i) of the
definition of ‘‘marketing,’’ which include
communications to describe a healthrelated product or service (or payment
for such product or service) that is
provided by, or included in a plan of
benefits of, the covered entity making
the communication. In addition, the
provision would encompass health care
operations communications for case
management or care coordination,
contacting of individuals with
information about treatment
alternatives, and related functions, to
the extent these activities do not fall
within the definition of treatment.
These are activities that currently fall
within paragraph (1)(iii) of the
definition of ‘‘marketing.’’
Although the HITECH Act uses the
term ‘‘direct or indirect payment’’ to
describe the limitation on permissible
health care operations disclosures, we
have substituted the term ‘‘financial
remuneration’’ to avoid confusion since
the Privacy Rule defines and uses the
term ‘‘payment’’ to mean payment for
health care and since the Privacy Rule’s
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
authorization requirements for
marketing at § 164.508(a)(3) use the term
‘‘remuneration.’’ We propose to define
‘‘financial remuneration’’ in paragraph
(3) of the definition of ‘‘marketing’’ to
mean direct or indirect payment from or
on behalf of a third party whose product
or service is being described. We also
propose to make clear, in accordance
with section 13406(a)(4) of the HITECH
Act, that financial remuneration does
not include any direct or indirect
payment for the treatment of an
individual. Additionally, because the
HITECH Act refers expressly to
‘‘payment,’’ rather than remuneration
more generally, we have specified that
only the receipt of financial
remuneration in exchange for making a
communication, as opposed to any other
type of remuneration, is relevant for
purposes of the definition of marketing.
We propose a small conforming change
to § 164.508(a)(3) to add the term
‘‘financial’’ before ‘‘remuneration’’ and to
refer to the definition of ‘‘financial
remuneration’’ for consistency with the
HITECH Act and the proposed changes
to the definition of ‘‘marketing.’’
We also emphasize that financial
remuneration for purposes of the
definition of ‘‘marketing’’ must be in
exchange for making the
communication itself and be from or on
behalf of the entity whose product or
service is being described. For example,
authorization would be required prior to
a covered entity making a
communication to its patients regarding
the acquisition of new state of the art
medical equipment if the equipment
manufacturer paid the covered entity to
send the communication to its patients.
In contrast, an authorization would not
be required if a local charitable
organization, such as a breast cancer
foundation, funded the covered entity’s
mailing to patients about the availability
of new state of the art medical
equipment, such as mammography
screening equipment, since the covered
entity would not be receiving
remuneration by or on behalf of the
entity whose product or service was
being described. Furthermore, it would
not constitute marketing and no
authorization would be required if a
hospital sent flyers to its patients
announcing the opening of a new wing
where the funds for the new wing were
donated by a third party, since the
financial remuneration to the hospital
from the third party was not in
exchange for the mailing of the flyers.
Second, in paragraph (2)(ii) of the
definition, we propose to include the
statutory exception to marketing at
section 13406(a)(2)(A) for
communications regarding refill
PO 00000
Frm 00019
Fmt 4701
Sfmt 4702
40885
reminders or otherwise about a drug or
biologic that is currently being
prescribed for the individual, provided
any financial remuneration received by
the covered entity for making the
communication is reasonably related to
the covered entity’s cost of making the
communication. Congress expressly
identified these types of
communications as being exempt from
the remuneration limitation only to the
extent that any payment received for
making the communication is
reasonable in amount. We request
comment on the scope of this exception,
that is, whether communications about
drugs that are related to the drug
currently being prescribed, such as
communications regarding generic
alternatives or new formulations of the
drug, should fall within the exception.
In addition, we considered proposing a
requirement that a covered entity could
only receive financial remuneration for
making such a communication to the
extent it did not exceed the actual cost
to make the communication. However,
we were concerned that such a
requirement would impose the
additional burden of calculating the
costs of making each communication.
Instead, we propose to allow costs that
are reasonably related to the covered
entity’s cost of making the
communication. We request comment
on the types and amount of costs that
should be allowed under this provision.
Third, proposed paragraph (2)(i)
would exclude from marketing
treatment communications about healthrelated products or services by a health
care provider to an individual,
including communications for case
management or care coordination for the
individual, or to direct or recommend
alternative treatments, therapies, health
care providers, or settings of care to the
individual, provided, however, that if
the communications are in writing and
financial remuneration is received in
exchange for making the
communications, certain notice and opt
out conditions are met. We note that
while section 13406(a) of the HITECH
Act expressly provides that a
communication to an individual about a
health-related product or service where
the covered entity receives payment
from a third party in exchange for
making the communication shall not be
considered a health care operation
(emphasis added) under the Privacy
Rule, and thus is marketing, it is unclear
how Congress intended these provisions
to apply to treatment communications
between a health care provider and a
patient. Specifically, it is unclear
whether Congress intended to restrict
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40886
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
only those subsidized communications
about products and services that are less
essential to an individual’s health care
(i.e., those classified as health care
operations communications) or all
subsidized communications about
products and services, including
treatment communications. Given this
ambiguity and to avoid preventing
communications to the individual by a
health care provider about health
related products or services that are
necessary for the treatment of the
individual, we do not propose to require
individual authorization where
financial remuneration is received by
the provider from a third party in
exchange for sending the individual
treatment communications about healthrelated products or services. However,
to ensure the individual is aware that he
or she may receive subsidized treatment
communications from his or her
provider and has the opportunity to
elect not to receive them, we propose to
require a statement in the notice of
privacy practices when a provider
intends to send such subsidized
treatment communications to an
individual, as well as the opportunity
for the individual to opt out of receiving
such communications. In particular, the
proposed rule would exclude from
marketing and the authorization
requirements written subsidized
treatment communications only to the
extent that the following requirements
proposed at § 164.514(f)(2) are met: (1)
The covered health care provider’s
notice of privacy practices includes a
statement informing individuals that the
provider may send treatment
communications to the individual
concerning treatment alternatives or
other health-related products or services
where the provider receives financial
remuneration from a third party in
exchange for making the
communication, and the individual has
a right to opt out of receiving such
communications; and (2) the treatment
communication itself discloses the fact
of remuneration and provides the
individual with a clear and conspicuous
opportunity to elect not to receive any
further such communications. Similar to
the modifications discussed below
regarding fundraising communications,
the opt out method provided to an
individual for subsidized treatment
communications may not cause the
individual to incur an undue burden or
more than a nominal cost. We encourage
covered entities to consider the use of
a toll-free phone number, an e-mail
address, or similar opt out mechanism
that would provide individuals with a
simple, quick, and inexpensive way to
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
opt out of receiving future
communications. We note that we
would consider requiring individuals to
write and send a letter to the covered
entity asking not to receive future
communications to constitute an undue
burden on the individual for purposes
of this proposed requirement. We
request comment on how the opt out
should apply to future subsidized
treatment communications. For
example, we request comment on
whether the opt out should prevent all
future subsidized treatment
communications by the provider or just
those dealing with the particular
product or service described in the
current communication. We also request
comment on the workability of requiring
health care providers that intend to send
subsidized treatment communications
to individuals to provide an individual
with the opportunity to opt out of
receiving such communications prior to
the individual receiving the first
communication and what mechanisms
could be put into place to implement
the requirement.
Given that the new marketing
limitations on the receipt of
remuneration by a covered entity would
apply differently depending on whether
a communication is for treatment or
health care operations purposes, it is
important to emphasize the difference
between the two types of
communications. We note first that
communications by health plans
concerning health-related products or
services included in a plan of benefits
or for case management or care
coordination are never considered
treatment for purposes of the Privacy
Rule but rather would always be health
care operations and require individual
authorization under the proposed rule if
financial remuneration is involved.
With respect to subsidized
communications by a health care
provider about health-related products
or services for case management or care
coordination or to recommend
alternative treatments or settings of care,
whether the communication would
require individual authorization, or a
statement in the notice and an
opportunity to opt out, would depend
on to what extent the provider is making
the communication in a populationbased fashion (health care operations) or
to further the treatment of a particular
individual based on that individual’s
health care status or condition
(treatment). For example, a covered
health care provider who sends a
pregnant patient a brochure
recommending a specific birthing center
suited to the patient’s particular needs
PO 00000
Frm 00020
Fmt 4701
Sfmt 4702
is recommending a setting of care
specific to the individual’s condition,
which constitutes treatment of the
individual. If the health care provider
receives financial remuneration in
exchange for making the
communication, the provider would be
required to have included a statement in
its notice of privacy practices informing
individuals that it may send subsidized
treatment communications to the
individual and that the individual has a
right to opt out of such
communications, and to disclose the
fact of remuneration with the
communication and provide the
individual with information on how to
opt out of receiving future such
communications. In contrast, a health
care provider who sends a blanket
mailing to all patients with information
about a new affiliated physical therapy
practice would not be making a
treatment communication. Rather, the
provider would be making a
communication for health care
operations if it does not receive any
financial remuneration for the
communication, but would be making a
communication for marketing if it does
receive financial remuneration.
We are aware of the difficulty in
making what may be in some cases close
judgments as to which communications
are for treatment purposes and which
are for health care operations purposes.
We also are aware of the need to avoid
unintended adverse consequences to a
covered health care provider’s ability to
provide treatment to an individual.
Therefore, we request comment on the
above proposal with regard to these
issues, as well as the alternatives of
excluding treatment communications
altogether even if they involve financial
remuneration from a third party or
requiring individual authorization for
both treatment and health care
operations communications made in
exchange for financial remuneration.
We note that face to face
communications about products or
services between a covered entity and
an individual and promotional gifts of
nominal value provided by a covered
entity are not impacted by these
proposed changes to the definition of
‘‘marketing.’’ These communications
may continue to be made without
obtaining an authorization under
§ 164.508 or meeting the notice and opt
out requirements of § 164.514(f)(2). We
also clarify that communications made
by covered entities to individuals
promoting health in general, such as
communications about the importance
of maintaining a healthy diet or getting
an annual physical are still not
considered to be marketing. These types
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
of communications do not constitute
marketing because they are not
promoting a specific product or service,
and thus do not meet the definition of
‘‘marketing.’’ Similarly, communications
about government and governmentsponsored programs do not fall within
the definition of ‘‘marketing’’ as there is
no commercial component to
communications about benefits
available through public programs.
Finally, we have proposed to remove
the language at paragraph (2) from the
definition of ‘‘marketing’’ at § 164.501.
The current language defines as
marketing an arrangement between a
covered entity and any other entity in
which the covered entity discloses
protected health information to the
other entity, in exchange for
remuneration, for the other entity or its
affiliate to make a communication about
its own product or service that
encourages recipients of the
communication to purchase or use that
product or service. This language
describes a situation which, as
explained more fully below, would now
constitute a ‘‘sale’’ of protected health
information under section 13405(d) of
the HITECH Act and § 164.508(a)(4) of
this proposed rule. Because we propose
to modify § 164.508 to implement
section 13405(d) of the HITECH Act by
prohibiting the sale of protected health
information without an authorization,
we propose to remove this paragraph
from the definition of ‘‘marketing’’ as
unnecessary and to avoid confusion.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
C. Business Associates
1. Section 164.502—Uses and
Disclosures
The Privacy Rule currently does not
directly govern business associates.
However, the provisions of the HITECH
Act make specific requirements of the
Privacy Rule applicable to business
associates, and create direct liability for
noncompliance by business associates
with regard to those Privacy Rule
requirements. In particular, section
13404 of the HITECH Act, which
became effective February 18, 2010,
addresses the application of the
provisions of the HIPAA Privacy Rule to
business associates of covered entities.
Section 13404(a) discusses the
application of contract requirements to
business associates, paragraph (b)
applies the provision of
§ 164.504(e)(1)(ii) regarding knowledge
of a pattern of activity or practice that
constitutes a material breach or
violation of a contract to business
associates, and paragraph (c) applies the
HIPAA civil and criminal penalties to
business associates. We discuss
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
paragraphs (a) and (b) of section 13404
of the HITECH Act below. We address
section 13404(c) regarding the
application of penalties to violations by
business associates above in the
discussion of the proposed changes to
the Enforcement Rule.
Section 13404(a) of the HITECH Act
creates direct liability for business
associates by providing that in the case
of a business associate of a covered
entity that obtains or creates protected
health information pursuant to a written
contract or other arrangement as
described in § 164.502(e)(2) of the
Privacy Rule, the business associate may
use and disclose such protected health
information only if such use or
disclosure is in compliance with the
applicable business associate contract
requirements of § 164.504(e) of the Rule.
Additionally, section 13404(a) applies
the other privacy requirements of the
HITECH Act to business associates just
as they apply to covered entities.
Accordingly, we propose to modify
§ 164.502(a) of the Privacy Rule
containing the general rules for uses and
disclosures of protected health
information to address the permitted
and required uses and disclosures of
protected health information by
business associates. First, we propose to
revise § 164.502(a) to provide that a
business associate, like a covered entity,
may not use or disclose protected health
information except as permitted or
required by the Privacy Rule or the
Enforcement Rule. Second, we propose
to revise the titles of § 164.502(a)(1) and
(2) regarding permitted and required
uses and disclosures to make clear that
these paragraphs apply only to covered
entities. Note that in § 164.502(a)(2)(ii),
we also propose a technical change to
replace the term ‘‘subpart’’ with
‘‘subchapter’’ to make clear that a
covered entity is required to disclose
protected health information to the
Secretary as needed to determine
compliance with any of the HIPAA
Rules and not just the Privacy Rule.
Third, we propose to add new
provisions at § 164.502(a)(4) and (5) to
address the permitted and required uses
and disclosures of protected health
information by business associates.4 In
accordance with section 13404(a) of the
HITECH Act, proposed § 164.502(a)(4)
would allow business associates to use
or disclose protected health information
only as permitted or required by their
business associate contracts or other
arrangements pursuant to § 164.504(e),
4 We propose to reserve § 164.502(a)(3) for
provisions implementing modifications to the
Privacy Rule required by the Genetic Information
Nondiscrimination Act of 2008 (GINA), which were
proposed on October 7, 2009. See 74 FR 51698.
PO 00000
Frm 00021
Fmt 4701
Sfmt 4702
40887
or as required by law. If a covered entity
and business associate have failed to
enter into a business associate contract
or other arrangement, then the business
associate may use or disclose protected
health information only as necessary to
perform its obligations for the covered
entity (pursuant to whatever agreement
sets the general terms for the
relationship between the covered entity
and business associate) or as required by
law; any other use or disclosure would
violate the Privacy Rule. In addition,
proposed § 164.502(a)(4) makes clear
that a business associate would not be
permitted to use or disclose protected
health information in a manner that
would violate the requirements of the
Privacy Rule, if done by the covered
entity, except that the business associate
would be permitted to use or disclose
protected health information for the
purposes specified under
§ 164.504(e)(2)(i)(A) or (B), pertaining to
uses and disclosures for the proper
management and administration of the
business associate and the provision of
data aggregation services for the covered
entity, if such uses and disclosures are
permitted by its business associate
contract or other arrangement.
Section 164.502(a)(5) would require
business associates to disclose protected
health information either when required
by the Secretary under subpart C of part
160 of this subchapter to investigate or
determine the business associate’s
compliance with this subchapter, or to
the covered entity, individual, or
individual’s designee, as necessary to
satisfy a covered entity’s obligations
under § 164.524(c)(2)(ii) and (3)(ii), as
modified, with respect to an
individual’s request for an electronic
copy of protected health information. As
section 13405(e) requires covered
entities that maintain protected health
information in an electronic health
record to provide an individual, or the
individual’s designee, with a copy of
such information in an electronic
format, if the individual so chooses, and
as section 13404(a) applies section
13405(e) to business associates as well,
we propose to include such language in
§ 164.502(a)(5).
We propose to modify the minimum
necessary standard at § 164.502(b) to
require that when business associates
use, disclose, or request protected
health information, they limit protected
health information to the minimum
necessary to accomplish the intended
purpose of the use, disclosure, or
request. Applying the minimum
necessary standard is a condition of the
permissibility of many uses and
disclosures of protected health
information. Thus, a business associate
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40888
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
is not making a permitted use or
disclosure under the Privacy Rule if it
does not apply the minimum necessary
standard, where appropriate.
Additionally, the HITECH Act at section
13405(b) addresses the application of
minimum necessary and, in accordance
with section 13404(a), also applies such
requirements to business associates. We
note that we have not added references
to ‘‘business associate’’ to other
provisions of the Privacy Rule that
address uses and disclosures by covered
entities. This is because we found such
changes to be unnecessary, since a
business associate generally may only
use or disclose protected health
information in the same manner as a
covered entity (therefore any Privacy
Rule limitation on how a covered entity
may use or disclose protected health
information automatically extends to
business associates).
Section 164.502(e) sets out the
requirements for disclosures to business
associates. We propose in
§ 164.502(e)(1)(i) to provide that covered
entities are not required to obtain
satisfactory assurances from business
associates that are subcontractors.
Rather, as we previously discussed with
regard to proposed modifications to the
Security Rule pertaining to business
associates, and as we discuss further
below, we propose in the Privacy and
Security Rules to require that business
associates obtain satisfactory
assurances, through a written contract
or other arrangement, from
subcontractors that provide that the
subcontractor will comply with the
applicable requirements of the Rules.
Accordingly, each business associate
subcontractor would be subject to the
terms and conditions of a business
associate agreement with a business
associate, eliminating the need for a
similar agreement with the covered
entity itself.
We also propose to move the current
exceptions to business associates at
§ 164.502(e)(1)(ii) to the revised
definition of business associates found
in § 160.103 for the reasons discussed in
that section.
We propose a new § 164.502(e)(1)(ii)
that provides that a business associate
may disclose protected health
information to a business associate that
is a subcontractor, and to allow the
subcontractor to create or receive
protected health information on behalf
of the business associate, if the business
associate obtains satisfactory
assurances, in accordance with
§ 164.504(e)(1)(i), that the subcontractor
will appropriately safeguard the
information. As such, the business
associate must enter into a contract or
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
other arrangement that complies with
§ 164.504(e)(1)(i) with business
associate subcontractors, in the same
manner that covered entities are
required to enter into contracts or other
arrangements with their business
associates. As we discussed with regard
to the requirements of the Security Rule
regarding business associates, we
believe that business associates are in
the best position to ensure that
subcontractors comply with the
requirements of the Privacy Rule. For
example, a covered entity may choose to
contract with a business associate
(contractor) to use or disclose protected
health information on its behalf, the
business associate may choose to obtain
the services of (and exchange protected
health information with) a subcontractor
(subcontractor 1), and that subcontractor
may, in turn, contract with another
subcontractor (subcontractor 2) for
services involving protected health
information. Under the current rules,
the covered entity would be required to
obtain a business associate agreement
with the contractor, the contractor
would have a contractual requirement to
obtain the same satisfactory assurances
from subcontractor 1, and subcontractor
1 would in turn have a contractual
requirement to obtain the same
satisfactory assurances from
subcontractor 2. The proposed revisions
to the Privacy and Security Rules would
not change the parties to the contracts.
However, the contractor and
subcontractors 1 and 2 all would now be
business associates with direct liability
under the HIPAA Rules, and would be
required to obtain business associate
agreements with the parties with whom
they contract for services that involve
access to protected health information.
(Note, however, as discussed above with
respect to the definition of ‘‘business
associate,’’ direct liability under the
HIPAA Rules attaches regardless of
whether the contractor and
subcontractors have entered into
business associate agreements.) The
proposed revisions ensure that the
covered entity does not have a new
obligation to enter into separate
contracts with the business associate
subcontractors.
We propose to remove
§ 164.502(e)(1)(iii), which provides that
a covered entity that violates the
satisfactory assurances it provided as a
business associate of another covered
entity will be in noncompliance with
the Privacy Rule’s business associate
provisions, given that new proposed
§ 164.502(a)(4) would restrict directly
the uses and disclosures of protected
health information by a business
PO 00000
Frm 00022
Fmt 4701
Sfmt 4702
associate, including a covered entity
acting as a business associate, to those
uses and disclosures permitted by its
business associate agreement.
2. Section 164.504(e)—Business
Associate Agreements
Section 164.504, among other
provisions, contains the specific
requirements for business associate
contracts and other arrangements. As
discussed previously, section 13404 of
the HITECH Act provides that a
business associate may use and disclose
protected health information only if
such use or disclosure is in compliance
with each applicable requirement of
§ 164.504(e), and also applies the
provisions of § 164.504(e)(1)(ii), which
outline the actions that must be taken if
the business associate has knowledge of
a breach of the contract, to business
associates. We propose a number of
modifications to this section to
implement these provisions and to
reflect the Department’s new regulatory
authority with respect to business
associates, as well as to reflect a covered
entity’s and business associate’s new
obligations under subpart D to provide
for notification in the case of breaches
of unsecured protected health
information.
Section 164.504(e)(1)(ii) provides that
a covered entity is not in compliance
with the business associate
requirements if the covered entity knew
of a pattern of activity or practice of the
business associate that constituted a
material breach or violation of the
business associate’s obligation under the
contract or other arrangement, unless
the covered entity took reasonable steps
to cure the breach or end the violation,
as applicable, and if such steps were
unsuccessful, terminated the contract or
arrangement or, if termination is not
feasible, reported the problem to the
Secretary. We propose to revise
§ 164.504(e)(1)(ii) to remove the
requirement that covered entities report
to the Secretary when termination of a
business associate contract is not
feasible. In light of a business associate’s
direct liability for civil money penalties
for violations of the HIPAA Rules and
both a covered entity’s and business
associate’s obligations under subpart D
to report breaches of unsecured
protected health information to the
Secretary, we have other mechanisms
through which we expect to learn of
such breaches and misuses of protected
health information by a business
associate. We also propose to add a new
provision at § 164.504(e)(1)(iii)
applicable to business associates with
respect to subcontractors to mirror the
requirements on covered entities in
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
§ 164.504(e)(1)(ii) (minus the
requirement to report to the Secretary if
termination of a contract is not feasible).
Thus, proposed § 164.504(e)(1)(iii)
would require a business associate, if it
knew of a pattern or practice of activity
of its business associate subcontractor
that constituted a material breach or
violation of the subcontractor’s contract
or other arrangement, to take reasonable
steps to cure the breach of the
subcontractor or to terminate the
contract, if feasible. We believe this
proposed provision would implement
the intent of section 13404(b) of the
HITECH Act, and aligns the
requirements for business associates
with regard to business associate
subcontractors with the requirements
for covered entities with regard to their
business associates. In other words, a
business associate that is aware of
noncompliance by its business associate
subcontractor must respond to the
situation in the same manner as a
covered entity that is aware of
noncompliance by its business
associate.
While business associates are now
directly liable for civil money penalties
under the HIPAA Rules for
impermissible uses and disclosures as
described above, business associates are
still contractually liable to covered
entities pursuant to their business
associate contracts, as provided for and
required by § 164.504(e). We propose
certain modifications to these contract
requirements. First, we propose to
revise § 164.504(e)(2)(ii)(B) through (D)
to require the following: in (B), that
business associates comply, where
applicable, with the Security Rule with
regard to electronic protected health
information; in (C), that business
associates report breaches of unsecured
protected health information to covered
entities, as required by § 164.410; and in
(D), that, in accordance with
§ 164.502(e)(1)(ii), business associates
ensure that any subcontractors that
create or receive protected health
information on behalf of the business
associate agree to the same restrictions
and conditions that apply to the
business associate with respect to such
information. These proposed revisions
align the requirements for the business
associate contract with the requirements
in the HITECH Act and elsewhere
within the HIPAA Rules.
Additionally with regard to business
associate contract requirements, we
propose to insert a new provision at
§ 164.502(e)(2)(ii)(H) and to renumber
the current paragraphs (H) and (I)
accordingly. Section
164.502(e)(2)(ii)(H), as proposed, would
require that, to the extent the business
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
associate is to carry out a covered
entity’s obligation under this subpart,
the business associate must comply
with the requirements of the Privacy
Rule that apply to the covered entity in
the performance of such obligation. The
HITECH Act places direct liability for
uses and disclosures and for the other
HITECH Act requirements on business
associates. Beyond such direct liability,
this provision clarifies that a business
associate is contractually liable not only
for uses and disclosures of protected
health information, but also for all other
requirements of the Privacy Rule, as
they pertain to the performance of the
business associate’s contract. For
example, if a third party administrator,
as a business associate of a group health
plan, fails to distribute the plan’s notice
of privacy practices to participants on a
timely basis, the third party
administrator would not be directly
liable under the HIPAA Rules, but
would be contractually liable, for the
failure. However, we emphasize that in
this example, even though the business
associate is not directly liable under the
HIPAA Rules for failure to provide the
notice, the covered entity remains
directly liable for failure to provide the
individuals with its notice of privacy
practices because it is the covered
entity’s ultimate responsibility to do so,
despite its having hired a business
associate to perform the function.
We also propose to revise
§ 164.504(e)(3) regarding other
arrangements for governmental entities
to include references to the Security
Rule requirements for business
associates to streamline the two rules
and, as discussed above, to avoid having
to repeat such provisions in the Security
Rule.
To implement the requirements of
sections 13404(a) of the HITECH Act,
we propose to include a new
§ 164.504(e)(5) that applies the
requirements of § 164.504(e)(2) through
(e)(4) to the contract or other
arrangement between a business
associate and its business associate
subcontractor as required by
§ 164.502(e)(1)(ii) in the same manner as
such requirements apply to contracts or
other arrangements between a covered
entity and its business associate. As
such, the business associate is required
by § 164.502(e)(1)(ii) and by this section
to enter into business associate
contracts, or other arrangements that
comply with the Privacy and Security
Rules, with their business associate
subcontractors in the same manner that
covered entities are required to enter
into contracts or other arrangements
with their business associates.
PO 00000
Frm 00023
Fmt 4701
Sfmt 4702
40889
Finally, we propose to remove the
reference to subcontractors in
§ 164.504(f)(2)(ii)(B) to avoid confusion
with the use of the term subcontractor
when referring to subcontractors as
business associates. For the same
reason, we propose to remove the
reference to subcontractors in
§ 164.514(e)(4)(ii)(C)(4) to avoid
confusion with the use of the term
subcontractor when referring to
subcontractors as business associates.
We do not intend these proposed
modifications to constitute substantive
changes.
3. Section 164.532—Transition
Provisions
We understand that covered entities
and business associates are concerned
with the anticipated administrative
burden and cost to implement the
revised business associate contract
provisions of the Privacy and Security
Rules. Covered entities may have
existing contracts that are not set to
terminate or expire until after the
compliance date of the modifications to
the Rules, and we understand that a six
month compliance period may not
provide enough time to reopen and
renegotiate all contracts. In response to
these concerns, we propose to relieve
some of the burden on covered entities
and business associates in complying
with the revised business associate
provisions by adding a transition
provision to grandfather certain existing
contracts for a specified period of time.
The Department’s authority to add the
transition provision is set forth in
§ 160.104(c), which allows the Secretary
to establish the compliance date for any
modified standard or implementation
specification, taking into account the
extent of the modification and the time
needed to comply with the
modification. We also note that the
Final Privacy Rule, 65 FR 82462 (Dec.
28, 2000), and the Modifications to the
HIPAA Privacy Rule, 67 FR 53182 (Aug.
14, 2002), both included transition
provisions to ensure that important
functions of the health care system were
not impeded (e.g., to prevent disruption
of ongoing research). Similarly, the
proposed transition period, here, will
prevent rushed and hasty changes to
thousands of on-going existing business
associate agreements. The following
discussion addresses the issue of the
business associate transition provisions.
We propose new transition provisions
at § 164.532(d) and (e) to allow covered
entities and business associates (and
business associates and business
associate subcontractors) to continue to
operate under certain existing contracts
for up to one year beyond the
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40890
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
compliance date of the revisions to the
Rules. The additional transition period
would be available to a covered entity
or business associate if, prior to the
publication date of the modified Rules,
the covered entity or business associate
had an existing contract or other written
arrangement with a business associate
or subcontractor, respectively, that
complied with the prior provisions of
the HIPAA Rules and such contract or
arrangement was not renewed or
modified between the effective date and
the compliance date of the
modifications to the Rules. The
proposed provisions are intended to
allow those covered entities and
business associates with contracts with
business associates and subcontractors,
respectively, that qualify as described
above to continue to disclose protected
health information to the business
associate or subcontractor, or to allow
the business associate or subcontractor
to create or receive protected health
information on behalf of the covered
entity or business associate, for up to
one year beyond the compliance date of
the modifications, regardless of whether
the contract meets the applicable
contract requirements in the
modifications to the Rules. With respect
to business associates and
subcontractors, this proposal would
grandfather existing written agreements
between business associates and
subcontractors entered into pursuant to
45 CFR 164.504(e)(2)(i)(D), which
requires the business associate to ensure
that its agents with access to protected
health information agree to the same
restrictions and conditions that apply to
the business associate. The Department
proposes to deem such contracts to be
compliant with the modifications to the
Rules until either the covered entity or
business associate has renewed or
modified the contract following the
compliance date of the modifications, or
until the date that is one year after the
compliance date, whichever is sooner.
In cases where a contract renews
automatically without any change in
terms or other action by the parties (also
known as ‘‘evergreen contracts’’), the
Department intends that such evergreen
contracts will be eligible for the
extension and that deemed compliance
would not terminate when these
contracts automatically roll over. These
transition provisions apply to covered
entities and business associates only
with respect to written contracts or
other written arrangements as specified
above, and not to oral contracts or other
arrangements.
These transition provisions only
apply to the requirement to amend
contracts; they do not affect any other
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
compliance obligations under the
HIPAA Rules. For example, beginning
on the compliance date of this rule, a
business associate may not use or
disclose protected health information in
a manner that is contrary to the Privacy
Rule, even if the business associate’s
contract with the covered entity has not
yet been amended.
D. Section 164.508—Uses and
Disclosures for Which an Authorization
is Required
Section 164.508 of the Privacy Rule
permits a covered entity to use and
disclose protected health information
only if it has obtained a valid
authorization (i.e., one that meets the
requirements of the section), unless
such use or disclosure is otherwise
permitted or required by the Privacy
Rule. Section 164.508 also lists two
specific circumstances in which an
authorization must be obtained: (1) Most
uses and disclosures of psychotherapy
notes; and (2) uses and disclosures for
marketing.
1. Sale of Protected Health Information
Section 13405(d) of the HITECH Act
adds a third circumstance that requires
authorization, specifically the sale of
protected health information. Section
13405(d)(1) prohibits a covered entity or
business associate from receiving direct
or indirect remuneration in exchange for
the disclosure of protected health
information unless the covered entity
has obtained a valid authorization from
the individual pursuant to § 164.508
that states whether the protected health
information can be further exchanged
for remuneration by the entity receiving
the information. Section 13405(d)(2)
sets forth several exceptions to the
authorization requirement. These
exceptions are where the purpose of the
exchange of information for
remuneration is for: (1) Public health
activities, as described in § 164.512(b);
(2) research purposes as described in
§§ 164.501 and 164.512(i), if the price
charged for the information reflects the
costs of preparation and transmittal of
the data; (3) treatment of the individual;
(4) the sale, transfer, merger, or
consolidation of all or part of a covered
entity and for related due diligence;
(5) services rendered by a business
associate pursuant to a business
associate agreement and at the specific
request of the covered entity;
(6) providing an individual with access
to his or her protected health
information pursuant to § 164.524; and
(7) such other purposes as the Secretary
determines to be necessary and
appropriate by regulation. Section
13405(d)(4) of the Act provides that the
PO 00000
Frm 00024
Fmt 4701
Sfmt 4702
prohibition on sale of protected health
information shall apply to disclosures
occurring 6 months after the date of the
promulgation of final regulations
implementing this section.
To implement section 13405(d) of the
HITECH Act, we propose to add new
provisions at § 164.508(a)(4) regarding
the sale of protected health information.
In proposed § 164.508(a)(4)(i), we
propose to require a covered entity to
obtain an authorization for any
disclosure of protected health
information in exchange for direct or
indirect remuneration. This
authorization must state that the
disclosure will result in remuneration to
the covered entity. In proposed
§ 164.508(a)(4)(ii), we propose to except
several disclosures of protected health
information, made in exchange for
remuneration, from this authorization
requirement. These exceptions, as
discussed more fully below, generally
follow the statutory exceptions
described in the above paragraph.
The proposed language in
§ 164.508(a)(4)(i) generally follows the
statutory language of section 13405(d)(1)
in prohibiting the disclosure of
protected health information without an
authorization if the covered entity
receives direct or indirect remuneration
from or on behalf of the recipient of the
protected health information. As
required by the Act, this proposed
provision would apply to business
associates as well as to covered entities.
We do not include language in
proposed § 164.508(a)(4) to require that
the authorization under § 164.508
specify whether the protected health
information disclosed by the covered
entity for remuneration can be further
exchanged for remuneration by the
entity receiving the information. We
believe the intent of this statutory
language was to ensure that, as currently
required by § 164.508 for marketing, the
authorization include a statement as to
whether remuneration will be received
by the covered entity with respect to the
disclosures subject to the authorization.
Otherwise, the individual would not be
put on notice that the disclosure
involves remuneration and thus, would
not be making an informed decision as
to whether to sign the authorization.
Accordingly, we propose to require that
the § 164.508(a)(4)(i) authorization
include a statement that the covered
entity is receiving direct or indirect
remuneration in exchange for the
protected health information. This
requirement would ensure that
individuals can make informed
decisions regarding whether to
authorize disclosure of their protected
health information when the disclosure
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
will result in remuneration to the
covered entity. We also note, with
respect to the recipient of the
information, if protected health
information is disclosed for
remuneration by a covered entity or
business associate to another covered
entity or business associate in
compliance with the authorization
requirements at proposed
§ 164.508(a)(4)(i), the recipient covered
entity or business associate could not
redisclose that protected health
information in exchange for
remuneration unless a valid
authorization is obtained in accordance
with proposed § 164.508(a)(4)(i) with
respect to such redisclosure. We request
comment on these provisions.
In proposed § 164.508(a)(4)(ii), we set
forth the exceptions to the authorization
requirement of proposed paragraph
(a)(4)(i). We propose the exceptions
provided for by section 13405(d)(2) of
the HITECH Act, but we also propose to
exercise the authority granted to the
Secretary in section 13405(d)(2)(G) to
include an additional exception that we
deem to be similarly necessary and
appropriate. We invite public comment
on the proposed exceptions to this
authorization requirement and whether
there are additional exceptions that
should be included in the final
regulation.
The exception at proposed
§ 164.508(a)(4)(ii)(A) covers exchanges
for remuneration for public health
activities pursuant to §§ 164.512(b) or
164.514(e). This exception largely tracks
the statutory language; however, we
have added a reference to § 164.514(e),
to ensure that a covered entity or
business associate that discloses
protected health information for public
health activities in limited data set form
is also excepted from the authorization
requirement. We believe it is consistent
with the statutory language to also
except the disclosure of a limited data
set where Congress has already excepted
the disclosure of fully identifiable
protected health information for the
same purpose from the remuneration
prohibition. With respect to the
exception for public health disclosures,
section 13405(d)(3)(A) of the HITECH
Act requires that the Secretary evaluate
the impact of restricting this exception
to require that the price charged for the
data reflects only the costs of
preparation and transmittal of the data
on research or public health activities,
including those conducted by or for the
use of the Food and Drug
Administration (FDA). Section
13405(d)(3)(B) further provides that if
the Secretary finds that such further
restriction will not impede such
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
activities, the Secretary may include the
restriction in the regulations. While we
do not propose to include such a
restriction on the remuneration that may
be received for disclosures for public
health purposes at this time, we request
public comment on this issue to assist
us in evaluating the impact of any such
restriction.
The proposed exception at
§ 164.508(a)(4)(ii)(B) generally tracks the
statutory language and excepts from the
authorization requirement disclosures of
protected health information for
research purposes, pursuant to
§§ 164.512(i) or 164.514(e), in which the
covered entity receives remuneration, as
long as the remuneration received by
the covered entity is a reasonable, costbased fee to cover the cost to prepare
and transmit the information for
research purposes. We request public
comment on the types of costs that
should be permitted under this
provision. As discussed above with
respect to the exception for public
health activities, we also propose to add
a reference to § 164.514(e) to ensure that
this exception likewise applies to the
disclosure of protected health
information in limited data set form for
research purposes.
Proposed § 164.508(a)(4)(ii)(C) would
create an exception from the
authorization requirement for
disclosures of protected health
information for treatment and payment
purposes, in which the covered entity
receives remuneration. Though the Act
only addressed treatment, we have
expressly included disclosures for
payment purposes and have also
included reference to § 164.506(a),
which sets forth the standard for
disclosures of protected health
information for treatment and payment
purposes. We also propose to except
disclosures made for payment for health
care from the remuneration limitation to
make clear that we do not consider the
exchange of protected health
information to obtain ‘‘payment,’’ as
such term is defined in the Privacy Rule
at § 164.501, to be a sale of protected
health information and thus, subject to
the authorization requirements in this
section.
Section 13405(d)(2)(D) of the HITECH
Act excepts from the authorization
requirement disclosures described in
paragraph (6)(iv) of the definition of
health care operations at § 164.501, i.e.,
disclosures for the sale, transfer, merger,
or consolidation of all or part of a
covered entity with another covered
entity, or an entity that following such
activity will become a covered entity,
and due diligence related to such
activity. Proposed § 164.508(a)(4)(ii)(D)
PO 00000
Frm 00025
Fmt 4701
Sfmt 4702
40891
would accordingly except from the
authorization requirement disclosures of
protected health information for the
events described in paragraph (6)(iv).
We also add a reference to § 164.506(a),
the provision which permits a covered
entity to disclose protected health
information for health care operations
purposes.
Proposed § 164.508(a)(4)(ii)(E) would
except from the authorization
requirements disclosures of protected
health information to or by a business
associate for activities that the business
associate undertakes on behalf of a
covered entity pursuant to §§ 164.502(e)
and 164.504(e), as long as the only
remuneration provided is by the
covered entity to the business associate
for the performance of such activities.
We have modified the statutory
language to provide specific references
to the provisions of the Privacy Rule
that set forth the standards through
which covered entities may make
disclosures of protected health
information to business associates and
the standards for business associate
contracts which govern the relationship
between covered entities and their
business associates. This proposed
exception would exempt from the
authorization requirement in
§ 164.508(a)(4)(i) a disclosure of
protected health information by a
covered entity to a business associate or
by a business associate to a third party
on behalf of the covered entity as long
as any remuneration received by the
business associate was for payment for
the activities performed by the business
associate pursuant to a business
associate contract.
Proposed § 164.508(a)(4)(ii)(F) would
except from the authorization
requirement disclosures of protected
health information by a covered entity
to an individual when requested under
§§ 164.524 or 164.528. While section
13405(d)(2)(F) explicitly refers only to
disclosures under § 164.524, we are
exercising our authority under section
13405(d)(2)(G) of the HITECH Act
(discussed below) to include in this
proposed section disclosures under
§ 164.528 as necessary and appropriate.
Section 164.502(a)(2)(i) requires covered
entities to disclose protected health
information relating to an individual to
that individual upon request pursuant
to §§ 164.524 or 164.528. Section
164.524 permits a covered entity to
impose a reasonable, cost-based fee for
the provision of access to an
individual’s protected health
information, upon request. Section
164.528 requires a covered entity to
provide a requesting individual with an
accounting of disclosures without
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40892
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
charge in any 12-month period but
permits a covered entity to impose a
reasonable, cost-based fee for each
subsequent request for an accounting of
disclosures during that 12-month
period. Therefore, as a disclosure of
protected health information under
§ 164.528 is similar to a disclosure
under § 164.524 in that a covered entity
may be paid a fee for making the
disclosure, we have included
disclosures pursuant to requests for
accountings of disclosures in this
exception. We note that this exception
would not permit a covered entity to
require that an individual pay a fee that
is not otherwise permitted by §§ 164.524
or 164.528.
We propose an additional exception
at § 164.508(a)(4)(ii)(G), pursuant to the
authority granted to the Secretary in
section 13405(d)(2)(G) of the HITECH
Act to except from the authorization
requirements at proposed
§ 164.508(a)(4)(i) disclosures that are
required by law as permitted under
§ 164.512(a). Section 164.512(a) permits
covered entities to use or disclose
protected health information to the
extent that such use or disclosure is
required by law. We propose to add this
exception to ensure that a covered entity
can continue to disclose protected
health information, where required by
law, even if the covered entity receives
remuneration for the disclosure. We
request comment on the inclusion of
such an exception.
Finally, we propose an additional
exception at § 164.508(a)(4)(ii)(H),
pursuant to the authority granted to the
Secretary in section 13405(d)(2)(G), to
except from the authorization
requirements at proposed
§ 164.508(a)(4)(i) a disclosure of
protected health information for any
other purpose permitted by and in
accordance with the applicable
requirements of subpart E, as long as the
only remuneration received by the
covered entity is a reasonable, costbased fee to cover the cost to prepare
and transmit the protected health
information for such purpose or is a fee
otherwise expressly permitted by other
law. We have included this proposed
exception as necessary and appropriate
to ensure that the proposed
authorization requirement does not
deter covered entities from disclosing
protected health information for
permissible purposes under subpart E
just because they routinely receive
payment equal to the cost of preparing,
producing, or transmitting the protected
health information. We emphasize that
this exception would not apply if a
covered entity received remuneration
above the actual cost incurred to
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
prepare, produce, or transmit the
protected health information for the
permitted purpose, unless such fee is
expressly permitted by other law.
We recognize that many States have
laws in place to limit the fees a health
care provider can charge to prepare,
copy, and transmit medical records.
Some States simply require any
reasonable costs incurred by the
provider in making copies of the
medical records to be paid for by the
requesting party, while other States set
forth specific cost limitations with
respect to retrieval, labor, supplies, and
copying costs and allow charges equal
to actual mailing or shipping costs.
Many of these State laws set different
cost limitations based on the amount
and type of information to be provided,
taking into account whether the
information is in paper or electronic
form as well as whether the requested
material includes x-rays, films, disks,
tapes, or other diagnostic imaging. We
intend that the reference in proposed
§ 164.508(a)(4)(ii)(H) to fees expressly
permitted by other laws to include fees
permitted by such State laws. Therefore,
if a covered entity discloses protected
health information in exchange for
remuneration that conforms to an
applicable State law with respect to
such fees, the exception would apply
and no authorization pursuant to
§ 164.508(a)(4)(i) would be required. We
do note, however, that of the States that
do have such laws in place, there is
great variation regarding the types of
document preparation activities for
which a provider can charge as well as
the permissible fee schedules for such
preparation activities. We invite public
comment on our proposal to include in
§ 164.508(a)(4)(ii)(H) a general exception
for disclosures made for permissible
purposes for which the covered entity
received remuneration that was
consistent with applicable State law.
We propose a conforming change to
§ 164.508(b)(1)(i) to include a reference
to the authorization requirement in
proposed § 164.508(a)(4)(i).
2. Research
a. Compound Authorizations
Section 164.508(b)(4) of the Privacy
Rule prohibits covered entities from
conditioning treatment, payment,
enrollment in a health plan, or
eligibility for benefits on the provision
of an authorization. This limitation is
intended to prevent covered entities
from coercing individuals into signing
an authorization for a use or disclosure
that is not necessary to carry out the
services that the covered entity provides
to the individual. However, this section
PO 00000
Frm 00026
Fmt 4701
Sfmt 4702
permits a covered entity to condition
the provision of research-related
treatment on obtaining the individual’s
authorization in limited situations, such
as for a clinical trial. Permitting the use
of protected health information is part
of the decision to receive care through
a clinical trial, and health care providers
conducting such trials are able to
condition research-related treatment on
the individual’s willingness to authorize
the use or disclosure of protected health
information for research associated with
the trial.
Section 164.508(b)(3) generally
prohibits what are termed ‘‘compound
authorizations,’’ i.e., where an
authorization for the use and disclosure
of protected health information is
combined with any other legal
permission. However, § 164.508(b)(3)(i)
carves out an exception to this general
prohibition, permitting the combining of
an authorization for a research study
with any other written permission for
the same study, including another
authorization or consent to participate
in the research. Nonetheless,
§ 164.508(b)(3)(iii) prohibits combining
an authorization that conditions
treatment, payment, enrollment in a
health plan, or eligibility for benefits
with an authorization for another
purpose for which treatment, payment,
enrollment, or eligibility may not be
conditioned. This limitation on certain
compound authorizations was intended
to help ensure that individuals
understand that they may decline the
activity described in the unconditioned
authorization yet still receive treatment
or other benefits or services by agreeing
to the conditioned authorization.
The impact of these authorization
requirements and limitations can be
seen during clinical trials that are
associated with a corollary research
activity, such as when protected health
information is used or disclosed to
create or to contribute to a central
research database or repository. For
example, § 164.508(b)(3)(iii) prevents
covered entities from obtaining a single
authorization for the use or disclosure of
protected health information for a
research study that includes both
treatment as part of a clinical trial and
tissue banking of specimens (and
associated protected health information)
collected, since a research-related
treatment authorization generally is
conditioned and a tissue banking
authorization generally is not
conditioned. Various groups, including
researchers and professional
organizations, have expressed concern
at this lack of integration. The
Secretary’s Advisory Committee for
Human Research Protections in 2004
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
(Recommendation V, in a letter to the
Secretary of HHS, available at https://
www.hhs.gov/ohrp/sachrp/
hipaalettertosecy090104.html), as well
as the Institute of Medicine (IOM) in its
2009 Report, ‘‘Beyond the HIPAA
Privacy Rule: Enhancing Privacy,
Improving Health Through Research’’
(Recommendation II.B.2), also made
specific recommendations to allow
combined authorizations for clinical
trials and biospecimen storage.
Research-related treatment offered
through a clinical trial is nearly always
conditioned upon signing the informed
consent to participate in the trial and
the authorization to use or disclose the
individual’s protected health
information for the trial. Thus, covered
entities must obtain separate
authorizations from research
participants for a clinical trial that also
collects specimens with associated
protected health information for a
central repository. For clinical research
trials that may have thousands of
participants, documenting and storing
twice as many authorizations is a major
concern. There is also a concern that
multiple forms may be confusing for
research subjects. The Department has
received reports that recruitment into
clinical trials has been hampered, in
part, because the multiplicity of forms
for research studies dissuades
individuals from participating in
research. We have also heard that
redundant information provided by two
authorization forms (one for the clinical
study and another for related research)
diverts an individual’s attention from
other content that describes how and
why the personal health information
may be used.
While seeking Institutional Review
Board (IRB) or Privacy Board waiver of
the authorization requirement is an
option under § 164.512 of the Privacy
Rule, an IRB or Privacy Board is less
likely to approve a request for a waiver
of authorization for a foreseeable use or
disclosure of protected health
information to create and maintain or
contribute to a central tissue or
information repository if the covered
entity is planning to seek informed
consent from the individual for this
purpose. Accordingly, the waiver
provisions generally do not resolve
concerns expressed by the research
community.
We agree that allowing a covered
provider to combine research
authorizations would streamline the
process for obtaining an individual’s
authorization for research and would
make the documentation
responsibilities of these covered entities
more manageable. Such a modification
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
would also result in an authorization
that would be simpler and, therefore,
more meaningful to the individual (in
contrast to the individual receiving
multiple forms that may be confusing).
We, therefore, propose to amend
§ 164.508(b)(3)(i) and (iii) to allow a
covered entity to combine conditioned
and unconditioned authorizations for
research, provided that the
authorization clearly differentiates
between the conditioned and
unconditioned research components
and clearly allows the individual the
option to opt in to the unconditioned
research activities. These provisions
would allow covered entities to
combine authorizations for scenarios
that often occur in research studies. For
example, a covered entity would be able
to combine an authorization permitting
the use and disclosure of protected
health information associated with a
specimen collection for a central
repository and authorization permitting
use and disclosure of protected health
information for clinical research that
conditions research-related treatment on
the execution of a HIPAA authorization.
While the proposed modifications do
not alter the core elements or required
statements integral to a valid
authorization, covered entities would
have some flexibility with respect to
how they met the authorization
requirements. For example, covered
entities could facilitate an individual’s
understanding of a compound
authorization by describing the
unconditioned research activity on a
separate page of a compound
authorization. They could also crossreference relevant sections of a
compound authorization to minimize
the potential for redundant language. In
addition, a covered entity could use a
separate check-box for the
unconditioned research activity to
signify whether an individual has
opted-in to the unconditioned research
activity, while maintaining one
signature line for the authorization.
Alternatively, a covered entity could
choose to provide a distinct signature
line for the unconditioned authorization
to signal that the individual is
authorizing optional research that will
not affect research-related treatment. We
request comment on additional methods
that would clearly differentiate to the
individual the conditioned and
unconditioned research activities on the
compound authorization.
b. Authorizing Future Research Use or
Disclosure
Research often involves obtaining
health information and biological
specimens to create a research database
PO 00000
Frm 00027
Fmt 4701
Sfmt 4702
40893
or repository for future research. For
example, this frequently occurs where
clinical trials are paired with corollary
research activities, such as the creation
of a research database or repository
where information and specimens
obtained from a research participant
during the trial are transferred and
maintained for future research. It also is
our understanding that IRBs in some
cases may approve an informed consent
document for a clinical trial that also
asks research participants to permit
future research on their identifiable
information or specimens obtained
during the course of the trial, or may
review an informed consent for a prior
clinical trial to determine whether a
subsequent research use is encompassed
within the original consent.
The Department has interpreted the
Privacy Rule, however, to require that
authorizations for research be study
specific for purposes of complying with
the Rule’s requirement at
§ 164.508(c)(1)(iv) that an authorization
must include a description of each
purpose of the requested use or
disclosure. See 67 FR 53182, 53226,
Aug. 14, 2002. In part, the Department’s
interpretation was based on a concern
that patients could lack necessary
information in the authorization to
make an informed decision about the
future research, due to a lack of
information about the future research at
the time the authorization was obtained.
In addition, it was recognized that not
all uses and disclosures of protected
health information for a future research
purpose would require a covered entity
to re-contact the individual to obtain
another authorization, to the extent
other conditions in the Privacy Rule
were met. For example, a covered entity
could obtain a waiver of authorization
from an IRB or Privacy Board as
provided under § 164.512(i) or use or
disclose only a limited data set pursuant
to a data use agreement under
§ 164.514(e) for the future research
purpose.
Subsequent to its issuing this
interpretation, the Department has
heard concerns from covered entities
and researchers that the Department’s
interpretation encumbers secondary
research, and limits an individual’s
ability to agree to the use or disclosure
of their protected health information for
future research without having to be recontacted to sign multiple authorization
forms at different points in the future.
In addition, many commenters noted
that the Department’s interpretation
limiting the scope of a HIPAA
authorization for research appeared to
diverge from the current practice under
the Common Rule with respect to the
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40894
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
ability of a researcher to seek subjects’
consent to future research so long as the
future research uses are described in
sufficient detail to allow an informed
consent. These commenters, as well as
the Secretary’s Advisory Committee for
Human Research Protections in 2004
(Recommendation IV, in a letter to the
Secretary of HHS, available at https://
www.hhs.gov/ohrp/sachrp/
hipaalettertosecy090104.html) and the
IOM in its 2009 Report entitled ‘‘Beyond
the HIPAA Privacy Rule: Enhancing
Privacy, Improving Health Through
Research’’ (Recommendation II.B.1),
have urged the Department to allow the
HIPAA authorization to permit future
research use and disclosure of protected
health information or, at a minimum, for
the Department to modify its
interpretation to allow the authorization
to encompass certain future use and
disclosure of protected health
information for research, provided
certain parameters are met.
Given these concerns, in addition to
the modifications mentioned in the
prior section, the Department is
considering whether to modify its
interpretation that an authorization for
the use or disclosure of protected health
information for research be researchstudy specific. In particular, the
Department is considering a number of
options and issues in this area,
including whether: (1) The Privacy Rule
should permit an authorization for uses
and disclosures of protected health
information for future research purposes
to the extent such purposes are
adequately described in the
authorization such that it would be
reasonable for the individual to expect
that his or her protected health
information could be used or disclosed
for such future research; (2) the Privacy
Rule should permit an authorization for
future research only to the extent the
description of the future research
included certain elements or statements
specified by the Privacy Rule, and if so,
what should those be; and (3) the
Privacy Rule should permit option (1) as
a general rule but require certain
disclosure statements on the
authorization in cases where the future
research may encompass certain types
of sensitive research activities, such as
research involving genetic analyses or
mental health research, that may alter
an individual’s willingness to
participate in the research. We request
comment on each of these options,
including their impact on the conduct of
research and patient understanding of
authorizations.
We note that any modification in this
area would not alter an individual’s
right to revoke the authorization for the
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
use or disclosure of protected health
information for future research at any
time and that the authorization would
have to include a description of how the
individual may do so. We request
comment on how a revocation would
operate with respect to future
downstream research studies.
The Department does not propose any
specific modifications to the Privacy
Rule at this time but requests public
comment on the options identified
above, as well as any others, for
purposes of addressing this issue at the
time the final rule is issued, if
appropriate. In addition, any change in
interpretation will be closely
coordinated with the HHS Office for
Human Research Protections (OHRP)
and the FDA to ensure the Privacy Rule
policies are appropriately harmonized
with those under the HHS human
subjects protections regulations (45 CFR
part 46) and FDA human subjects
protections regulations governing
informed consent for research (21 CFR
part 50).
E. Protected Health Information About
Decedents
1. Section 164.502(f)—Period of
Protection for Decedent Information
Section 164.502(f) requires covered
entities to protect the privacy of a
decedent’s protected health information
generally in the same manner and to the
same extent that is required for the
protected health information of living
individuals. Thus, if an authorization is
required for the use or disclosure of
protected health information, a covered
entity may use or disclose a decedent’s
protected health information in that
situation only if the covered entity
obtains an authorization from the
decedent’s personal representative. The
personal representative for a decedent is
the executor, administrator, or other
person who has authority under
applicable law to act on behalf of the
decedent or the decedent’s estate. The
Department has heard a number of
concerns since the publication of the
Privacy Rule that it can be difficult to
locate a personal representative to
authorize the use or disclosure of the
decedent’s protected health information,
particularly after an estate is closed.
Furthermore, archivists, biographers
and historians have expressed
frustration regarding the lack of access
to ancient or old records of historical
value held by covered entities, even
when there are likely few remaining
individuals concerned with the privacy
of such information. Archives and
libraries may hold medical records that
are centuries old. Furthermore,
PO 00000
Frm 00028
Fmt 4701
Sfmt 4702
fragments of health information may be
found throughout all types of archival
holdings, such as correspondence files,
diaries, and photograph collections, that
are also in some cases centuries old.
Currently, to the extent such
information is maintained by a covered
entity, it is subject to the Privacy Rule.
For example, currently the Privacy Rule
would apply in the same manner to the
casebook of a 19th century physician as
it would to the medical records of
current patients of a physician.
Accordingly, we propose to amend
§ 164.502(f) to require a covered entity
to comply with the requirements of the
Privacy Rule with regard to the
protected health information of a
deceased individual for a period of 50
years following the date of death. We
also propose to modify the definition of
‘‘protected health information’’ at
§ 160.103 to make clear that the
individually identifiable health
information of a person who has been
deceased for more than 50 years is not
protected health information under the
Privacy Rule. We believe that fifty years
is an appropriate time span, because by
approximately covering the span of two
generations we believe it will both
protect the privacy interests of most, if
not all, living relatives, or other affected
individuals, and it reflects the difficulty
of obtaining authorizations from
personal representatives as time passes.
A fifty-year period of protection also
was suggested at a prior National
Committee for Vital and Health
Statistics (NCVHS) (the public advisory
committee which advises the Secretary
on the implementation of the
Administrative Simplification
provisions of HIPAA, among other
issues) meeting, at which committee
members heard testimony from
archivists regarding the problems
associated with applying the Privacy
Rule to very old records. See https://
ncvhs.hhs.gov/050111mn.htm. We
request public comment on the
appropriateness of this time period.
We note that these proposed
modifications would have no impact on
a covered entity’s permitted disclosures
related to decedents for law
enforcement purposes (§ 164.512(f)(4)),
to coroners or medical examiners and
funeral directors (§ 164.512(g)), for
research that is solely on the protected
health information of decedents
(§ 164.512(i)(1)(iii)), and for organ
procurement organizations or other
entities engaged in the procurement,
banking, or transplantation of cadaveric
organs, eyes, or tissue for the purpose of
facilitating organ, eye or tissue donation
and transplantation (§ 164.512(h)).
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
These disclosures are governed by other
provisions of the Privacy Rule.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
2. Section 164.510(b)—Disclosures
About a Decedent to Family Members
and Others Involved in Care
Section 164.510(b) describes how a
covered entity may use or disclose
protected health information to persons,
such as family members or others, who
are involved in an individual’s care or
payment related to the individual’s
health care. We have received a number
of questions about the scope of the
section, specifically with regard to the
protected health information of
decedents. We have heard concerns that
family members, relatives, and others,
many of whom may have had access to
the health information of the deceased
individual prior to death, have had
difficulty obtaining access to such
information after the death of the
individual, because many do not qualify
as a ‘‘personal representative’’ under
§ 164.502(g)(4).
As such, we propose to amend
§ 164.510(b) to add a new paragraph (5),
which would permit covered entities to
disclose a decedent’s information to
family members and others who were
involved in the care or payment for care
of the decedent prior to death, unless
doing so is inconsistent with any prior
expressed preference of the individual
that is known to the covered entity. We
propose to add conforming crossreferences to paragraphs (b)(1)(i) and (ii)
and (b)(4). We note that this disclosure
would be permitted, but would not be
required. We request comment on any
unintended consequences that this
permissive disclosure provision might
cause.
We also note that these modifications
do not change the authority of a
decedent’s personal representative with
regard to the decedent’s protected
health information. Thus, a personal
representative may continue to request
access to or an accounting of a
decedent’s protected health information,
and may continue to authorize uses and
disclosures of the decedent’s protected
health information that are not
otherwise permitted or required by the
Privacy Rule.
F. Section 164.512(b)—Disclosure of
Student Immunizations to Schools
The Privacy Rule, in § 164.512(b),
recognizes that covered entities must
balance protecting the privacy of health
information with sharing health
information with those responsible for
ensuring public health and safety, and
permits covered entities to disclose the
minimum necessary protected health
information to public health authorities
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
or other designated persons or entities
without an authorization for public
health purposes specified by the Rule.
Covered entities may disclose protected
health information: (1) To a public
health authority that is legally
authorized to collect or receive the
information for the purpose of
preventing or controlling disease,
injury, or disability (such as reporting
communicable diseases, births, and
deaths, or conducting public health
interventions, investigations, and
surveillance); (2) to a public health
authority or other appropriate
government authority to report child
abuse if the authority is legally
authorized to receive such reports; (3) to
a person or entity subject to the
jurisdiction of the FDA about the
quality, safety, or effectiveness of an
FDA-regulated product or activity for
which the person or entity has
responsibility (such as reporting adverse
drug events to the drug manufacturer);
(4) to notify a person that (s)he is at risk
of contracting or spreading a disease or
condition, as authorized by law, to carry
out a public health intervention or
investigation; and (5) to an employer
under limited circumstances and
conditions when the employer needs
the information to comply with
Occupational Safety and Health
Administration (OSHA) or Mine Safety
and Health Administration (MSHA)
requirements. Any other disclosures
that do not conform to these provisions,
and that are not otherwise permitted by
the Rule, require the individual’s prior
written authorization.
Schools play an important role in
preventing the spread of communicable
diseases among students by ensuring
that students entering classes have been
immunized. Most States have ‘‘school
entry laws’’ which prohibit a child from
attending school unless the school has
proof that the child has been
appropriately immunized. Typically,
schools ensure compliance with those
requirements by requesting the
immunization records from parents
(rather than directly from a health care
provider), particularly because the
Privacy Rule generally requires written
authorization by the child’s parent
before a covered health care provider
may disclose protected health
information directly to the school. Some
States allow a child to enter school
provisionally for a period of 30 days
while the school waits for the necessary
immunization information.
We have heard concerns that the
Privacy Rule may make it more difficult
for parents to provide, and for schools
to obtain, the necessary immunization
documentation for students, which may
PO 00000
Frm 00029
Fmt 4701
Sfmt 4702
40895
prevent students’ admittance to school.
The NCVHS submitted these concerns
to the HHS Secretary and recommended
that HHS regard disclosure of
immunization records to schools to be a
public health disclosure. See https://
www.ncvhs.hhs.gov/040617l2.htm.
As such, we propose to amend
§ 164.512(b)(1) by adding a new
paragraph that permits covered entities
to disclose proof of immunization to
schools in States that have school entry
or similar laws. While written
authorization that complies with
§ 164.508 would no longer be required
for disclosure of such information, the
covered entity would still be required to
obtain agreement, which may be oral,
from a parent, guardian or other person
acting in loco parentis for the
individual, or from the individual himor herself, if the individual is an adult
or emancipated minor. Because the
proposed provision would permit a
provider to accept a parent’s oral
agreement to disclose immunization
results to a school—as opposed to a
written agreement—there is a potential
for a miscommunication and later
objection by the parent. We, therefore,
request comment on whether the
Privacy Rule should require that a
provider document any oral agreement
under this provision to help avoid such
problems, or whether a requirement for
written documentation would be overly
cumbersome, on balance. We also
request comment on whether the rule
should mandate that the disclosures go
to a particular school official and if so,
who that should be.
In addition, the Privacy Rule does not
currently define the term ‘‘school’’ and
we understand that the types of schools
subject to the school entry laws may
vary by State. For example, depending
on the State, such laws may apply to
public and private elementary or
primary schools and secondary schools
(kindergarten through 12th grade), as
well as daycare and preschool facilities,
and post-secondary institutions. Thus,
we request comment on the scope of the
term ‘‘school’’ for the purposes of this
section and whether we should include
a specific definition of ‘‘school’’ within
the regulation itself. In addition, we
request comment on the extent to which
schools that may not be subject to these
school entry laws but that may also
require proof of immunization have
experienced problems that would
warrant their being included in this
category of public health disclosures.
Finally, we note that once a student’s
immunization records are obtained and
maintained by an educational
institution or agency to which the
Family Educational Rights and Privacy
E:\FR\FM\14JYP2.SGM
14JYP2
40896
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Act (FERPA) applies, the records are
protected by FERPA, rather than the
HIPAA Privacy Rule. See paragraphs
(2)(i) and (2)(ii) of the definition of
‘‘protected health information’’ at
§ 160.103, which exclude from coverage
under the Privacy Rule student records
protected by FERPA. In addition, for
more information on the intersection of
FERPA and HIPAA, readers are
encouraged to consult the Joint HHS/ED
Guidance on the Application of FERPA
and HIPAA to Student Health Records,
available at https://www.hhs.gov/ocr/
privacy/hipaa/understanding/
coveredentities/
hipaaferpajointguide.pdf.
G. Section 164.514(d)—Minimum
Necessary
Section 164.502(b)(1) of the Privacy
Rule requires covered entities to limit
uses and disclosures of, and requests
for, protected health information to ‘‘the
minimum necessary to accomplish the
intended purpose of the use, disclosure,
or request.’’ Section 164.502(b)(2)
outlines situations in which the
minimum necessary rule does not
apply. With respect to uses of protected
health information, § 164.514(d)(2)
requires covered entities to identify
workforce members who need access to
protected health information, to identify
the categories and conditions of such
access, and to make reasonable efforts to
limit access consistent with such
policies. With respect to disclosures of,
and requests for, protected health
information, § 164.514(d)(3) and (4)
require that covered entities adopt
policies and procedures addressing
minimum necessary, including with
regard to uses and disclosures that occur
routinely.
Section 13405(b)(1)(A) of the HITECH
Act provides that a covered entity shall
be treated as being in compliance with
the minimum necessary requirements
with respect to the use or disclosure of
or the request for protected health
information ‘‘only if the covered entity
limits such protected health
information, to the extent practicable, to
the limited data set (as defined in
section 164.514(e)(2) of such title) or, if
needed by such entity, to the minimum
necessary.’’ Section 13405(b)(1)(B)
requires the Secretary to issue guidance
on what constitutes ‘‘minimum
necessary’’ within 18 months after the
date of enactment. This guidance must
take into account the guidance required
by section 13424(c), relating to the deidentification of protected health
information, as well as ‘‘the information
necessary to improve patient outcomes
and to detect, prevent, and manage
chronic disease.’’ Section 13405(b)(1)(C)
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
provides that the provisions of
paragraph (A) no longer apply as of the
effective date of the guidance issued
under paragraph (B).
Section 13405(b)(2) provides that,
with respect to disclosures of protected
health information, the covered entity or
business associate making the
disclosure shall determine what
constitutes the minimum necessary.
Section 13405(b)(3) provides that
section 13405(b)(1) does not affect the
application of the exceptions to the
minimum necessary requirement, while
section 13405(b)(4) provides that
nothing in subsection (b) is to be
construed as affecting the use or
disclosure of or request for de-identified
health information.
Section 13405(b)(1)(A) requires that
covered entities consider the feasibility
of utilizing the limited data set in
complying with the minimum necessary
requirements of the Privacy Rule.
However, that provision also permits a
covered entity to employ its traditional
minimum necessary policies and
procedures if it decides that the limited
data set will not meet the needs of the
particular use, disclosure, or request in
question. The requirement of this
section, moreover, is an interim one;
under section 13405(b)(1)(C), issuance
of the guidance required by section
13405(b)(1)(B) effectively sunsets the
requirement of section 13405(b)(1)(A).
For purposes of the required
guidance, we take this opportunity to
solicit public comment on what aspects
of the minimum necessary standard
covered entities and business associates
believe would be most helpful to have
the Department address in the guidance
and the types of questions entities may
have about how to appropriately
determine the minimum necessary for
purposes of complying with the Privacy
Rule. We propose to leave the current
regulatory text unchanged in this
rulemaking as the issuance of the
required guidance will obviate the need
to make any regulatory modifications in
this area.
H. Section 164.514(f)—Fundraising
Section 164.514(f)(1) of the Privacy
Rule permits a covered entity to use, or
disclose to a business associate or an
institutionally related foundation, the
following protected health information
for its own fundraising purposes
without an individual’s authorization:
(1) Demographic information relating to
an individual; and (2) the dates of
health care provided to an individual.
Section 164.514(f)(2) of the Privacy Rule
requires a covered entity that plans to
use or disclose protected health
information for fundraising under this
PO 00000
Frm 00030
Fmt 4701
Sfmt 4702
paragraph to inform individuals in its
notice of privacy practices that it may
contact them to raise funds for the
covered entity. In addition,
§ 164.514(f)(2) requires that a covered
entity include in any fundraising
materials it sends to an individual a
description of how the individual may
opt out of receiving future fundraising
communications and that a covered
entity must make reasonable efforts to
ensure that individuals who do opt out
are not sent future fundraising
communications.
Section 13406(b) of the HITECH Act,
which became effective on February 18,
2010, requires the Secretary to provide
by rule that a covered entity provide the
recipient of any fundraising
communication with a clear and
conspicuous opportunity to opt out of
receiving any further fundraising
communications. Additionally, section
13406(b) states that if an individual
does opt out of receiving further
fundraising communications, the
individual’s choice to opt out must be
treated as a revocation of authorization
under § 164.508 of the Privacy Rule.
We propose a number of changes to
the Privacy Rule’s fundraising
requirements to implement these
statutory provisions. First, we propose
to strengthen the opt out by requiring
that a covered entity provide, with each
fundraising communication sent to an
individual under these provisions, a
clear and conspicuous opportunity for
the individual to elect not to receive
further fundraising communications. To
satisfy this requirement, we also
propose to require that the method for
an individual to elect not to receive
further fundraising communications
may not cause the individual to incur an
undue burden or more than nominal
cost. We encourage covered entities to
consider the use of a toll-free phone
number, an e-mail address, or similar
opt out mechanism that would provide
individuals with a simple, quick, and
inexpensive way to opt out of receiving
future communications. We note that
we would consider requiring
individuals to write and send a letter to
the covered entity asking not to receive
future fundraising communications to
constitute an undue burden on the
individual for purposes of this proposed
requirement.
We also propose to provide that a
covered entity may not condition
treatment or payment on an individual’s
choice with respect to receiving
fundraising communications. We
believe this modification would
implement the language in section
13406(b) of the HITECH Act that
provides that an election by an
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
individual not to receive further
fundraising communications shall be
treated as a revocation of authorization
under the Privacy Rule. The legislative
history of the HITECH Act indicates that
it was Congress’ intent with this
language that the protections that apply
under § 164.508 to an individual who
has revoked an authorization similarly
apply to an individual who has opted
out of fundraising communications,
‘‘including the right not to be denied
treatment as a result of making that
choice.’’ See H.R. Conf. Rep. 111–16, p.
498. Therefore, we make clear in this
proposed rule that a covered entity
would not be permitted to condition
treatment or payment for care on an
individual’s choice of whether to
receive fundraising communications.
Further, we propose to provide that a
covered entity may not send fundraising
communications to an individual who
has elected not to receive such
communications. This proposed
language would strengthen the current
requirement at § 164.514(f)(2)(iii) that a
covered entity make ‘‘reasonable efforts’’
to ensure that those individuals who
have opted out of receiving fundraising
communications are not sent such
communications. We have proposed
stronger language to make clear the
expectation that covered entities abide
by an individual’s decision not to
receive fundraising communications, as
well as to make the fundraising opt out
operate more like a revocation of
authorization, consistent with the
statutory language and legislative
history of section 13406(b) of the
HITECH Act discussed above.
With respect to the operation of the
opt out, we request comment regarding
to what fundraising communications the
opt out should apply. For example, if an
individual receives a fundraising letter
and opts out of receiving future
fundraising communications, should the
opt out apply to all future fundraising
communications or should and can the
opt out be structured in a way to only
apply to the particular fundraising
campaign described in the letter? In
addition, given that we would require
the opt out method to be simple and
quick for the individual to exercise,
such as the use of a phone number or
e-mail address, we request comment on
whether the Rule should allow a similar
method, short of the individual signing
an authorization, by which an
individual who has previously opted
out can put his or her name back on an
institution’s fundraising list.
We propose to retain the requirement
that a covered entity that intends to
contact the individual to raise funds
under these provisions must include a
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
statement to that effect in its notice of
privacy practices. However, we do
propose to modify the required
statement slightly, as indicated below in
the discussion of the notice
requirements at § 164.520, by requiring
that the notice also inform individuals
that they have a right to opt out of
receiving such communications. We
also propose to move all of the
fundraising requirements described
above to § 164.514(f)(1), given that the
proposed provisions for subsidized
treatment communications discussed
above now would be located at
§ 164.514(f)(2).
In addition to the above modifications
proposed in response to the HITECH
Act, we also solicit public comment on
the requirement at § 164.514(f)(1) which
limits the information a covered entity
may use or disclose for fundraising
demographic information about and
dates of health care service provided to
an individual. Since the promulgation
of the Privacy Rule, certain covered
entities have raised concerns regarding
this limitation, maintaining that the
Privacy Rule’s prohibition on the use or
disclosure of certain treatment
information without an authorization,
such as the department of service where
care was received and outcomes
information, harms their ability to raise
funds from often willing and grateful
patients. In particular, covered entities
have argued that the restrictions in the
Privacy Rule prevent them from
targeting their fundraising efforts and
avoiding inappropriate solicitations to
individuals who may have had a bad
treatment outcome, and obtaining an
individual’s authorization for
fundraising as the individual enters or
leaves the hospital for treatment is often
impracticable or inappropriate. NCVHS
also held a hearing and heard public
testimony on this issue in July 2004.
After considering the testimony
provided, the NCVHS recommended to
the Secretary that the Privacy Rule
should allow covered entities to use or
disclose information related to the
patient’s department of service (broad
designations, such as surgery or
oncology, but not narrower designations
or information relating to diagnosis or
treating physician) for fundraising
activities without patient authorization.
NCVHS also recommended that a
covered entity’s notice of privacy
practices inform patients that their
department of service information may
be used in fundraising, and that patients
should be afforded the opportunity to
opt out of the use of their department
of service information for fundraising or
all fundraising contacts altogether. See
PO 00000
Frm 00031
Fmt 4701
Sfmt 4702
40897
https://www.ncvhs.hhs.gov/
040902lt1.htm.
In light of these concerns and the
prior recommendation of the NCVHS,
the Department takes this opportunity to
solicit public comment on whether and
how the current restriction on what
information may be used and disclosed
should be modified to allow covered
entities to more effectively target
fundraising and avoid inappropriate
solicitations to individuals, as well as to
reduce the need to send solicitations to
all patients. In particular, we solicit
comment on: (1) Whether the Privacy
Rule should allow additional categories
of protected health information to be
used or disclosed for fundraising, such
as department of service or similar
information, and if so, what those
categories should be; (2) the adequacy of
the minimum necessary standard to
appropriately limit the amount of
protected health information that may
be used or disclosed for fundraising
purposes; or (3) whether the current
limitation should remain unchanged.
We also solicit comment on whether, if
additional information is permitted to
be used or disclosed for fundraising
absent an authorization, covered entities
should be required to provide
individuals with an opportunity to opt
out of receiving any fundraising
communications before making the first
fundraising solicitation, in addition to
the opportunity to opt out with every
subsequent communication. We invite
public comment on whether such a presolicitation opt out would be workable
for covered entities and individuals and
what mechanisms could be put into
place to implement the requirement.
I. Section 164.520—Notice of Privacy
Practices for Protected Health
Information
Section 164.520 of the Privacy Rule
sets out the requirements for most
covered entities to have and to
distribute a notice of privacy practices
(NPP). The NPP must describe the uses
and disclosures of protected health
information a covered entity is
permitted to make, the covered entity’s
legal duties and privacy practices with
respect to protect protected health
information, and the individual’s rights
concerning protected health
information.
With regard to the description of
permitted uses and disclosures,
§ 164.520(b)(1)(ii) requires a covered
entity to include separate statements
about the uses and disclosures that the
covered entity intends to make for
certain treatment, payment, or health
care operations activities. Further,
§ 164.520(b)(1)(ii)(E) currently requires
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40898
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
that the NPP contain a statement that
any uses and disclosures other than
those permitted by the Privacy Rule will
be made only with the written
authorization of the individual, and that
the individual has the right to revoke an
authorization pursuant to
§ 164.508(b)(5). The purpose of this
statement is to put individuals on notice
that covered entities may make certain
uses and disclosures only with an
authorization from the individual.
Section 164.520(b)(1)(iv) requires that
the NPP contain statements regarding
the rights of individuals with respect to
their protected health information and a
brief description of how individuals
may exercise such rights. Section
164.520(b)(1)(iv)(A) currently requires a
statement and a brief description
addressing an individual’s right to
request restrictions on the uses and
disclosures of protected health
information pursuant to § 164.522(a),
including the fact that the covered
entity is not required to agree to this
request.
We propose to amend
§ 164.520(b)(1)(ii)(E) to require that the
NPP include a statement that describes
the uses and disclosures of protected
health information that require an
authorization under § 164.508(a)(2)
through (a)(4), and to provide that other
uses and disclosures not described in
the notice will be made only with the
individual’s authorization. The
proposed provision would ensure that
covered entities provide notice to
individuals indicating that most
disclosures of protected health
information for which the covered
entity receives remuneration would
require the authorization of the
individual. Such uses and disclosures
may have previously been permitted
under other provisions of the Rule but
now require authorization, as discussed
in connection with proposed
§ 164.508(a)(4).
We propose to require, in addition,
that covered entities provide notice that
most uses and disclosures of
psychotherapy notes and for marketing
purposes require an authorization so
that individuals will be made aware of
all situations in which authorization is
required. We are concerned that
omission of such a specific statement
may be somewhat misleading or
confusing, in that the NPP would state
that the covered entity may use or
disclose protected health information
without authorization for purposes of
treatment, payment, and health care
operations and some individuals might
assume that psychotherapy notes and
marketing would be covered by these
permissions.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Section 164.520(b)(1)(iii) requires a
covered entity to include in its NPP
separate statements about certain
activities if the covered entity intends to
engage in any of the activities. In
particular, § 164.520(b)(1)(iii) requires a
separate statement in the notice if the
covered entity intends to contact the
individual to provide appointment
reminders or information about
treatment alternatives or other healthrelated benefits or services; to contact
the individual to fundraise for the
covered entity; or, with respect to a
group health plan, to disclose protected
health information to the plan sponsor.
We propose the following changes to
these provisions. First, we propose to
modify § 164.520(b)(1)(iii)(A) to align
the required statement with the
proposed modifications related to
marketing and subsidized treatment
communications. A covered health care
provider that intends to send treatment
communications to the individual in
accordance with proposed
§ 164.514(f)(2) concerning treatment
alternatives or other health-related
products or services where the provider
receives financial remuneration in
exchange for making the
communication would be required to
inform the individual in advance in the
NPP, as well as inform the individual
that he or she has the opportunity to opt
out of receiving such communications.
Second, at § 164.520(b)(1)(iii)(B) we
propose to require that if a covered
entity intends to contact the individual
to raise funds for the entity as permitted
under § 164.514(f)(1), the covered entity
must not only inform the individual in
the NPP of this intention but also that
the individual has the right to opt out
of receiving such communications.
We also propose to modify the
requirement of § 164.520(b)(1)(iv)(A)
which requires covered entities to notify
individuals of the individuals’ right to
request restrictions. This provision
currently includes a requirement that
the NPP state that the covered entity is
not required to agree to such a request.
Since this statement will no longer be
accurate when the modifications to
proposed § 164.522(a)(1)(vi) that are
required by the HITECH Act are made
(see discussion in the following
section), proposed § 160.520(b)(1)(iv)(A)
would require, in addition, that the
statement include an exception for
requests under § 164.522(a)(1)(vi).
Under subpart D of part 164, covered
entities now have new obligations to
comply with the requirements for
notification to affected individuals, the
media, and the Secretary following a
breach of unsecured protected health
information. We request comment on
PO 00000
Frm 00032
Fmt 4701
Sfmt 4702
whether the Privacy Rule should require
a specific statement regarding this new
legal duty and what particular aspects of
this new duty would be important for
individuals to be notified of in the NPP.
The proposed modifications to
§ 164.520 represent material changes to
the NPP of covered entities. Section
164.520(b)(3) requires that when there is
a material change to the NPP, covered
entities must promptly revise and
distribute the NPP as outlined by
§ 164.520(c). Section 164.520(c)(1)(i)(C)
requires that health plans provide notice
to individuals covered by the plan
within 60 days of any material revision
to the NPP. We recognize that revising
and redistributing a NPP may be costly
for health plans and request comment
on ways to inform individuals of this
change to privacy practices without
unduly burdening health plans. In
particular, we are considering a number
of options in this area: (1) Replace the
60-day requirement with a requirement
for health plans to revise their NPPs and
redistribute them (or at least notify
members of the material change to the
NPP and how to obtain the revised NPP)
in their next annual mailing to members
after a material revision to the NPP,
such as at the beginning of the plan year
or during the open enrollment period;
(2) provide a specified delay or
extension of the 60-day timeframe for
health plans; (3) retain the provision
generally to require health plans to
provide notice within 60-days of a
material revision but provide that the
Secretary will waive the 60-day
timeframe in cases where the timing or
substance of modifications to the
Privacy Rule call for such a waiver; or
(4) make no change, and thus, require
that health plans provide notice to
individuals within 60 days of the
material change to the NPP that would
be required by this proposed rule. We
request comment on these options, as
well as on any other options for
informing individuals in a timely
manner of this proposed or other
material changes to the NPP.
Section 164.520(c)(2)(iv) requires that
when a health care provider with a
direct treatment relationship with an
individual revises the NPP, the health
care provider must make the NPP
available upon request on or after the
effective date of the revision and must
comply with the requirements of
§ 164.520(c)(2)(iii) to have the NPP
available at the delivery site and to post
the notice in a clear and prominent
location. We do not believe these
requirements will be overly burdensome
on health care providers and do not
propose changes to them, but we request
comment on this issue.
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
J. Section 164.522(a)—Right To Request
Restriction of Uses and Disclosures
Section 164.522(a) of the Privacy Rule
requires covered entities to permit
individuals to request that a covered
entity restrict uses or disclosures of
their protected health information for
treatment, payment, and health care
operations purposes, as well as for
disclosures to family members and
certain others permitted under
§ 164.510(b). While covered entities are
not required to agree to such requests
for restrictions, if a covered entity does
agree to restrict the use or disclosure of
an individual’s protected health
information, the covered entity must
abide by that restriction, except in
emergency circumstances when the
information is required for the treatment
of the individual. Section 164.522 also
includes provisions for the termination
of such a restriction and requires that
covered entities that have agreed to a
restriction document the restriction in
writing.
Section 13405(a) of the HITECH Act,
which became effective February 18,
2010, requires that when an individual
requests a restriction on disclosure
pursuant to § 164.522, the covered
entity agree to the requested restriction
unless otherwise required by law, if the
request for restriction is on disclosures
of protected health information to a
health plan for the purpose of carrying
out payment or health care operations
and if the restriction applies to
protected health information that
pertains solely to a health care item or
service for which the health care
provider involved has been paid out of
pocket in full. This statutory
requirement overrides the provision in
§ 164.522(a)(1)(ii) that the covered entity
is not required to agree to requests for
restrictions and requires that we modify
the regulation.
To implement section 13405(a), we
propose to add a new § 164.522(a)(1)(vi)
to describe the elements of the required
restriction. We also propose to add
conforming language to
§ 164.522(a)(1)(ii) to reflect the
mandatory nature of the restriction as
required by the statute. Finally, we
propose conforming modifications to
§ 164.522(a)(2) and (3), which address
terminating and documentation of
restrictions. We discuss these
modifications in more detail below.
We propose to add a new paragraph
(vi) to § 164.522(a)(1), which would
require a covered entity, upon request
from an individual, to agree to a
restriction on the disclosure of protected
health information to a health plan if:
(A) the disclosure is for the purposes of
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
carrying out payment or healthcare
operations and is not otherwise required
by law; and (B) the protected health
information pertains solely to a health
care item or service for which the
individual, or person on behalf of the
individual other than the health plan,
has paid the covered entity in full. We
also propose to modify the language in
§ 164.522(a)(1)(ii), which states that a
covered entity is not required to agree
to a restriction, to refer to this exception
to that general rule. We note that under
the Privacy Rule, a covered entity may
make a disclosure to a business
associate of another covered entity only
where the disclosure would be
permitted directly to the other covered
entity. Thus, in cases where an
individual has exercised his or her right
to have a restriction placed under this
paragraph on a disclosure to a health
plan, the covered entity is also
prohibited from making such disclosure
to a business associate of the health
plan.
Section 13405(a) makes clear that an
individual has a right to have
disclosures regarding certain health care
items or services for which the
individual pays out of pocket in full
restricted from a health plan. We believe
the Act provides the individual with the
right to determine for which health care
items or services the individual wishes
to pay out of pocket and restrict. Thus,
we do not believe a covered entity could
require individuals who wish to restrict
disclosures about only certain health
care items or services to a health plan
to restrict disclosures of protected
health information regarding all health
care to the health plan—i.e., to require
an individual to have to pay out of
pocket for all services to take advantage
of this right regardless of the particular
health care item or service about which
the individual requested the restriction.
We believe such a policy would be
contrary to Congressional intent, in that
it would discourage individuals from
requesting restrictions in situations
where Congress clearly intended they be
able to do so. For example, an
individual who regularly visits the same
provider for the treatment of both
asthma and diabetes must be able to
request, and have the provider honor, a
restriction on the disclosure of diabetesrelated treatment to the health plan as
long as the individual pays out of
pocket for this care. The provider
cannot require that the individual apply
the restriction to all care given by the
provider and, as a result, cannot require
the individual to pay out of pocket for
both the diabetes and asthma-related
care in order to have the restriction on
PO 00000
Frm 00033
Fmt 4701
Sfmt 4702
40899
the diabetes care honored. We
encourage covered entities to work with
individuals who wish to restrict certain
information from disclosure to health
plans to determine the best method for
ensuring that the appropriate
information is restricted from disclosure
to a health plan.
Due to the myriad of treatment
interactions between covered entities
and individuals, we recognize that this
provision may be more difficult to
implement in some circumstances than
in others, and we request comment on
the types of interactions between
individuals and covered entities that
would make requesting or implementing
a restriction more difficult. For example,
an individual visits a provider for
treatment of a condition, and the
individual requests the provider not
disclose information about the
condition to the health plan and pays
out of pocket for the care. The provider
prescribes a medication to treat the
condition, and the individual also
wishes to restrict the health plan from
receiving information about the
medication. Many providers
electronically send prescriptions to the
pharmacy to be filled so that the
medication is ready when the
individual arrives to pick it up;
however, at the point the individual
arrives at the pharmacy, the pharmacy
would have already sent the information
to the health plan for payment, not
permitting the individual an
opportunity to request a restriction at
the pharmacy. A provider who knows
that an individual intends to request
such a restriction can always provide
the individual with a paper prescription
to take to the pharmacy, allowing the
individual an opportunity to request
that the pharmacy restrict the disclosure
of information relating to the
medication. However, this might not be
practical in every case, especially as
covered entities begin to replace paperbased systems with electronic systems.
We request comment on this issue, and
we ask specifically for suggestions of
methods through which a provider,
using an automated electronic
prescribing tool, could alert the
pharmacy that the individual may wish
to request that a restriction be placed on
the disclosure of their information to the
health plan and that the individual
intends to pay out of pocket for the
prescription.
Additionally, we request comment on
the obligation of covered health care
providers that know of a restriction to
inform other health care providers
downstream of such restriction. For
example, a provider has been treating an
individual for an infection for several
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40900
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
months pursuant to the individual’s
requested restriction that none of the
protected health information relating to
the treatment of the infection be
disclosed to the individual’s health
plan. If the individual requests that the
provider send a copy of his medical
records to another health care provider
for treatment, what, if any, obligation
should the original provider have to
notify the recipient provider (including
a pharmacy filling the individual’s
prescription) that the individual has
placed a restriction upon much of the
protected health information in the
medical record? We request comment
on whether a restriction placed upon
certain protected health information
should apply to, and the feasibility of it
continuing to attach to, such
information as it moves downstream, or
if the restriction should no longer apply
until the individual visits the new
provider for treatment or services,
requests a restriction, and pays out of
pocket for the treatment. In addition, we
request comment on the extent to which
technical capabilities exist that would
facilitate notification among providers
of restrictions on the disclosure of
protected health information, how
widely these technologies are currently
utilized, and any limitations in the
technology that would require
additional manual or other procedures
to provide notification of restrictions.
In accordance with the HITECH Act,
proposed § 164.522(a)(1)(vi)(A) would
permit a covered entity to disclose
protected health information to a health
plan if such disclosure is required by
law, despite an individual’s request for
a restriction. We note that the term
‘‘required by law’’ is defined at
§ 164.103. We request comment on
examples of types of disclosures that
may fall under this provision.
With respect to the proposed
requirement in § 164.522(a)(1)(vi)(B)
that the covered entity be paid in full for
the health care item or service for which
the individual requests a restriction, we
have added some language to the
statutory provision to ensure that this
requirement not be limited to solely the
individual as the person paying the
covered entity for the individual’s care.
There are many situations in which
family members or other persons may
pay for the individual’s treatment. Thus,
this proposed paragraph would provide
that as long as the covered entity is paid
for the services by the individual or
another person on behalf of the
individual other than the health plan,
the covered entity would be required to
abide by the restriction.
With regard to proposed
§ 164.522(a)(1)(vi)(B), we emphasize
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
that when an individual requests a
restriction of information to a health
plan and pays out of pocket for the
treatment or service, the individual
should not expect that this payment will
count towards the individual’s out of
pocket threshold with respect to his or
her health plan benefits. As the very
nature of this provision is to restrict
information from flowing to the health
plan, the health plan will be unaware of
any payment for treatment or services
for which the individual has requested
a restriction, and thus, this out of pocket
payment cannot be used to reach the
threshold for benefits a health plan
offers.
We request public comment on how
this provision will function with respect
to HMOs. A provider who contracts
with an HMO generally receives a fixed
payment from an HMO based on the
number of patients seen and not based
on the treatment or service provided,
and an individual patient of that
provider pays a flat co-payment for
every visit regardless of the treatment or
service received. Therefore, it is our
understanding that under most current
HMO contracts with providers an
individual could not pay the provider
for the treatment or service received.
Thus, individuals who belong to an
HMO may have to use an out-of-network
provider if they wish to ensure that
certain protected health information is
not disclosed to the HMO. We request
public comment on this issue.
Finally, with respect to proposed
§ 164.522(a)(1)(vi)(B), we emphasize
that if an individual’s out of pocket
payment for a health care item or
service to restrict disclosure of the
information to a health plan is not
honored (for example, the individual’s
check bounces), the covered entity may
then submit the information to the
health plan for payment as the
individual has not fulfilled the
requirements necessary to obtain a
restriction. We do not believe that the
statutory intent was to permit
individuals to avoid payment to
providers for the health care services
they provide. Therefore, if an individual
does not pay in full for the treatment or
services provided to the individual,
then the provider is under no obligation
to restrict the information and may
disclose the protected health
information to the health plan to receive
payment. However, we expect covered
entities to make some attempt to resolve
the payment issue with the individual
prior to sending the protected health
information to the health plan, such as
by notifying the individual that his or
her payment did not go through and to
give the individual an opportunity to
PO 00000
Frm 00034
Fmt 4701
Sfmt 4702
submit payment. We request comment
on the extent to which covered entities
must make reasonable efforts to secure
payment from the individual prior to
submitting protected health information
to the health plan for payment.
We propose to modify § 164.522(a)(2)
and (3) regarding terminating
restrictions and documentation of
restrictions to reflect the addition of
these new requirements. First, we
would modify the language in
§ 164.522(a)(2) to remove the term ‘‘its
agreement to’’ to clarify that the
termination provisions apply to all
restrictions, even those which are
mandatory for the covered entity.
Similarly, we would modify the
language in § 164.522(a)(3) regarding
documentation to remove the words
‘‘that agrees to a restriction’’ to make
clear that the documentation
requirements apply to all restrictions,
including those that would be required
by proposed paragraph (a)(1)(vi).
Additionally, we propose to modify
§ 164.522(a)(2)(iii) to conform to
proposed paragraph (a)(1)(vi), requiring
the mandatory restrictions for certain
disclosures to health plans. In
particular, in cases in which a covered
entity is required to agree to a restriction
under this section, we propose to add a
new paragraph (A) to paragraph
(a)(2)(iii) to clarify that a covered entity
may not unilaterally terminate such a
restriction.
The proposed modifications would
operate as follows with respect to
termination of a restriction under
proposed paragraph (a)(1)(vi). For
example, an individual who has
requested a restriction on the disclosure
of protected health information to a
health plan about a particular health
care service visits the provider for
follow-up treatment, asks the provider
to bill the health plan for the follow-up
visit, and does not request a restriction
at the time, nor pays out of pocket for
the follow-up treatment. In such
circumstances, there is no restriction in
effect with respect to the follow-up
treatment. However, the provider may
need to submit information about the
original treatment to the health plan so
that it can determine the medical
appropriateness or medical necessity of
the follow-up care provided to the
individual. At this time, we would
consider the lack of a restriction with
respect to the follow-up treatment to
extend to any protected health
information necessary to effect payment
for such treatment, even if such
information pertained to prior treatment
that was subject to a restriction. We
encourage covered entities to have an
open dialogue with individuals to
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
ensure that they are aware that
protected health information may be
disclosed to the health plan unless they
request an additional restriction and pay
out of pocket for the follow-up care. We
request public comment on this issue.
K. Section 164.524—Access of
Individuals to Protected Health
Information
Section 164.524 of the Privacy Rule
currently establishes, with limited
exceptions, an enforceable means by
which individuals have a right to review
or obtain copies of their protected
health information, to the extent such
information is maintained in the
designated record set(s) of a covered
entity. An individual’s right of access
exists regardless of the format of the
protected health information, and the
standards and implementation
specifications that address individuals’
requests for access and timely action by
the covered entity (i.e., provision of
access, denial of access, and
documentation) apply to an electronic
environment in a similar manner as they
do to a paper-based environment. See
The HIPAA Privacy Rule’s Right of
Access and Health Information
Technology (providing guidance with
respect to how § 164.524 applies in an
electronic environment and how health
information technology can facilitate
providing individuals with this
important privacy right), available at:
https://www.hhs.gov/ocr/privacy/hipaa/
understanding/special/healthit/
eaccess.pdf.
Section 13405(e) of the HITECH Act,
which became effective February 18,
2010, strengthens the Privacy Rule’s
right of access with respect to covered
entities that use or maintain an
electronic health record on an
individual. Section 13405(e) provides
that when a covered entity uses or
maintains an electronic health record
with respect to protected health
information of an individual, the
individual shall have a right to obtain
from the covered entity a copy of such
information in an electronic format and
the individual may direct the covered
entity to transmit such copy directly to
the individual’s designee, provided that
any such choice is clear, conspicuous,
and specific. Section 13405(e) also
provides that any fee imposed by the
covered entity for providing such an
electronic copy shall not be greater than
the entity’s labor costs in responding to
the request for the copy.
Section 13405(e) applies by its terms
only to protected health information in
electronic health records. However,
incorporating these new provisions in
such a limited manner in the Privacy
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Rule could result in a complex set of
disparate requirements for access to
protected health information in
electronic health records systems versus
other types of electronic records
systems. As such, the Department
proposes to use its authority under
section 264(c) of HIPAA to prescribe the
rights individuals should have with
respect to their individually identifiable
health information to strengthen the
right of access as provided under
section 13405(e) of the HITECH Act
more uniformly to all protected health
information maintained in one or more
designated record sets electronically,
regardless of whether the designated
record set is an electronic health record.
We discuss our proposed amendments
to each provision implicated by section
13405(e) more specifically below.
Section 164.524(c)(2) of the Privacy
Rule requires a covered entity to
provide the individual with access to
the protected health information in the
form or format requested by the
individual, if it is readily producible in
such form or format, or, if not, in a
readable hard copy form or such other
form or format as agreed to by the
covered entity and the individual.
Section 13405(e) of the HITECH Act
expands this requirement by explicitly
requiring a covered entity that uses or
maintains an electronic health record
with respect to protected health
information to provide the individual
with a copy of such information in an
electronic format.
We propose to implement this
statutory provision, in conjunction with
our broader authority under section
264(c) of HIPAA, by requiring, in
proposed § 164.524(c)(2)(ii), that if the
protected health information requested
is maintained electronically in one or
more designated record sets, the covered
entity must provide the individual with
access to the electronic information in
the electronic form and format
requested by the individual, if it is
readily producible, or, if not, in a
readable electronic form and format as
agreed to by the covered entity and the
individual. This provision would
require any covered entity that
electronically maintains the protected
health information about an individual,
in one or more designated record sets,
to provide the individual with an
electronic copy of such information (or
summary or explanation if agreed to by
the individual in accordance with
proposed § 164.524(c)(2)(iii)) in the
electronic form and format requested or
in an otherwise agreed upon form and
format. While an individual’s right of
access to an electronic copy of protected
health information is currently limited
PO 00000
Frm 00035
Fmt 4701
Sfmt 4702
40901
under the Privacy Rule by whether the
form or format requested is readily
producible, covered entities that
maintain such information
electronically in a designated record set
would be required under these proposed
modifications to provide some type of
electronic copy, if requested by an
individual.
Because we do not want to bind
covered entities to standards that may
not yet be technologically mature, we
propose to permit covered entities to
make some other agreement with
individuals as to an alternative means
by which they may provide a readable
electronic copy, to the extent the
requested means is not readily
producible. If, for example, a covered
entity received a request to provide
electronic access via a secure Web-based
portal, but the only readily producible
version of the protected health
information was in portable document
format (PDF), proposed
§ 164.524(c)(2)(ii) would require the
covered entity to provide the individual
with a PDF copy of the protected health
information, if agreed to by the covered
entity and the individual. We note that
while there may be circumstances
where a covered entity determines that
it can comply with the Privacy Rule’s
right of access by providing individuals
with limited access rights to their
electronic health record, such as
through a secure Web-based portal,
nothing under the current Rule or
proposed modifications would require a
covered entity to do so where the
covered entity determines it is not
reasonable or appropriate.
We note that the option of arriving at
an alternative agreement that satisfies
both parties is already part of the
requirement to provide access under
§ 164.524(c)(2)(i), so extension of such a
requirement to electronic access should
present few implementation difficulties.
Further, as with other disclosures of
protected health information, in
providing the individual with an
electronic copy of protected health
information through a Web-based portal,
e-mail, on portable electronic media, or
other means, covered entities should
ensure that reasonable safeguards are in
place to protect the information. We
also note that the proposed modification
presumes that covered entities have the
capability of providing an electronic
copy of protected health information
maintained in their designated record
set(s) electronically through a secure
Web-based portal, via e-mail, on
portable electronic media, or other
manner. We invite public comment on
this presumption.
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40902
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
Section 164.524(c)(3) of the Privacy
Rule currently requires the covered
entity to provide the access requested by
the individual in a timely manner,
which includes arranging with the
individual for a convenient time and
place to inspect or obtain a copy of the
protected health information, or mailing
the copy of protected health information
at the individual’s request. The
Department has previously interpreted
this provision as requiring a covered
entity to mail the copy of protected
health information to an alternative
address requested by the individual,
provided the request was clearly made
by the individual and not a third party.
Section 13405(e)(1) of the HITECH Act
provides that if the individual chooses,
he or she shall have a right to direct the
covered entity to transmit an electronic
copy of protected health information in
an electronic health record directly to
an entity or person designated by the
individual, provided that such choice is
clear, conspicuous, and specific.
Based on section 13405(e)(1) of the
HITECH Act and our authority under
section 264(c) of HIPAA, we propose to
expand § 164.524(c)(3) to expressly
provide that, if requested by an
individual, a covered entity must
transmit the copy of protected health
information directly to another person
designated by the individual. This
proposed amendment is consistent with
the Department’s prior interpretation on
this issue and would apply without
regard to whether the protected health
information is in electronic or paper
form. We propose to implement the
requirement of section 13405(e)(1) that
the individual’s ‘‘choice [be] clear,
conspicuous, and specific’’ by requiring
that the individual’s request be ‘‘in
writing, signed by the individual, and
clearly identify the designated person
and where to send the copy of protected
health information.’’ We note that the
Privacy Rule allows for electronic
documents to qualify as written
documents for purposes of meeting the
Rule’s requirements, as well as
electronic signatures to satisfy any
requirements for a signature, to the
extent the signature is valid under
applicable law. Thus, a covered entity
could employ an electronic process for
receiving an individual’s request to
transmit a copy of protected health
information to his or her designee under
this proposed provision. Whether the
process is electronic or paper-based, a
covered entity must implement
reasonable policies and procedures
under § 164.514(h) to verify the identity
of any person who requests protected
health information, as well as
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
implement reasonable safeguards under
§ 164.530(c) to protect the information
that is used or disclosed.
Section 164.524(c)(4) of the Privacy
Rule currently permits a covered entity
to impose a reasonable, cost-based fee
for a copy of protected health
information (or a summary or
explanation of such information).
However, such a fee may only include
the cost of: (1) The supplies for, and
labor of, copying the protected health
information; (2) the postage associated
with mailing the protected health
information, if applicable; and (3) the
preparation of an explanation or
summary of the protected health
information, if agreed to by the
individual. With respect to providing a
copy (or summary or explanation) of
protected health information from an
electronic health record in electronic
form, however, section 13405(e)(2) of
the HITECH Act provides that a covered
entity may not charge more than its
labor costs in responding to the request
for the copy.
In response to section 13405(e)(2) of
the HITECH Act, we propose to amend
§ 164.524(c)(4)(i) to identify separately
the labor for copying protected health
information, whether in paper or
electronic form, as one factor that may
be included in a reasonable cost-based
fee. While we do not propose more
detailed considerations for this factor
within the regulatory text, we retain all
prior interpretations of labor with
respect to paper copies—that is, that the
labor cost of copying may not include
the costs associated with searching for
and retrieving the requested
information. With respect to electronic
copies, we believe that a reasonable
cost-based fee includes costs
attributable to the labor involved to
review the access request and to
produce the electronic copy, which we
expect would be negligible. However,
we would not consider a reasonable
cost-based fee to include a standard
‘‘retrieval fee’’ that does not reflect the
actual labor costs associated with the
retrieval of the electronic information or
that reflects charges that are unrelated to
the individual’s request (e.g., the
additional labor resulting from technical
problems or a workforce member’s lack
of adequate training). We invite public
comment on this aspect of our
rulemaking, specifically with respect to
what types of activities related to
managing electronic access requests
should be compensable aspects of labor.
We also propose to amend
§ 164.524(c)(4)(ii) to provide separately
for the cost of supplies for creating the
paper copy or electronic media (i.e.,
physical media such as a compact disc
PO 00000
Frm 00036
Fmt 4701
Sfmt 4702
(CD) or universal serial bus (USB) flash
drive), if the individual requests that the
electronic copy be provided on portable
media. This reorganization and the
addition of the phrase ‘‘electronic
media’’ reflects our understanding that
since section 13405(e)(2) of the HITECH
Act permits only the inclusion of labor
costs in the charge for electronic copies,
it by implication excludes charging for
the supplies that are used to create an
electronic copy of the individual’s
protected health information, such as
the hardware (computers, scanners, etc.)
or software that is used to generate an
electronic copy of an individual’s
protected health information in
response to an access request. We note
this limitation is in contrast to a covered
entity’s ability to charge for supplies for
hard copies of protected health
information (e.g., the cost of paper, the
prorated cost of toner and wear and tear
on the printer). See 65 FR 82462, 82735,
Dec. 28, 2000 (responding to a comment
seeking clarification on ‘‘capital cost for
copying’’ and other supply costs by
indicating that a covered entity was free
to recoup all of their reasonable costs for
copying). We believe this interpretation
is consistent with the fact that, unlike a
hard copy, which generally exists on
paper, an electronic copy exists
independent of media, and can be
transmitted securely via multiple
methods (e.g., e-mail, a secure Webbased portal, or an individual’s own
electronic media) without accruing any
ancillary supply costs.
We also note, however, that our
interpretation of the statute would
permit a covered entity to charge a
reasonable and cost-based fee for any
electronic media it provided, as
requested or agreed to by an individual
who does not provide their own. For
example, a covered entity can offer to
make protected health information
available on an encrypted USB flash
drive, and can charge a reasonable costbased fee for the flash drive. If, however,
an individual has brought his or her
own electronic media (such as a
recordable CD), requested that an
electronic copy be placed on it, and the
covered entity’s systems are readily able
to do so, then the covered entity would
not be allowed to require the individual
to purchase an encrypted USB flash
drive instead. Likewise, if an individual
requests that an electronic copy be sent
via unencrypted e-mail, the covered
entity should advise the individual of
the risks associated with unencrypted email, but the covered entity would not
be allowed to require the individual to
instead purchase a USB flash drive.
While we propose to renumber the
remaining factors in § 164.524(c)(4), we
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
do not propose to amend their
substance. With respect to
§ 164.524(c)(4)(iii), however, we note
that our interpretation of the statute
would permit a covered entity to charge
for postage if an individual requests that
the covered entity transmit portable
media containing an electronic copy
through mail or courier (e.g., if the
individual requests that the covered
entity save protected health information
to a CD and then mail the CD to a
designee).
Finally, we are requesting comment
on one aspect of the right to access and
obtain a copy of protected health
information which the HITECH Act did
not amend. In particular, the HITECH
Act did not change the timeliness
requirements for provision of access in
§ 164.524(b). Under the current
requirements, a request for access must
be approved or denied, and if approved,
access or a copy of the information
provided, within 30 days of the request.
In cases where the records requested are
only accessible from an off-site location,
the covered entity has an additional 30
days to respond to the request. In
extenuating circumstances where access
cannot be provided within these
timeframes, the covered entity may have
a one-time 30-day extension if the
individual is notified of the need for the
extension within the original
timeframes.
With regard to the timeliness of the
provision of access, we are aware that
with the advance of electronic health
records, there is an increasing
expectation and capacity to provide
individuals with almost instantaneous
electronic access to the protected health
information in those records through
personal health records or similar
electronic means. On the other hand, we
are not proposing to limit the right to
electronic access of protected health
information to certified electronic
health records, and the variety of
electronic systems that are subject to
this proposed requirement would not all
be able to comply with a timeliness
standard based on personal health
record capabilities. It is our assumption
that a single timeliness standard that
would address a variety of electronic
systems, rather than having a multitude
of standards based on system capacity,
would be the preferred approach to
avoid workability issues for covered
entities. Even under a single standard,
nothing would prevent electronic health
record systems from being developed
through the HITECH Act’s standards
and certification process with the
technological capabilities to exceed the
Privacy Rule’s timeliness requirements
for providing access to individuals.
Based on the assumption that a single
standard would be the preferred
approach, we are interested in public
comment on an appropriate, common
timeliness standard for the provision of
access by covered entities with
electronic designated record sets
generally. We would appreciate
comment on aspects of existing systems
that would create efficiencies in
processing of requests for electronic
information, as well as those aspects of
electronic systems that would provide
little change from the time required for
processing a paper record. Alternatively,
we request comment on whether the
current standard could be altered for all
systems, paper and electronic, such that
all requests for access should be
responded to without unreasonable
delay and not later than 30 days.
We are also interested in public
comment on whether, contrary to our
assumption, a variety of timeliness
standards based on the type of
electronic designated record set is the
preferred approach and if so, how we
should operationalize such an approach.
For example, how should we identify
and characterize the various electronic
designated record sets to which the
40903
different standards would apply, such
as personal health records, electronic
health records, and others? What
functionality within these electronic
systems would drive the need for more
or less time to provide an individual
with electronic access? What timeliness
standards would be appropriate for the
different systems? What timeliness
standard(s) would be required of entities
with protected health information
spread across hybrid systems that have
different functionalities? What would be
the impact of and challenges to having
multiple timeliness standards for
access?
Finally, we request comment on the
time necessary for covered entities to
review access requests and make
necessary determinations, such as
whether the granting of access would
endanger the individual or other
persons so as to better understand how
the time needed for these reviews
relates to the overall time needed to
provide the individual with access.
Further, we request comment generally
on whether the provision which allows
a covered entity an additional 30 days
to provide access to the individual if the
protected health information is
maintained off-site should be eliminated
altogether for both paper and electronic
records, or at least for protected health
information maintained or archived
electronically because the physical
location of electronic data storage is not
relevant to its accessibility.
L. Other Technical and Conforming
Changes
We propose to make a number of
technical and conforming changes to the
Privacy Rule to fix minor problems such
as incorrect cross-references, mistakes of
grammar, and typographical errors.
Technical and conforming changes of
this nature are described and explained
in the table below.
Regulation §
Current language
Proposed change
164.510(b)(2)(iii) .................
‘‘based the exercise of professional
judgment’’.
‘‘Permitted disclosures’’ and ‘‘may disclose’’.
Insert ‘‘on’’ after ‘‘based’’ .....................
Correct typographical error.
Insert ‘‘uses and’’ and ‘‘use or’’ before
‘‘disclosures’’ and ‘‘disclose,’’ respectively.
Change ‘‘protecting’’ to ‘‘protected’’ ....
Correct inadvertent omission.
164.512(b)(1) ......................
srobinson on DSKHWCL6B1PROD with PROPOSALS2
164.512(e)(1)(iii) .................
164.512(e)(1)(vi) .................
164.512(k)(3) ......................
‘‘seeking protecting health information’’.
‘‘paragraph (e)(1)(iv) of this section’’ ..
‘‘authorized by 18 U.S.C. 3056, or to
foreign heads of state . . ., or to
for the conduct of investigations’’.
In addition to the technical changes
listed in the table above, we propose to
make a few changes that are technical or
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Change ‘‘(e)(1)(iv)’’ to ‘‘(e)(1)(v)’’ ........
Remove the comma after ‘‘U.S.C.
3056’’ and the ‘‘to’’ before ‘‘for’’.
conforming in nature, but for which the
reason for the change is more
PO 00000
Frm 00037
Reason for change
Fmt 4701
Sfmt 4702
Correct typographical error.
Correct cross-reference.
Correct typographical errors.
programmatic in nature. These are as
follows:
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40904
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
Section 164.506(c)(5) permits a
covered entity to disclose protected
health information ‘‘to another covered
entity that participates in the organized
health care arrangement.’’ We propose to
change the words ‘‘another covered
entity that participates’’ to ‘‘other
participants’’ because not all
participants in an organized health care
arrangement may be covered entities; for
example, some physicians with staff
privileges at a hospital may not be
covered entities.
Section 164.510(a)(1)(ii) permits the
disclosure of directory information to
members of the clergy and other persons
who ask for the individual by name. We
propose to add the words ‘‘use or’’ to this
permission, to cover the provision of
such information to clergy who are part
of a facility’s workforce.
Section 164.510(b)(3) covers uses and
disclosures of protected health
information when the individual is not
present to agree or object to the use or
disclosure, and, as pertinent here,
permits disclosure to persons only of
‘‘the protected health information that is
directly relevant to the person’s
involvement with the individual’s
health care.’’ We propose to delete the
last two quoted words and substitute
therefore the following: ‘‘care or
payment related to the individual’s
health care or needed for notification
purposes.’’ This change would align the
text of paragraph (b)(3) with the
permissions provided for at paragraph
(b)(1) of this section.
Where an employer needs protected
health information to comply with
workplace medical surveillance laws,
such as OSHA or MSHA,
§ 164.512(b)(1)(v)(A) permits a covered
entity to disclose, subject to certain
conditions, protected health information
of an individual to the individual’s
employer if the covered entity is a
covered health care provider ‘‘who is a
member of the workforce of such
employer or who provides health care to
the individual at the request of the
employer.’’ We propose to amend the
quoted language by removing the words
‘‘who is a member of the workforce of
such employer or’’, as the language is
unnecessary.
In § 164.512(k)(1)(ii), we propose to
replace the word ‘‘Transportation’’ with
‘‘Homeland Security.’’ The language
regarding a component of the
Department of Transportation was
included to refer to the Coast Guard;
however, the Coast Guard was
transferred to the Department of
Homeland Security in 2003. In addition,
at § 164.512(k)(5)(i)(E), we propose to
replace the word ‘‘and’’ after the semicolon with the word ‘‘or.’’ The intent of
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
§ 164.512(k)(5)(i) is not that the
existence of all of the conditions is
necessary to permit the disclosure, but
rather that the existence of any would
permit the disclosure.
VII. Regulatory Analyses
A. Introduction
We have prepared a regulatory impact
statement in compliance with Executive
Order 12866 (September 1993,
Regulatory Planning and Review), the
Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96–354),
the Unfunded Mandates Reform Act of
1995 (Pub. L. 104–4), and Executive
Order 13132 on Federalism.
1. Executive Order 12866
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis must be prepared for major
rules that have economically significant
effects ($100 million or more in any one
year) or adversely affect in a material
way the economy, a sector of the
economy, productivity, competition,
jobs, the environment, public health or
safety, or State, local, or Tribal
government or communities (58 FR
51741).
We estimate that the effects of the
requirement for covered entities
(including indirect costs incurred by
third party administrators, which
frequently send out notices on behalf of
health plans) to issue new notices of
privacy practices, will result in new
costs of $166.1 million within 12
months of the effective date of the final
rule. We estimate that the private sector
will bear approximately 71 percent of
the costs, with State and Federal plans
bearing the remaining 29 percent of the
costs. As a result of the economic
impact, and other costs that are
expected but not quantified in the
regulatory analysis below, we
determined that this proposed rule is an
economically significant regulatory
action within the meaning of section
3(f)(4) of Executive Order 12866. We
present our analysis of the costs of the
proposed rule in section C below.
2. Regulatory Flexibility Act
The RFA requires agencies to analyze
options for regulatory relief of small
businesses if a rule has a significant
impact on a substantial number of small
entities. We present our regulatory
PO 00000
Frm 00038
Fmt 4701
Sfmt 4702
flexibility analysis of this proposed rule
in section E below.
The Act generally defines a ‘‘small
entity’’ as (1) a proprietary firm meeting
the size standards of the Small Business
Administration (SBA), (2) a nonprofit
organization that is not dominant in its
field, or (3) a small government
jurisdiction with a population of less
than 50,000. Because 90 percent or more
of all health care providers meet the
SBA size standard for a small business
or are nonprofit organizations, we
generally treat all health care providers
as small entities for purposes of
performing a regulatory flexibility
analysis. The SBA size standard for
health care providers ranges between
$7.0 million and $34.5 million in
annual receipts.
With respect to health insurers and
third party administrators, the SBA size
standard is $7.0 million in annual
receipts. While some insurers are
classified as nonprofit, it is possible
they are dominant in their market. For
example, a number of Blue Cross/Blue
Shield insurers are organized as
nonprofit entities; yet they dominate the
health insurance market in the States
where they are licensed. In addition, we
lack the detailed information on annual
receipts for insurers and plan
administrators and, therefore, we do not
know how many firms qualify as small
entities. We welcome comments on the
number of small entities in the health
insurer and health plan administrator
market.
3. Unfunded Mandates Reform Act
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates would require
spending in any one year $100 million
in 1995 dollars, updated annually for
inflation. In 2010, that threshold is
approximately $135 million. UMRA
does not address the total cost of a rule.
Rather, it focuses on certain categories
of cost, mainly those ‘‘Federal mandate’’
costs resulting from: (1) Imposing
enforceable duties on State, local, or
Tribal governments, or on the private
sector; or (2) increasing the stringency of
conditions in, or decreasing the funding
of, State, local, or Tribal governments
under entitlement programs.
We are able to identify approximately
$166.1 million in costs on both the
private sector and State and Federal
health plans. There may be other costs
we are not able to monetize because we
lack data, and the proposed rule may
produce savings that may offset some or
all of the added costs. For this purpose,
we must also separately identify costs to
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
be incurred by the private sector and
those incurred by State and Federal
entities.
As noted above, of the costs we can
identify, we estimate that approximately
71 percent or $118.1 million of new
costs will fall on the private sector. For
the purpose of this calculation, we
included all $46 million in provider
costs as private sector costs. While we
recognize that some providers are State
or Federal entities, we do not have
adequate information to estimate the
number of public providers, but we
believe the number to be significantly
less than 10% of all providers shown in
Table 1. Therefore, as we did for the
RFA analysis and for ease of calculation,
we assumed that all provider costs are
private sector costs. We welcome
comment on this assumption and any
information regarding the number of the
public sector providers for future
analysis. With regard to identifying the
costs to private sector health plans,
based on the data discussed in section
C below, we estimate that 60 percent of
policy holders are served by private
sector health plans and, therefore, have
allocated 60 percent of the costs to be
incurred by all health plans as private
sector costs, or $72.1 million.
Similarly, we estimate that
approximately 29 percent or $48 million
of the new costs will fall on State and
Federal plans. As noted above, based on
the data discussed in section C below,
we estimate that 40 percent of policy
holders are served by public sector
plans and, therefore, have allocated 40
percent of the costs for all health plans
as public sector costs, or $48 million.
Because the amount of unfunded
mandates incurred separately by either
the private sector or by State, local, and
Tribal governments will not exceed the
unfunded mandates threshold of $133
million, we are not required to perform
a cost-benefit analysis under the UMRA.
Nonetheless, we have prepared a costbenefit analysis of the proposed rule in
sections C and D, below, as required by
Executive Order 12866 for an
economically significant regulation. We
welcome public comment on the
analysis as it bears upon our
assumptions and calculations under the
UMRA.
4. Federalism
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
The Federalism implications of the
Privacy and Security Rules were
assessed as required by Executive Order
13132 and published as part of the
preambles to the final rules on
December 28, 2000 (65 FR 82462,
82797) and February 20, 2003 (68 FR
8334, 8373), respectively. Regarding
preemption, the preamble to the final
Privacy Rule explains that the HIPAA
statute dictates the relationship between
State law and Privacy Rule
requirements, and the Rule’s
preemption provisions do not raise
Federalism issues. The HITECH Act, at
section 13421(a), provides that the
HIPAA preemption provisions shall
apply to the HITECH provisions and
requirements. While we have made
minor technical changes to the
preemption provisions in Subpart B of
Part 160 to conform to and incorporate
the HITECH Act preemption provisions,
these changes do not raise new
Federalism issues. The proposed
changes include: (1) Amending the
definitions of ‘‘contrary’’ and ‘‘more
stringent’’ to reference business
associates; and (2) further amending the
definition of contrary to provide that
State law would be contrary to the
HIPAA Administrative Simplification
provisions if it stands as an obstacle to
the accomplishment and execution of
the full purposes and objectives of not
only HIPAA, but also the HITECH Act.
We do not believe that this rule will
impose substantial direct compliance
costs on State and local governments
that are not required by statute. It is our
understanding that State and local
government covered entities do not
engage in marketing, the sale of
protected health information, or
fundraising. Therefore, the proposed
modifications in these areas would not
cause additional costs to State and local
governments. We anticipate that the
most significant direct costs on State
and local governments will be the cost
for State and local government-owned
covered entities of drafting, printing,
and distributing revised notices of
privacy practices, which would include
the cost of mailing these notices for
State health plans, such as Medicaid.
However, the costs involved can be
attributed to the statutory requirements.
In considering the principles in and
requirements of Executive Order 13132,
the Department has determined that
these proposed modifications to the
Privacy and Security Rules will not
significantly affect the rights, roles, and
responsibilities of the States.
B. Why is This Rule Needed?
The proposed rule is needed to
implement several provisions of the
PO 00000
Frm 00039
Fmt 4701
Sfmt 4702
40905
HITECH Act that require us to amend
our regulations at 45 CFR Parts 160 and
164. These amendments primarily
strengthen the privacy and security
protections for protected health
information, as well as broaden the
privacy rights of individuals.
C. Costs
1. Notifying Individuals of Their New
Privacy Rights
Covered entities must provide
individuals with NPPs that detail how
the covered entity may use and disclose
protected health information and
individuals’ rights with respect to their
own health information. Due to the
proposed modifications pursuant to the
HITECH Act, covered entities must
modify their NPPs and distribute them
to affected individuals to advise them of
the following strengthened privacy
protections: (1) The addition of the sale
of protected health information as a use
or disclosure that requires the express
written authorization of the individual;
(2) a separate statement that provides
advance notice to the individual if the
healthcare provider receives financial
remuneration from a third party to send
treatment communications to the
individual about that party’s products or
services, and the right of the individual
to elect not to receive such
communications; and (3) the right of the
individual to restrict disclosures of
protected health information to a health
plan with respect to treatment services
for which the individual has paid out of
pocket in full.
For providers, the cost of developing
a new NPP consists of drafting and
printing the notice. The costs of
distribution are minimal because
providers will hand out the NPPs when
patients come for their appointments.
We estimate that drafting the updated
NPPs will require approximately onethird of an hour of professional, legal
time at approximately $90 per hour—or
$30—that includes hourly wages of $60
plus 50 percent 5. The total cost for
attorneys for the approximately
697,000 6 health care providers in the
5 https://www.bls.gov/oes/2008/may/
oes231011.htm for lawyers.
6 We identified 701,325 entities that must prepare
and deliver NPPs that are shown in Table 1 below.
This includes 696,758 HIPAA covered entities that
are health care providers, including hospitals,
nursing facilities, doctor offices, outpatient care
centers, medical diagnostic, imaging service, home
health service and other ambulatory care service
covered entities, medical equipment suppliers, and
pharmacies. For the purposes of our calculation, we
have rounded this number to 697,000. Table 1 also
includes 4,567 health insurance carriers and third
party administrators working on behalf of covered
health plans. The cost estimates for these entities
are addressed later.
E:\FR\FM\14JYP2.SGM
14JYP2
40906
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
U.S. is, therefore, expected to be
approximately $21 million. Printing the
NPPs will require paper and clerical
time at a cost of $0.10 per notice. We
estimate that within 12 months from the
effective date of the final rule, providers
will print approximately 250 million
NPPs to hand to patients who visit their
offices. Printing costs for 250 million
NPPs will be $25 million. The total cost
for providers is approximately $46
million.
For health plans, the cost of
developing a new NPP consists of
drafting, printing and mailing the
notice. With the exception of a few large
health plans, most health plans do not
self-administer their plans. The majority
of plans are either health insurance
issuers (approximately 1,000) or utilize
third party administrators that act on
their behalf in the capacity as business
associates. We identified approximately
3,500 third party administrators acting
as business associates for approximately
446,400 ERISA plans identified by the
Department of Labor. In addition, the
Department of Labor identified 20,300
public non-Federal health plans that
may use third party administrators.
Almost all of the public and ERISA
plans, we believe, employ third party
administrators to administer their health
plans. While the third party
administrators will bear the direct costs
of issuing the revised NPPs, the costs
will generally be passed on to the plans
that contract with them. Those plans
that self-administer their own plans will
also incur the costs of issuing the
revised NPPs. We do not know how
many plans administer as well as
sponsor health plans and invite
comments on the number of selfadministered plans; however, unless
there were many such plans it would
not have much effect on these estimates.
For the approximately 4,500 health
insurance issuers and health plan
administrators, the cost of composing
and printing the NPPs will be a similar
amount per NPP to the amount
calculated for providers. However,
health insurers and plan administrators
will have to mail the NPPs to policy
holders. The costs for the mailing will
consist of postage and clerical time. The
cost, therefore, depends on the estimate
of the number of policy holders who
must receive NPPs. We did not assume
that health plans would communicate
with policy holders by e-mail because
we have no data that indicate the extent
to which insurance plans and third
party administrators communicate
currently with their policy holders
through e-mail. We request public
comment on this assumption.
Because the Privacy Rule requires that
only the named insured or policy holder
be notified of changes to the health
plans’ privacy practices even if that
policy also covers dependents, we
expect that only policy holders will
receive the revised NPPs mandated by
this rule. For public programs such as
Medicare, where each individual is a
policy holder, Medicare has a policy of
mailing one notice or a set of program
materials to a household of four or fewer
beneficiaries at the same address.
Although there are 45.6 million
individual Medicare beneficiaries, the
program only sends out 38.8 million
pieces of mail per mailing.
Actuarial Research Corporation
(ARC), our consultant, estimated the
number of policy holders for all classes
of insurance products to be
approximately 183.6 million, including
all public programs. The data comes
from the Medical Expenditure Panel
Survey from 2004–2006 projected to
2010. ARC estimated 112.6 million
private sector policy holders and 71.0
million public ‘‘policy holders.’’ The
total, including more recent Medicare
data, is 188.3 million persons (which
results in roughly a split of 60 percent
private policy holders and 40 percent
public ‘‘policy holders’’), whom we
expect to receive NPPs from their plans.
The estimates do not capture policy
holders who are in hospitals or nursing
homes at the time of the survey, or
individuals who may have been insured
under more than one plan in a year, for
example, because their job status
changed, they have supplemental
policies, or they have more than one
employer, creating duplicate coverage.
Therefore, ARC recommended we use
200 million for the number of NPPs that
will actually be sent.
The costs of drafting, printing, and
distributing the NPP are estimated to be
the following. First, drafting the NPP is
estimated to require one-third hour of
legal services at a cost of $30 × 4,500
insurance plans and insurance
administrative entities, which equals
$135,000. Second, the cost of printing
the NPP, which includes the cost of
paper and actual printing, is estimated
to be $0.10 per notice × 200 million
notices, which equals $20 million.
Third, the cost of distributing the NPPs
would involve clerical time to prepare
the mailings and the cost of postage,
which we estimate to be a unit cost of
$0.50 per NPP for postage and handling
using the rate of $0.44 per stamp and
$0.06 for labor (the same rates we used
in the Breach Notification for Unsecured
Protected Health Information
Regulations published in the Federal
Register at 74 FR 42763), results in an
estimated $100 million cost for
distribution. The total cost for all plans
for drafting, printing, and distributing
the NPP therefore, is approximately
$120.1 million. We note that this total
may be an overestimation of the costs
because many insurers may use bulk
mailing rates to distribute their NPPs
which would reduce their mailing costs.
The total estimated cost for both
providers and health plans to notify
individuals and policy holders of
changes in their privacy rights is
approximately $166.1 million in the
first year following implementation of
the rule. Annualized over 10 years at
three percent and seven percent, the
cost equals $194,720 and $236,489,
respectively.
Table 1 below shows the number of
covered entities by class of provider and
insurer that would be required to issue
NPPs under the proposed rule.
TABLE 1—NUMBER OF ENTITIES BY NAICS CODE1 EXPECTED TO PREPARE AND DISTRIBUTE REVISED NPPS
srobinson on DSKHWCL6B1PROD with PROPOSALS2
NAICS
Providers/Suppliers
622 ...........
623 ...........
Hospitals (General Medical and Surgical, Psychiatric, Substance Abuse, Other Specialty) ...........................................
Nursing Facilities (Nursing Care Facilities, Residential Mental Retardation Facilities, Residential Mental Health and
Substance Abuse Facilities, Community Care Facilities for the Elderly, Continuing Care Retirement Communities).
Office of MDs, DOs, Mental Health Practitioners, Dentists, PT, OT, ST, Audiologists ...................................................
Outpatient Care Centers (Family Planning Centers, Outpatient Mental Health and Drug Abuse Centers, Other Outpatient Health Centers, HMO Medical Centers, Kidney Dialysis Centers, Freestanding Ambulatory Surgical and
Emergency Centers, All Other Outpatient Care Centers).
Medical Diagnostic, and Imaging Service Covered Entities ............................................................................................
Home Health Service Covered Entities ............................................................................................................................
Other Ambulatory Care Service Covered Entities (Ambulance and Other) .....................................................................
Durable Medical Equipment Suppliers2 ............................................................................................................................
6211–6213
6214 .........
6215 .........
6216 .........
6219 .........
n/a ............
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
PO 00000
Frm 00040
Fmt 4701
Sfmt 4702
Entities
E:\FR\FM\14JYP2.SGM
14JYP2
4,060
34,400
419,286
13,962
7,879
15,329
5,879
107,567
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
40907
TABLE 1—NUMBER OF ENTITIES BY NAICS CODE1 EXPECTED TO PREPARE AND DISTRIBUTE REVISED NPPS—
Continued
NAICS
Providers/Suppliers
Entities
4611 .........
524114 .....
524292 .....
Pharmacies3 .....................................................................................................................................................................
Health Insurance Carriers .................................................................................................................................................
Third Party Administrators Working on Behalf of Covered Health Plans ........................................................................
Total Entities .....................................................................................................................................................................
88,396
1,045
3,522
701,325
1 Office
of Advocacy, SBA, https://www.sba.gov/advo/research/data.html.
for Medicare & Medicaid Services covered entities.
Chain Pharmacy Industry https://www.nacds.org/wmspage.cfm?parm1=507.
2 Centers
srobinson on DSKHWCL6B1PROD with PROPOSALS2
3 The
2. Authorization and Other
Requirements for Disclosures Related to
Marketing and Sale of Protected Health
Information
The proposed rule would make
modifications to the definition of
‘‘marketing,’’ such that some
communications to individuals about
health-related products or services that
are made under health care operations
would now be considered marketing
communications if the covered entity
receives financial remuneration by a
third party to make the communication.
For marketing communications,
individual authorization is required. In
addition, the proposal would require
that a health care provider that receives
financial remuneration by a third party
in exchange for sending a treatment
communication to an individual about
the third party’s product or service must
disclose the fact of remuneration in the
communication and provide the
individual with a clear and conspicuous
opportunity to opt out of receiving
future subsidized communications.
Although this proposed rule would
modify the current definition of
‘‘marketing,’’ because we do not have
information on the extent to which
covered entities currently receive
financial remuneration from third
parties in exchange for sending
information to individuals about the
third parties’ health-related products or
services, we do not know how these
modifications would change how
covered entities operate. We invite
public comment on this issue.
In addition, the proposed rule would
require an individual authorization
before a covered entity could disclose
protected health information in
exchange for remuneration (i.e., ‘‘sell’’
protected health information). The
proposal includes several exceptions to
this authorization requirement. On its
face, this proposed modification would
appear to increase the burden to covered
entities by requiring them to obtain
authorizations in situations in which no
authorization is currently required.
However, we believe such a scenario is
unlikely to occur. Even if covered
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
entities attempted to obtain
authorizations in compliance with the
proposed modifications, we believe
most individuals would not authorize
these types of disclosures. It would not
be worthwhile for covered entities to
continue to attempt to obtain such
authorizations, and as a result, we
believe covered entities would simply
discontinue making such disclosures.
Therefore, we believe this proposed
modification would have little to no
impact on covered entities. We request
comment on this issue.
The proposed provision requiring
individual authorization prior to the
sale of protected health information
contains several exceptions in which
protected health information could be
disclosed in exchange for remuneration
without first obtaining individual
authorization. Most of the excepted
disclosures would not impose
additional requirements and, therefore,
would not impose any additional
burden on covered entities to
implement. However, the exception for
research disclosures may impose an
additional burden on researchers. The
exception applies to disclosure of
protected health information for
research as long as the remuneration
received does not exceed the cost to
produce and transmit the information.
Researchers who purchase data from
covered entities may now incur
additional costs as a result of the
proposed rule, in order to obtain newly
required authorizations, if they are
currently paying a covered entity more
than the cost to produce and transmit
the protected health information (unless
the covered entity is willing to reduce
its charges for the data). The proposed
change would classify such transactions
as a sale, and as such would require an
individual’s authorization prior to the
covered entity’s disclosure. This
authorization requirement also may
have additional effects on research, such
that the need for authorization may
skew the sample, or if the researcher
does not have the resources to obtain
the authorizations from the research
subjects, the research may be
PO 00000
Frm 00041
Fmt 4701
Sfmt 4702
jeopardized. Since we have no
information on the amounts currently
paid to covered entities by researchers
for protected health information, we
have no way to estimate the impact of
the provision. We welcome any
comments and information on the
impact of these provisions.
3. Authorization for Compound
Disclosures
The proposed rule would permit
compound authorizations for research
purposes as long as it is clear to
individuals that they do not have to
agree to both the conditioned and
unconditioned components of an
authorization in order to receive
research-related treatment. We believe
that the proposed provision would
reduce burden on the research
community by eliminating the need for
multiple forms for research studies
involving both a clinical trial and a
related research repository or study.
However we have no data which would
permit us to estimate the amount of
burden reduction associated with this
proposal. We welcome public comment
on this issue.
4. Uses and Disclosures of Decedents’
Protected Health Information
The proposed rule would modify the
current rule to limit the period for
which a covered entity must protect an
individual’s health information to 50
years after the individual’s death. We
believe this will reduce the burden on
both covered entities and on those
seeking the protected health information
of persons who have been deceased for
many years by eliminating the need to
search for and find a personal
representative of the decedent, who in
many cases may not be known or even
exist after so many years, to authorize
the disclosure. We believe this change
would benefit family members and
historians who may seek access to the
medical information of these decedents
for personal and public interest reasons.
However, we lack any data to be able to
estimate the benefits or costs of this
E:\FR\FM\14JYP2.SGM
14JYP2
40908
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
provision. We welcome comments on
this proposed change.
5. Uses and Disclosures for Care and
Notification Purposes
The proposed rule would permit
covered entities to disclose a decedent’s
protected health information to family
members, or other persons involved in
the individual’s care or payment for care
before the individual’s death, unless
doing so would be inconsistent with any
prior expressed preference of the
individual that is known to the covered
entity. The rights of the decedent’s
personal representative to have access to
the protected health information of the
decedent would remain unchanged. We
believe the proposed change would
reduce burden by permitting covered
entities to continue to disclose protected
health information to family members
and other persons who were involved in
an individual’s care while the
individual was alive after the death of
the individual without needing to
obtain authorization from the decedent’s
personal representative, who may not be
known or even exist. However, we have
no data to permit us to estimate the
reduction in burden and we welcome
comment on this change.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
6. Public Health Disclosures
The proposed rule would create a new
public health provision to permit
disclosure of proof of a child’s
immunization by a covered entity to a
school in States that have school entry
or similar laws. This proposed change
would allow a covered health care
provider to release proof of
immunization to a school without
having to obtain a written authorization,
provided the provider obtained the
agreement (oral or otherwise) to the
disclosure from either the parent or
guardian, or the individual, if the
individual is an adult or emancipated
minor. We expect the proposed change
to the regulations may reduce the
burden on covered entities and parents
in obtaining and providing written
authorizations but it is unclear by how
much. Since the proposed rule would
require the covered entity and the
responsible party for the student to
agree that the covered entity may release
proof of immunization, some covered
entities may request the agreement in
writing. In these cases, there may be
little change from the current
authorization requirement in terms of
the burden. Because we lack data on the
burden reduction, we cannot provide an
estimate of the possible savings. We
welcome comment on the proposed
change.
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
7. Fundraising Requirements
The proposed rule would require that
any fundraising communication sent to
an individual must provide the
recipient with a clear and conspicuous
opportunity to opt out of receiving any
further fundraising communications. If
an individual elects to opt out, the
fundraising entity must not send that
individual additional fundraising
communications. We believe that the
strengthened language from the HITECH
Act that requires fundraisers to clearly
and conspicuously provide the recipient
an opt-out choice from receiving future
communication and to treat such a
choice as a revocation of authorization
will result in fewer unwanted
fundraising communications. However,
we lack the data to estimate the effects
of this change. We request comment on
the extent to which the requirement that
the opportunity to elect not to receive
further fundraising communications be
clear and conspicuous would have an
impact on covered entities and their
current fundraising materials.
8. Individuals’ Access to Protected
Health Information
Under the proposed regulations, if a
covered entity maintains protected
health information electronically and
the recipient requests copies of his or
her protected health information in an
electronic format, the covered entity or
business associate must provide the
information in the electronic format
requested by the individual if readily
producible in that format, or, if not, in
a different electronic format agreed to by
the covered entity and the individual. If
the covered entity provides an
individual with electronic access to
protected health information, the
proposed rule would only allow the
covered entity to charge the costs of
labor associated with the preparation of
the request. The proposed rule clarifies
the labor and supply costs applicable to
preparation of electronic requests vs.
paper requests. Labor costs to produce
an electronic copy involve the cost of
reviewing and preparing the copy.
Supplies for an electronic copy apply
only to the cost of the media, if
applicable, for providing the
information to the individual. If the
individual provides the media (e.g., a
CD or flash drive), there would be no
cost for the media. Similarly, if the
information is transmitted via e-mail or
some other electronic mode, there
would be no charge for media.
It is unclear whether there will be any
cost increase or decrease to either the
individual or the covered entity with
respect to the individual’s increased
PO 00000
Frm 00042
Fmt 4701
Sfmt 4702
access to their electronic protected
health information. The fact that the
proposed rule requires the covered
entity to provide information in an
electronic format may be, in practice, no
different than the current requirement to
provide protected health information to
the individual in electronic format, if
readily producible in such format. Both
the current and proposed rules continue
to permit the covered entity and
individual to negotiate over the format
and delivery of protected health
information. By emphasizing the
provision of protected health
information electronically, the proposed
rule may lower costs because postage
costs are eliminated or reduced and
labor and supply costs are significantly
reduced. In conclusion, there may be
some savings that result from the greater
use of electronic access to protected
health information, but we cannot
quantify them.
9. Business Associates and Covered
Entities and Their Contractual
Relationships
The proposed rule would extend
liability for failure to comply with the
Privacy and Security Rules directly to
business associates and business
associate subcontractors in a manner
similar to how they now apply to
covered entities. The proposed rule
would subject business associates to
many of the same standards and
implementation specifications, and to
the same penalties, that apply to
covered entities under the Security Rule
and to some of the same standards and
implementation specifications, and to
the same penalties, that apply to
covered entities under the Privacy Rule.
Additionally, business associates would
also be required to obtain satisfactory
assurances in the form of a business
associate agreement from subcontractors
that the subcontractors will safeguard
any protected health information in
their possession. If the business
associate learns of a pattern of activity
or practice of a subcontractor that
constitutes a material breach or
violation of the contract, the business
associate would be required to make
reasonable attempts to repair the breach
or correct the violation. If unsuccessful,
the business associate would be
required to terminate the contract, if
feasible. In addition, a business
associate would be required to furnish
any information the Secretary requires
to investigate whether the business
associate is in compliance with the
regulations.
In the absence of reliable data to the
contrary, we assume that business
associates’ compliance with their
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
contracts range from the minimal
compliance to avoid contract
termination to being fully compliant.
The burden of the proposed rules on
business associates depends on the
terms of the contract between the
covered entity and business associate,
and the degree to which a business
associate established privacy policies
and adopted security measures that
comport with the HIPAA Rules. For
business associates that have already
taken HIPAA-compliant measures to
protect the privacy and security of the
protected health information in their
possession, the proposed rules with
their increased penalties would impose
limited burden.
We assume that business associates in
compliance with their contracts would
have already designated personnel to be
responsible for formulating the
organization’s privacy and security
policies, performed a risk analysis, and
invested in hardware and software to
prevent and monitor for internal and
external breaches of protected health
information. We expect that most
business associates make a good-faith
effort to follow the terms of their
contracts and comply with current
security and privacy standards.
For those business associates that
have not already adopted HIPAAcompliant privacy and security
standards for protected health
information, the risk of criminal and/or
civil monetary penalties may spur them
to increase their efforts to comply with
the privacy and security standards. Up
to this point, the consequences of failing
to meet the privacy and security
standards were limited to a business
loss in the form of a terminated contract.
In the context of the business associate’s
overall business, the risk of losing the
contract may not be a sufficient
incentive to warrant investing in added
security or establishing privacy policies
potentially at significant expense. There
may be other more benign reasons such
as ignorance of potential threats or lack
of knowledgeable personnel on staff.
Regardless of the reason, to avoid the
risk of the far more serious penalties in
this proposed rule, we expect that
business associates and subcontractors
that have been lax in their complying
with the privacy and security standards
may now take steps to enhance their
security procedures and strengthen their
policies for protecting the privacy of the
protected health information under their
control.
As stated above, we have no
information on the degree of contract
enforcement and compliance among
business associates. We also lack
information regarding the size or type of
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
business associates that contract with
covered entities. We have only rough
estimates as to the overall number of
business associates, which ranges from
approximately one million to two
million depending upon the number of
business associates which serve
multiple covered entities. As the area of
health information technology expands,
we note that the proposed rule also
includes in the definition of business
associates entities such as e-prescribing
gateways, health information
organizations or other organizations that
provide data transmission services with
respect to protected health information
to a covered entity.
As a result of the lack of information,
we can only assume that some business
associates and subcontractors comply
with existing privacy and security
standards. For them, the proposed rules
would impose only a limited burden.
For business associates that do not have
HIPAA-compliant privacy policies and
security procedures, the proposed rules
imposing criminal and civil monetary
penalties directly on business associates
and their subcontractors may
incentivize these organizations to
bolster their security and privacy
policies. Depending on the current level
of compliance, for some business
associates, the proposed rule could
impose significant burdens. We
welcome comments on our analysis and
especially invite information regarding
the amount of burden and the number
of affected business associates.
The cost to renegotiate contracts
between covered entities and business
associates and between business
associates and subcontractors may be
minimal if we assume that all parties are
living up to their current contractual
agreements. At the same time, we
anticipate that an unknown number of
contracts will have to be modified to
reflect the changes in law and in the
rules we propose. The time involved in
modifying a contract is estimated to be
one hour of a legal professional’s time.
Based on the Bureau of Labor Statistics
reports, the average hourly wage of $60
plus an estimated additional 50 percent
for benefits brings the hourly rate to
$90.
Because we are allowing contracts to
be phased in over one year from the
compliance date or 18 months from the
effective date of the final rule, we expect
that the costs of modifying contracts
will be incorporated into the normal
renegotiation of contracts as the
contracts expire. We believe that most
contracts will be renegotiated over the
phase-in period. In addition, the
Department expects to issue revised
sample business associate contract
PO 00000
Frm 00043
Fmt 4701
Sfmt 4702
40909
language when these rules are finalized,
which may help to lessen the costs
associated with contract modifications.
Under these assumptions, the costs will
be minimal. We request comments on
the number of contracts and covered
entities that will not be able to complete
renegotiation of their contracts with
their business associates within 18
months.
Even with the phase-in period for
renegotiating contracts, we expect there
will be an unknown number of covered
entities and business associates that will
have to renegotiate their contracts before
the term of their current contracts expire
because: (1) some contracts may extend
beyond the eighteen month period, (2)
fear of incurring civil or criminal
penalties may motivate the parties to
ensure they are in compliance with the
new rules, and (3) the covered entity
and business associate may have
established only the minimum
requirements and seek to strengthen
their compliance under the new rules.
As stated previously, we are unsure
which of these scenarios applies. We
welcome comments on the extent of cost
to renegotiate contracts.
D. Benefits
The proposed modifications pursuant
to the HITECH Act would provide
benefits to individuals. The benefits for
individuals include added information
on their rights through an expanded
NPP and greater control over the uses
and disclosures of their personal health
information by expanding the
requirements to obtain authorization
before a covered entity or business
associate can disclose their protected
health information in exchange for
remuneration and to restrict certain
disclosures at the request of the
individual. Under the proposed rule,
individuals would also have easier
access to their protected health
information in an electronic format, and
relatives and friends of deceased
persons would be able to obtain the
person’s protected health information
when there is no personal representative
or without obtaining authorization
under some circumstances. In addition,
covered entities would only need to
protect the health information of
decedents for 50 years after their death,
as opposed to protecting the information
in perpetuity as is required by the
current rule. This would also mean that
the personal health information of
persons who had been deceased for
many years would be available to
historians, researchers, and family
members. Also, individuals’ rights with
respect to fundraising communications
would be strengthened. In States that
E:\FR\FM\14JYP2.SGM
14JYP2
40910
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
require immunization information for
school attendance, schools would have
an easier time obtaining immunization
records because the proposed rule
would eliminate the need for written
authorization.
Under the proposed rule, pursuant to
the HITECH Act, an individual’s health
information will be afforded greater
protection since business associates of
covered entities would share
responsibility with the covered entity
for safeguarding against impermissible
disclosures of protected health
information. Business associates and
subcontractors would be subject to
criminal and civil penalties for violating
the privacy and security of protected
health information entrusted to them.
While we are certain that the
proposed regulatory changes represent
distinct benefits, we cannot monetize
their value. We have no measure for
valuing the benefit an individual would
gain from the authorization requirement
when a covered entity or business
associate exchanges protected health
information for remuneration. Neither
do we know how much value would be
added when an individual receives their
protected health information in an
electronic format nor the amount of time
saved as a result of the public health
disclosure provision for student
immunizations. Also, the value that
relatives and friends of a deceased
person would gain from obtaining the
protected health information of the
decedent that they would not otherwise
be able to obtain because there is no
personal representative or, if there is a
personal representative, without the
delay of obtaining authorization, is
beyond our ability to measure. We
welcome comments and information
that could improve our analysis of the
benefits of the proposed rule.
E. Regulatory Flexibility Analysis
The Regulatory Flexibility Act
requires agencies that issue a proposed
rule to analyze and consider options for
reducing regulatory burden if the
regulation will impose a significant
burden on a substantial number of small
entities. The Act requires the head of
the agency to either certify that the rule
would not impose such a burden or
perform a regulatory flexibility analysis
and consider alternatives to lessen the
burden.
The proposed rule would have an
impact on covered providers of health
care, health insurance issuers, and third
party administrators acting on behalf of
health plans, which we estimate to total
701,325. Of the approximately $166.1
million in costs we are able to identify,
the private sector will incur
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
approximately 71 percent of the costs or
$118.1 million. The average cost per
covered entity is therefore
approximately $168. We do not view
this as a significant burden. We note
that the 3,500 third party administrators
included in this calculation serve as
business associates to the approximately
446,000 ERISA plans, most of which are
small entities. We have no information
on how many of these plans selfadminister, and we request any data the
public may provide on this question.
Based on the relatively small cost per
covered entity, the Secretary certifies
that the proposed rule would not have
a significant impact on a substantial
number of small entities. However,
because we are not certain of all the
costs this rule may impose or the exact
number of small health insurers or third
party administrators, we welcome
comments that may further inform our
analysis.
Although we certify that the proposed
rule will not impose a significant
burden on a substantial number of small
entities, in drafting the proposed
provisions of the rule, we considered
alternatives for reducing the burden on
small entities.
First, in the rule we are proposing to
allow covered entities and business
associates with existing HIPAA
compliant contracts twelve months from
the compliance date to renegotiate their
contracts unless the contract is renewed
or modified before such date. This
amount of time plus the six months
from the effective date of the rule to the
compliance date generally gives the
parties 18 months to renegotiate their
agreements. We believe that the added
time will reduce the cost to revise
agreements because the changes the rule
requires will be incorporated into the
routine updating of covered entities and
business associates contracts.
Second, as we did in the final Privacy
Rule published August 14, 2002 (67 FR
53182, 53264–53266) we will provide
sample language for revising the
contracts between covered entities and
business associates. While the language
is generic and may not suit complex
organizations with complex agreements,
we believe that it will help small
entities with their contract revisions and
save them time and money in redrafting
their contracts to conform to the new
rules.
VIII. Collection of Information
Requirements
Under the Paperwork Reduction Act
of 1995 (PRA), agencies are required to
provide a 60-day notice in the Federal
Register and solicit public comment
before a collection of information
PO 00000
Frm 00044
Fmt 4701
Sfmt 4702
requirement is submitted to the Office of
Management and Budget (OMB) for
review and approval. In order to fairly
evaluate whether an information
collection should be approved by OMB,
section 3506(c)(2)(A) of the PRA
requires that we solicit comment on the
following issues:
a. Whether the information collection
is necessary and useful to carry out the
proper functions of the agency;
b. The accuracy of the agency’s
estimate of the information collection
burden;
c. The quality, utility, and clarity of
the information to be collected; and
d. Recommendations to minimize the
information collection burden on the
affected public, including automated
collection techniques.
Under the PRA, the time, effort, and
financial resources necessary to meet
the information collection requirements
referenced in this section are to be
considered. We explicitly seek, and will
consider, public comment on our
assumptions as they relate to the PRA
requirements summarized in this
section. To comment on this collection
of information or to obtain copies of the
supporting statement and any related
forms for the proposed paperwork
collections referenced above, e-mail
your comment or request, including
your address and phone number to
sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be directed
to the OS Paperwork Clearance Officer
at the above e-mail address within 60
days.
A. Abstract
As a result of the Health Information
Technology for Economic and Clinical
Health (HITECH) Act, Title XIII of
Division A and Title IV of Division B of
the American Recovery and
Reinvestment Act of 2009 (ARRA) (Pub.
L. 111–5), the Office for Civil Rights
(OCR) is required to revise its
information collection under the Health
Insurance Portability and
Accountability Act of 1996 (HIPAA)
Privacy and Security Rules (45 CFR
Parts 160 and 164). ARRA was enacted
on February 17, 2009. This supporting
statement revises a previously approved
OCR data collection, OMB # 0990–0294.
The HITECH Act requires modification
of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA)
(Pub. L. 104–191) implementing
regulations at 45 CFR Parts 160 and 164,
the HIPAA Privacy and Security Rules,
to extend jurisdiction to business
associates and to strengthen privacy and
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
security protections for health
information.
We have integrated this PRA notice
into the Notice of Proposed Rulemaking,
because these costs represent costs to be
incurred as one-time, first year
implementation costs. The estimated
annualized burden table below was
developed using the same estimates and
workload assumptions in the impact
statement in the section regarding
Executive Order 12866, above. Because
the HIPAA Privacy and Security Rules
have been in effect for several years,
these numbers, as revised pursuant to
the HITECH modifications, are based on
past experience with the current
information collection.
With respect to the § 164.520
requirement to revise the Notice of
Privacy Practices, the ‘‘Number of
Respondents’’ column represents the
number of covered entities that would
be required to revise their Notices of
Privacy Practices pursuant to the
HITECH modifications. As such,
701,500 covered entities would be
required to modify their Notices of
Privacy Practices. Each covered entity
would have to revise one Notice of
Privacy Practices, which is represented
by the ‘‘Average Number of Responses
per Respondent’’ column. We estimate
that each revision would require 20
minutes to complete. As such, it would
take 233,833 total burden hours for
701,500 covered entities to revise their
Notices of Privacy Practices. With
respect to the § 164.520 requirement for
health plans to disseminate the revised
Notice of Privacy Practices, the ‘‘Number
of Respondents’’ column represents the
200 million individuals to whom the
revised Notice of Privacy Practices
would be sent. Each individual would
receive one Notice of Privacy Practices,
which is represented by the ‘‘Average
Number of Responses per Respondent’’
column. We estimate that each health
plan would need one hour to prepare
100 Notices of Privacy Practices for
mailing to individuals. As such, the
total burden hours it would take health
plans to disseminate Notices of Privacy
Practices to 200 million individuals
would be two million.
With regard to the proposed business
associate provisions, as discussed in
Section VI of this proposed rule, we
assume that business associates
currently comply with the HIPAA
Privacy and Security Rules, and that
their contracts range from the minimal
compliance to avoid contract
termination to being fully compliant.
Because the proposed rule provides that
most business associates may
renegotiate their contracts during the
compliance period in the normal course
of business, we anticipate no or minimal
additional burden. However, for those
business associates with subcontractors,
we anticipate an increased burden
associated with bringing their
subcontractors into compliance with the
HIPAA Privacy and Security Rules,
specifically with regard to business
associate agreements.
Currently, business associates must
obtain satisfactory assurance from their
subcontractors regarding their
compliance with the HIPAA Privacy
and Security Rules. We assume that
business associates obtained this
satisfactory assurance via contract with
their subcontractors. This proposed rule
contains a new explicit requirement that
business associates enter into contracts
with their subcontractors to ensure
compliance with the HIPAA Privacy
and Security Rules. Because most
business associates already have
contracts in place, this new requirement
creates a minimal additional burden
associated with modification of these
contracts. As discussed in Section VI
above, we estimated that it will require
one hour of a legal professional’s time
Type of respondent
164.504 ....................
164.520 ....................
Business Associates ..................................................
Revision of Notice of Privacy Practices for Protected
Health Information (drafting revised language).
Dissemination of Notice of Privacy Practices for Protected Health Information (health plans).
srobinson on DSKHWCL6B1PROD with PROPOSALS2
164.520 ....................
Total .................
....................................................................................
List of Subjects
45 CFR Part 160
Administrative practice and
procedure, Computer technology,
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
Frm 00045
Fmt 4701
B. Estimated Annualized Burden Table
Average burden hours per
response
1,500,000
701,500
1
1
1
20/60
1,500,000
233,833
200,000,000
1
1 per 100
2,000,000
........................
........................
........................
3,733,833
Electronic information system,
Electronic transactions, Employer
benefit plan, Health, Health care, Health
facilities, Health insurance, Health
records, Hospitals, Investigations,
PO 00000
to modify these contracts. We estimate
the number of business associates that
may have to bring subcontractors into
compliance to be 1,500,000. Our
estimate is based on an average of one
to two million business associates. This
correlates to 1,500,000 burden hours.
The overall total for respondents to
comply with the information collection
requirements of the Rules is 3,733,833
burden hours. We request comment on
this estimate.
As discussed in the above paragraph,
we consider the majority of, if not all of,
the burden associated with this
proposed rule to result from the
requirements with regard to the Notice
of Privacy Practices and costs for
business associates. However, as there
may be an additional minimal burden
associated with other provisions of the
proposed rule, we request comment on
the impacts of such provisions, as
follows.
With regard to the proposed
marketing, sale, fundraising, and access
provisions discussed above in Section
VI of this proposed rule, we do not
anticipate any significant increase in the
burden to covered entities and business
associates, because covered entities
already have in place routine business
policies, procedures, and forms to
address the current requirements
regarding an opt-out for fundraising,
authorizations for marketing and sale of
protected health information, and the
provision of access to electronic
protected health information. While the
proposed rule strengthens consumer
protections in each of these areas, we do
not have sufficient data on the current
marketing, sale, fundraising, and access
activities of covered entities and their
business associates to calculate the
impact of the increased protections on
the use of these forms and processes.
Average
number of responses per
respondent
Number of
respondents
Section
40911
Sfmt 4702
Total burden
hours
Medicaid, Medical research, Medicare,
Penalties, Privacy, Reporting and record
keeping requirements, Security.
E:\FR\FM\14JYP2.SGM
14JYP2
40912
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
45 CFR Part 164
Administrative practice and
procedure, Computer technology,
Electronic information system,
Electronic transactions, Employer
benefit plan, Health, Health care, Health
facilities, Health insurance, Health
records, Hospitals, Medicaid, Medical
research, Medicare, Privacy, Reporting
and record keeping requirements,
Security.
For the reasons set forth in the
preamble, the Department proposes to
amend 45 CFR Subtitle A, Subchapter C,
parts 160 and 164, as set forth below:
PART 160—GENERAL
ADMINISTRATIVE REQUIREMENTS
1. The authority citation for part 160
is revised to read as follows:
Authority: 42 U.S.C. 1302(a); 42 U.S.C.
1320d–1320d–8; sec. 264, Pub. L. 104–191,
110 Stat. 2033–2034 (42 U.S.C. 1320d–
2(note)); 5 U.S.C. 552; and secs. 13400–
13424, Pub. L. 111–5, 123 Stat. 258–279.
2. Revise § 160.101 to read as follows:
§ 160.101
Statutory basis and purpose.
The requirements of this subchapter
implement sections 1171–1179 of the
Social Security Act (the Act), as added
by section 262 of Public Law 104–191,
section 264 of Public Law 104–191, and
sections 13400–13424 of Public Law
111–5.
3. Amend § 160.102 as follows:
a. Redesignate paragraph (b) as
paragraph (c); and
b. Add new paragraph (b) to read as
follows:
§ 160.102
Applicability.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
*
*
*
*
*
(b) Where provided, the standards,
requirements, and implementation
specifications adopted under this
subchapter apply to a business
associate.
*
*
*
*
*
4. Amend § 160.103 as follows:
a. Revise the definitions of ‘‘business
associate’’, ‘‘compliance date’’,
‘‘disclosure’’, ‘‘electronic media’’,
paragraph (2) of ‘‘protected health
information,’’ and the definitions of
‘‘standard’’, ‘‘State’’, and ‘‘workforce’’;
and
b. Add, in alphabetical order, new
definitions of ‘‘administrative
simplification provision’’, ‘‘ALJ’’, ‘‘civil
money penalty or penalty’’,
‘‘respondent’’, ‘‘subcontractor’’, and
‘‘violation or violate’’.
The revisions and additions read as
follows:
§ 160.103
Definitions.
*
*
*
VerDate Mar<15>2010
*
*
15:51 Jul 13, 2010
Jkt 220001
Administrative simplification
provision means any requirement or
prohibition established by:
(1) 42 U.S.C. 1320d–1320d–4, 1320d–
7, and 1320d–8;
(2) Section 264 of Pub. L. 104–191;
(3) Sections 13400–13424 of Public
Law 111–5; or
(4) This subchapter.
ALJ means Administrative Law Judge.
*
*
*
*
*
Business associate: (1) Except as
provided in paragraph (4) of this
definition, business associate means,
with respect to a covered entity, a
person who:
(i) On behalf of such covered entity or
of an organized health care arrangement
(as defined in this section) in which the
covered entity participates, but other
than in the capacity of a member of the
workforce of such covered entity or
arrangement, performs, or assists in the
performance of:
(A) A function or activity involving
the use or disclosure of protected health
information, including claims
processing or administration, data
analysis, processing or administration,
utilization review, quality assurance,
patient safety activities listed at 42 CFR
3.20, billing, benefit management,
practice management, and repricing; or
(B) Any other function or activity
regulated by this subchapter; or
(ii) Provides, other than in the
capacity of a member of the workforce
of such covered entity, legal, actuarial,
accounting, consulting, data aggregation
(as defined in § 164.501 of this
subchapter), management,
administrative, accreditation, or
financial services to or for such covered
entity, or to or for an organized health
care arrangement in which the covered
entity participates, where the provision
of the service involves the disclosure of
protected health information from such
covered entity or arrangement, or from
another business associate of such
covered entity or arrangement, to the
person.
(2) A covered entity may be a business
associate of another covered entity.
(3) Business associate includes:
(i) A Health Information Organization,
E-prescribing Gateway, or other person
that provides data transmission services
with respect to protected health
information to a covered entity and that
requires access on a routine basis to
such protected health information.
(ii) A person that offers a personal
health record to one or more individuals
on behalf of a covered entity.
(iii) A subcontractor that creates,
receives, maintains, or transmits
protected health information on behalf
of the business associate.
PO 00000
Frm 00046
Fmt 4701
Sfmt 4702
(4) Business associate does not
include:
(i) A health care provider, with
respect to disclosures by a covered
entity to the health care provider
concerning the treatment of the
individual.
(ii) A plan sponsor, with respect to
disclosures by a group health plan (or
by a health insurance issuer or HMO
with respect to a group health plan) to
the plan sponsor, to the extent that the
requirements of § 164.504(f) of this
subchapter apply and are met.
(iii) A government agency, with
respect to determining eligibility for, or
enrollment in, a government health plan
that provides public benefits and is
administered by another government
agency, or collecting protected health
information for such purposes, to the
extent such activities are authorized by
law.
(iv) A covered entity participating in
an organized health care arrangement
that performs a function or activity as
described by paragraph (1)(i) of this
definition for or on behalf of such
organized health care arrangement, or
that provides a service as described in
paragraph (1)(ii) of this definition to or
for such organized health care
arrangement by virtue of such activities
or services.
Civil money penalty or penalty means
the amount determined under § 160.404
of this part and includes the plural of
these terms.
*
*
*
*
*
Compliance date means the date by
which a covered entity or business
associate must comply with a standard,
implementation specification,
requirement, or modification adopted
under this subchapter.
*
*
*
*
*
Disclosure means the release, transfer,
provision of access to, or divulging in
any manner of information outside the
entity holding the information.
*
*
*
*
*
Electronic media means:
(1) Electronic storage material on
which data is or may be recorded
electronically, including, for example,
devices in computers (hard drives) and
any removable/transportable digital
memory medium, such as magnetic tape
or disk, optical disk, or digital memory
card;
(2) Transmission media used to
exchange information already in
electronic storage media. Transmission
media include, for example, the Internet
(wide-open), extranet or intranet (using
Internet technology to link a business
with information accessible only to
collaborating parties), leased lines, dial-
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
up lines, private networks, and the
physical movement of removable/
transportable electronic storage media.
Certain transmissions, including of
paper, via facsimile, and of voice, via
telephone, are not considered to be
transmissions via electronic media if the
information being exchanged did not
exist in electronic form before the
transmission.
*
*
*
*
*
Protected health information * * *
(2) Protected health information
excludes individually identifiable
health information:
(i) In education records covered by
the Family Educational Rights and
Privacy Act, as amended, 20 U.S.C.
1232g;
(ii) In records described at 20 U.S.C.
1232g(a)(4)(B)(iv);
(iii) In employment records held by a
covered entity in its role as employer;
and
(iv) Regarding a person who has been
deceased for more than 50 years.
*
*
*
*
*
Respondent means a covered entity or
business associate upon which the
Secretary has imposed, or proposes to
impose, a civil money penalty.
*
*
*
*
*
Standard means a rule, condition, or
requirement:
(1) Describing the following
information for products, systems,
services, or practices:
(i) Classification of components;
(ii) Specification of materials,
performance, or operations; or
(iii) Delineation of procedures; or
(2) With respect to the privacy of
protected health information.
*
*
*
*
*
State refers to one of the following:
(1) For a health plan established or
regulated by Federal law, State has the
meaning set forth in the applicable
section of the United States Code for
such health plan.
(2) For all other purposes, State
means any of the several States, the
District of Columbia, the
Commonwealth of Puerto Rico, the
Virgin Islands, Guam, American Samoa,
and the Commonwealth of the Northern
Mariana Islands.
Subcontractor means a person who
acts on behalf of a business associate,
other than in the capacity of a member
of the workforce of such business
associate.
*
*
*
*
*
Violation or violate means, as the
context may require, failure to comply
with an administrative simplification
provision.
Workforce means employees,
volunteers, trainees, and other persons
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
whose conduct, in the performance of
work for a covered entity or business
associate, is under the direct control of
such covered entity or business
associate, whether or not they are paid
by the covered entity or business
associate.
5. Add § 160.105 to subpart A to read
as follows:
§ 160.105 Compliance dates for
implementation of new or modified
standards and implementation
specifications.
In accordance with § 160.104, with
respect to new standards and
implementation specifications or
modifications to standards and
implementation specifications in this
subchapter that become effective after
[DATE OF PUBLICATION OF THE
FINAL RULE IN THE FEDERAL
REGISTER], except as otherwise
provided, covered entities and business
associates must comply with the
applicable new standards and
implementation specifications or
modifications to standards and
implementation specifications no later
than 180 days from the effective date of
any such standards or implementation
specifications.
6. Revise § 160.201 to read as follows:
§ 160.201
Statutory basis.
The provisions of this subpart
implement section 1178 of the Act, as
added by section 262 of Public Law
104–191, section 264(c) of Public Law
104–191, and section 13421(a) of Public
Law 111–5.
7. In § 160.202, revise the definition of
‘‘contrary’’ and paragraph (1)(i) of the
definition of ‘‘more stringent’’ to read as
follows:
§ 160.202
Definitions.
*
*
*
*
*
Contrary, when used to compare a
provision of State law to a standard,
requirement, or implementation
specification adopted under this
subchapter, means:
(1) A covered entity or business
associate would find it impossible to
comply with both the State and Federal
requirements; or
(2) The provision of State law stands
as an obstacle to the accomplishment
and execution of the full purposes and
objectives of part C of title XI of the Act,
section 264 of Public Law 104–191, or
sections 13400–13424 of Public Law
111–5, as applicable.
More stringent * * *
(1) * * *
(i) Required by the Secretary in
connection with determining whether a
PO 00000
Frm 00047
Fmt 4701
Sfmt 4702
40913
covered entity or business associate is in
compliance with this subchapter; or
*
*
*
*
*
8. Revise § 160.300 to read as follows:
§ 160.300
Applicability.
This subpart applies to actions by the
Secretary, covered entities, business
associates, and others with respect to
ascertaining the compliance by covered
entities and business associates with,
and the enforcement of, the applicable
provisions of this part 160 and parts 162
and 164 of this subchapter.
§ 160.302
[Removed and Reserved]
9. Remove and reserve § 160.302.
10. Revise § 160.304 to read as
follows:
§ 160.304 Principles for achieving
compliance.
(a) Cooperation. The Secretary will, to
the extent practicable and consistent
with the provisions of this subpart, seek
the cooperation of covered entities and
business associates in obtaining
compliance with the applicable
administrative simplification
provisions.
(b) Assistance. The Secretary may
provide technical assistance to covered
entities and business associates to help
them comply voluntarily with the
applicable administrative simplification
provisions.
11. In § 160.306, revise paragraphs (a)
and (c) to read as follows:
§ 160.306
Complaints to the Secretary.
(a) Right to file a complaint. A person
who believes a covered entity or
business associate is not complying
with the administrative simplification
provisions may file a complaint with the
Secretary.
*
*
*
*
*
(c) Investigation.
(1) The Secretary will investigate any
complaint filed under this section when
a preliminary review of the facts
indicates a possible violation due to
willful neglect.
(2) The Secretary may investigate any
other complaint filed under this section.
(3) An investigation under this section
may include a review of the pertinent
policies, procedures, or practices of the
covered entity or business associate and
of the circumstances regarding any
alleged violation.
(4) At the time of the initial written
communication with the covered entity
or business associate about the
complaint, the Secretary will describe
the acts and/or omissions that are the
basis of the complaint.
12. Revise § 160.308 to read as
follows:
E:\FR\FM\14JYP2.SGM
14JYP2
40914
§ 160.308
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
Compliance reviews.
(a) The Secretary will conduct a
compliance review to determine
whether a covered entity or business
associate is complying with the
applicable administrative simplification
provisions when a preliminary review
of the facts indicates a possible violation
due to willful neglect.
(b) The Secretary may conduct a
compliance review to determine
whether a covered entity or business
associate is complying with the
applicable administrative simplification
provisions in any other circumstance.
13. Revise § 160.310 to read as
follows:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 160.310 Responsibilities of covered
entities and business associates.
(a) Provide records and compliance
reports. A covered entity or business
associate must keep such records and
submit such compliance reports, in such
time and manner and containing such
information, as the Secretary may
determine to be necessary to enable the
Secretary to ascertain whether the
covered entity or business associate has
complied or is complying with the
applicable administrative simplification
provisions.
(b) Cooperate with complaint
investigations and compliance reviews.
A covered entity or business associate
must cooperate with the Secretary, if the
Secretary undertakes an investigation or
compliance review of the policies,
procedures, or practices of the covered
entity or business associate to determine
whether it is complying with the
applicable administrative simplification
provisions.
(c) Permit access to information.
(1) A covered entity or business
associate must permit access by the
Secretary during normal business hours
to its facilities, books, records, accounts,
and other sources of information,
including protected health information,
that are pertinent to ascertaining
compliance with the applicable
administrative simplification
provisions. If the Secretary determines
that exigent circumstances exist, such as
when documents may be hidden or
destroyed, a covered entity or business
associate must permit access by the
Secretary at any time and without
notice.
(2) If any information required of a
covered entity or business associate
under this section is in the exclusive
possession of any other agency,
institution, or person and the other
agency, institution, or person fails or
refuses to furnish the information, the
covered entity or business associate
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
must so certify and set forth what efforts
it has made to obtain the information.
(3) Protected health information
obtained by the Secretary in connection
with an investigation or compliance
review under this subpart will not be
disclosed by the Secretary, except if
necessary for ascertaining or enforcing
compliance with the applicable
administrative simplification
provisions, if otherwise required by law,
or if permitted under 5 U.S.C.
552a(b)(7).
14. Revise § 160.312 to read as
follows:
§ 160.312 Secretarial action regarding
complaints and compliance reviews.
(a) Resolution when noncompliance is
indicated.
(1) If an investigation of a complaint
pursuant to § 160.306 or a compliance
review pursuant to § 160.308 indicates
noncompliance, the Secretary may
attempt to reach a resolution of the
matter satisfactory to the Secretary by
informal means. Informal means may
include demonstrated compliance or a
completed corrective action plan or
other agreement.
(2) If the matter is resolved by
informal means, the Secretary will so
inform the covered entity or business
associate and, if the matter arose from
a complaint, the complainant, in
writing.
(3) If the matter is not resolved by
informal means, the Secretary will—
(i) So inform the covered entity or
business associate and provide the
covered entity or business associate an
opportunity to submit written evidence
of any mitigating factors or affirmative
defenses for consideration under
§§ 160.408 and 160.410 of this part. The
covered entity or business associate
must submit any such evidence to the
Secretary within 30 days (computed in
the same manner as prescribed under
§ 160.526 of this part) of receipt of such
notification; and
(ii) If, following action pursuant to
paragraph (a)(3)(i) of this section, the
Secretary finds that a civil money
penalty should be imposed, inform the
covered entity or business associate of
such finding in a notice of proposed
determination in accordance with
§ 160.420 of this part.
(b) Resolution when no violation is
found. If, after an investigation pursuant
to § 160.306 or a compliance review
pursuant to § 160.308, the Secretary
determines that further action is not
warranted, the Secretary will so inform
the covered entity or business associate
and, if the matter arose from a
complaint, the complainant, in writing.
PO 00000
Frm 00048
Fmt 4701
Sfmt 4702
15. In § 160.316, revise the
introductory text to read as follows:
§ 160.316 Refraining from intimidation or
retaliation.
A covered entity or business associate
may not threaten, intimidate, coerce,
harass, discriminate against, or take any
other retaliatory action against any
individual or other person for—
*
*
*
*
*
16. In § 160.401, revise the definition
of reasonable cause to read as follows:
§ 160.401
Definitions.
*
*
*
*
*
Reasonable cause means an act or
omission in which a covered entity or
business associate knew, or by
exercising reasonable diligence would
have known, that the act or omission
violated an administrative
simplification provision, but in which
the covered entity or business associate
did not act with willful neglect.
*
*
*
*
*
17. Revise § 160.402 to read as
follows:
§ 160.402
Basis for a civil money penalty.
(a) General rule. Subject to § 160.410,
the Secretary will impose a civil money
penalty upon a covered entity or
business associate if the Secretary
determines that the covered entity or
business associate has violated an
administrative simplification provision.
(b) Violation by more than one
covered entity or business associate.
(1) Except as provided in paragraph
(b)(2) of this section, if the Secretary
determines that more than one covered
entity or business associate was
responsible for a violation, the Secretary
will impose a civil money penalty
against each such covered entity or
business associate.
(2) A covered entity that is a member
of an affiliated covered entity, in
accordance with § 164.105(b) of this
subchapter, is jointly and severally
liable for a civil money penalty for a
violation of part 164 of this subchapter
based on an act or omission of the
affiliated covered entity, unless it is
established that another member of the
affiliated covered entity was responsible
for the violation.
(c) Violation attributed to a covered
entity or business associate. (1) A
covered entity is liable, in accordance
with the Federal common law of agency,
for a civil money penalty for a violation
based on the act or omission of any
agent of the covered entity, including a
workforce member or business
associate, acting within the scope of the
agency.
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
(2) A business associate is liable, in
accordance with the Federal common
law of agency, for a civil money penalty
for a violation based on the act or
omission of any agent of the business
associate, including a workforce
member or subcontractor, acting within
the scope of the agency.
18. In § 160.404, revise the
introductory text of paragraphs (b)(2)(i),
(b)(2)(iii), and (b)(2)(iv) to read as
follows:
§ 160.404
Amount of a civil money penalty.
*
*
*
*
*
(b) * * *
(2) * * *
(i) For a violation in which it is
established that the covered entity or
business associate did not know and, by
exercising reasonable diligence, would
not have known that the covered entity
or business associate violated such
provision,
*
*
*
*
*
(iii) For a violation in which it is
established that the violation was due to
willful neglect and was corrected during
the 30-day period beginning on the first
date the covered entity or business
associate liable for the penalty knew, or,
by exercising reasonable diligence,
would have known that the violation
occurred,
*
*
*
*
*
(iv) For a violation in which it is
established that the violation was due to
willful neglect and was not corrected
during the 30-day period beginning on
the first date the covered entity or
business associate liable for the penalty
knew, or, by exercising reasonable
diligence, would have known that the
violation occurred,
*
*
*
*
*
19. Revise § 160.406 to read as
follows:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 160.406 Violations of an identical
requirement or prohibition.
The Secretary will determine the
number of violations of an
administrative simplification provision
based on the nature of the covered
entity’s or business associate’s
obligation to act or not act under the
provision that is violated, such as its
obligation to act in a certain manner, or
within a certain time, or to act or not act
with respect to certain persons. In the
case of continuing violation of a
provision, a separate violation occurs
each day the covered entity or business
associate is in violation of the provision.
20. Revise § 160.408 to read as
follows:
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
§ 160.408 Factors considered in
determining the amount of a civil money
penalty.
In determining the amount of any
civil money penalty, the Secretary will
consider the following factors, which
may be mitigating or aggravating as
appropriate:
(a) The nature and extent of the
violation, consideration of which may
include but is not limited to:
(1) The number of individuals
affected; and
(2) The time period during which the
violation occurred;
(b) The nature and extent of the harm
resulting from the violation,
consideration of which may include but
is not limited to:
(1) Whether the violation caused
physical harm;
(2) Whether the violation resulted in
financial harm;
(3) Whether the violation resulted in
harm to an individual’s reputation; and
(4) Whether the violation hindered an
individual’s ability to obtain health
care;
(c) The history of prior compliance
with the administrative simplification
provisions, including violations, by the
covered entity or business associate,
consideration of which may include but
is not limited to:
(1) Whether the current violation is
the same or similar to previous
indications of noncompliance;
(2) Whether and to what extent the
covered entity or business associate has
attempted to correct previous
indications of noncompliance;
(3) How the covered entity or business
associate has responded to technical
assistance from the Secretary provided
in the context of a compliance effort;
and
(4) How the covered entity or business
associate has responded to prior
complaints;
(d) The financial condition of the
covered entity or business associate,
consideration of which may include but
is not limited to:
(1) Whether the covered entity or
business associate had financial
difficulties that affected its ability to
comply;
(2) Whether the imposition of a civil
money penalty would jeopardize the
ability of the covered entity or business
associate to continue to provide, or to
pay for, health care; and
(3) The size of the covered entity or
business associate; and
(e) Such other matters as justice may
require.
21. Revise § 160.410 to read as
follows:
PO 00000
Frm 00049
Fmt 4701
Sfmt 4702
§ 160.410
40915
Affirmative defenses.
(a) The Secretary may not:
(1) Prior to February 18, 2011, impose
a civil money penalty on a covered
entity or business associate for an act
that violates an administrative
simplification provision if the covered
entity or business associate establishes
that the violation is punishable under
42 U.S.C. 1320d–6.
(2) On or after February 18, 2011,
impose a civil money penalty on a
covered entity or business associate for
an act that violates an administrative
simplification provision if the covered
entity or business associate establishes
that a penalty has been imposed under
42 U.S.C. 1320d-6 with respect to such
act.
(b) For violations occurring prior to
February 18, 2009, the Secretary may
not impose a civil money penalty on a
covered entity for a violation if the
covered entity establishes that an
affirmative defense exists with respect
to the violation, including the following:
(1) The covered entity establishes, to
the satisfaction of the Secretary, that it
did not have knowledge of the violation,
determined in accordance with the
Federal common law of agency, and by
exercising reasonable diligence, would
not have known that the violation
occurred; or
(2) The violation is—
(i) Due to circumstances that would
make it unreasonable for the covered
entity, despite the exercise of ordinary
business care and prudence, to comply
with the administrative simplification
provision violated and is not due to
willful neglect; and
(ii) Corrected during either:
(A) The 30-day period beginning on
the first date the covered entity liable
for the penalty knew, or by exercising
reasonable diligence would have
known, that the violation occurred; or
(B) Such additional period as the
Secretary determines to be appropriate
based on the nature and extent of the
failure to comply.
(c) For violations occurring on or after
February 18, 2009, the Secretary may
not impose a civil money penalty on a
covered entity or business associate for
a violation if the covered entity or
business associate establishes to the
satisfaction of the Secretary that the
violation is—
(1) Not due to willful neglect; and
(2) Corrected during either:
(i) The 30-day period beginning on
the first date the covered entity or
business associate liable for the penalty
knew, or, by exercising reasonable
diligence, would have known that the
violation occurred; or
E:\FR\FM\14JYP2.SGM
14JYP2
40916
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
(ii) Such additional period as the
Secretary determines to be appropriate
based on the nature and extent of the
failure to comply.
22. Revise § 160.412 to read as
follows:
§ 160.412
Waiver.
For violations described in
§ 160.410(b)(2) or (c) that are not
corrected within the period specified
under such paragraphs, the Secretary
may waive the civil money penalty, in
whole or in part, to the extent that the
payment of the penalty would be
excessive relative to the violation.
23. Revise § 160.418 to read as
follows:
§ 160.418
Penalty not exclusive.
Except as otherwise provided by 42
U.S.C. 1320d–5(b)(1) and 42 U.S.C.
299b–22(f)(3), a penalty imposed under
this part is in addition to any other
penalty prescribed by law.
PART 164—SECURITY AND PRIVACY
24. The authority citation for part 164
is revised to read as follows:
Authority: 42 U.S.C. 1302(a); 42 U.S.C.
1320d—1320d–8; sec. 264, Pub. L. 104–191,
110 Stat. 2033–2034 (42 U.S.C. 1320–
2(note)); and secs. 13400—13424, Pub. L.
111–5, 123 Stat. 258–279.
25. Revise § 164.102 to read as
follows:
§ 164.102
Statutory basis.
The provisions of this part are
adopted pursuant to the Secretary’s
authority to prescribe standards,
requirements, and implementation
specifications under part C of title XI of
the Act, section 264 of Public Law 104–
191, and sections 13400—13424 of
Public Law 111–5.
26. In § 164.104, revise paragraph (b)
to read as follows:
§ 164.104
Applicability.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
*
*
*
*
*
(b) Where provided, the standards,
requirements, and implementation
specifications adopted under this part
apply to a business associate.
27. Amend § 164.105 as follows:
a. Revise the introductory text of
paragraph (a)(1), the introductory text of
paragraph (a)(2)(i), paragraph (a)(2)(ii),
the introductory text of paragraph
(a)(2)(iii), and paragraphs (a)(2)(iii)(A)
and (B);
b. Redesignate paragraph (a)(2)(iii)(C)
as paragraph (a)(2)(iii)(D) and add new
paragraph (a)(2)(iii)(C); and
c. Revise paragraph (b).
The revisions read as follows:
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
§ 164.105
Organizational requirements.
(a)(1) Standard: Health care
component. If a covered entity is a
hybrid entity, the requirements of this
part, other than the requirements of this
section, § 164.314, and § 164.504, apply
only to the health care component(s) of
the entity, as specified in this section.
(2) * * *
(i) Application of other provisions. In
applying a provision of this part, other
than the requirements of this section,
§ 164.314, and § 164.504, to a hybrid
entity:
*
*
*
*
*
(ii) Safeguard requirements. The
covered entity that is a hybrid entity
must ensure that a health care
component of the entity complies with
the applicable requirements of this part.
In particular, and without limiting this
requirement, such covered entity must
ensure that:
(A) Its health care component does
not disclose protected health
information to another component of
the covered entity in circumstances in
which subpart E of this part would
prohibit such disclosure if the health
care component and the other
component were separate and distinct
legal entities;
(B) Its health care component protects
electronic protected health information
with respect to another component of
the covered entity to the same extent
that it would be required under subpart
C of this part to protect such
information if the health care
component and the other component
were separate and distinct legal entities;
(C) If a person performs duties for
both the health care component in the
capacity of a member of the workforce
of such component and for another
component of the entity in the same
capacity with respect to that
component, such workforce member
must not use or disclose protected
health information created or received
in the course of or incident to the
member’s work for the health care
component in a way prohibited by
subpart E of this part.
(iii) Responsibilities of the covered
entity. A covered entity that is a hybrid
entity has the following responsibilities:
(A) For purposes of subpart C of part
160 of this subchapter, pertaining to
compliance and enforcement, the
covered entity has the responsibility of
complying with this part.
(B) The covered entity is responsible
for complying with § 164.316(a) and
§ 164.530(i), pertaining to the
implementation of policies and
procedures to ensure compliance with
applicable requirements of this part,
PO 00000
Frm 00050
Fmt 4701
Sfmt 4702
including the safeguard requirements in
paragraph (a)(2)(ii) of this section.
(C) The covered entity is responsible
for complying with § 164.314 and
§ 164.504 regarding business associate
arrangements and other organizational
requirements.
*
*
*
*
*
(b)(1) Standard: Affiliated covered
entities. Legally separate covered
entities that are affiliated may designate
themselves as a single covered entity for
purposes of this part.
(2) Implementation specifications.
(i) Requirements for designation of an
affiliated covered entity. (A) Legally
separate covered entities may designate
themselves (including any health care
component of such covered entity) as a
single affiliated covered entity, for
purposes of this part, if all of the
covered entities designated are under
common ownership or control.
(B) The designation of an affiliated
covered entity must be documented and
the documentation maintained as
required by paragraph (c) of this section.
(ii) Safeguard requirements. An
affiliated covered entity must ensure
that it complies with the applicable
requirements of this part, including, if
the affiliated covered entity combines
the functions of a health plan, health
care provider, or health care
clearinghouse, § 164.308(a)(4)(ii)(A) and
§ 164.504(g), as applicable.
*
*
*
*
*
28. Revise § 164.106 to read as
follows:
§ 164.106
Relationship to other parts.
In complying with the requirements
of this part, covered entities and, where
provided, business associates, are
required to comply with the applicable
provisions of parts 160 and 162 of this
subchapter.
29. The authority citation for subpart
C of part 164 is revised to read as
follows:
Authority: 42 U.S.C. 1320d–2 and 1320d–
4; sec. 13401, Pub. L. 111–5, 123 Stat. 260.
30. Revise § 164.302 to read as
follows:
§ 164.302
Applicability.
A covered entity or business associate
must comply with the applicable
standards, implementation
specifications, and requirements of this
subpart with respect to electronic
protected health information of a
covered entity.
31. In § 164.304, revise the definitions
of Administrative safeguards and
Physical safeguards to read as follows:
§ 164.304
Definitions.
*
*
E:\FR\FM\14JYP2.SGM
*
14JYP2
*
*
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
Administrative safeguards are
administrative actions, and policies and
procedures, to manage the selection,
development, implementation, and
maintenance of security measures to
protect electronic protected health
information and to manage the conduct
of the covered entity’s or business
associate’s workforce in relation to the
protection of that information.
*
*
*
*
*
Physical safeguards are physical
measures, policies, and procedures to
protect a covered entity’s or business
associate’s electronic information
systems and related buildings and
equipment, from natural and
environmental hazards, and
unauthorized intrusion.
*
*
*
*
*
32. Amend § 164.306 as follows:
a. Revise the introductory text of
paragraph (a) and paragraph (a)(1);
b. Revise paragraph (b)(1), the
introductory text of paragraph (b)(2),
and paragraphs (b)(2)(i) and (b)(2)(ii);
c. Revise paragraph (c);
d. Revise paragraph (d)(2), the
introductory text of paragraph (d)(3),
paragraph (d)(3)(i), and the introductory
text of paragraph (d)(3)(ii); and
e. Revise paragraph (e).
The revisions read as follows:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 164.306
rules.
Security standards: General
(a) General requirements. Covered
entities and business associates must do
the following:
(1) Ensure the confidentiality,
integrity, and availability of all
electronic protected health information
the covered entity or business associate
creates, receives, maintains, or
transmits.
*
*
*
*
*
(b) * * * (1) Covered entities and
business associates may use any
security measures that allow the
covered entity or business associate to
reasonably and appropriately
implement the standards and
implementation specifications as
specified in this subpart.
(2) In deciding which security
measures to use, a covered entity or
business associate must take into
account the following factors:
(i) The size, complexity, and
capabilities of the covered entity or
business associate.
(ii) The covered entity’s or the
business associate’s technical
infrastructure, hardware, and software
security capabilities.
*
*
*
*
*
(c) Standards. A covered entity or
business associate must comply with
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
the applicable standards as provided in
this section and in § 164.308, § 164.310,
§ 164.312, § 164.314 and § 164.316 with
respect to all electronic protected health
information.
(d) * * *
(2) When a standard adopted in
§ 164.308, § 164.310, § 164.312,
§ 164.314, or § 164.316 includes
required implementation specifications,
a covered entity or business associate
must implement the implementation
specifications.
(3) When a standard adopted in
§ 164.308, § 164.310, § 164.312,
§ 164.314, or § 164.316 includes
addressable implementation
specifications, a covered entity or
business associate must—
(i) Assess whether each
implementation specification is a
reasonable and appropriate safeguard in
its environment, when analyzed with
reference to the likely contribution to
protecting electronic protected health
information; and
(ii) As applicable to the covered entity
or business associate—
*
*
*
*
*
(e) Maintenance. A covered entity or
business associate must review and
modify the security measures
implemented under this subpart as
needed to continue provision of
reasonable and appropriate protection of
electronic protected health information,
and update documentation of such
security measures in accordance with
§ 164.316(b)(2)(iii).
33. Amend § 164.308 as follows:
a. Revise the introductory text of
paragraph (a), paragraph (a)(1)(ii)(A),
paragraph (a)(1)(ii)(C), paragraph (a)(2),
paragraph (a)(3)(ii)(C), paragraph
(a)(4)(ii)(C), paragraph (a)(6)(ii), and
paragraph (a)(8); and
b. Revise paragraph (b).
The revisions read as follows:
§ 164.308
Administrative safeguards.
(a) A covered entity or business
associate must, in accordance with
§ 164.306:
(1) * * *
(ii) * * *
(A) Risk analysis (Required). Conduct
an accurate and thorough assessment of
the potential risks and vulnerabilities to
the confidentiality, integrity, and
availability of electronic protected
health information held by the covered
entity or business associate.
*
*
*
*
*
(C) Sanction policy (Required). Apply
appropriate sanctions against workforce
members who fail to comply with the
security policies and procedures of the
covered entity or business associate.
*
*
*
*
*
PO 00000
Frm 00051
Fmt 4701
Sfmt 4702
40917
(2) Standard: Assigned security
responsibility. Identify the security
official who is responsible for the
development and implementation of the
policies and procedures required by this
subpart for the covered entity or
business associate.
(3) * * *
(ii) * * *
(C) Termination procedures
(Addressable). Implement procedures
for terminating access to electronic
protected health information when the
employment of, or other arrangement
with, a workforce member ends or as
required by determinations made as
specified in paragraph (a)(3)(ii)(B) of
this section.
(4) * * *
(ii) * * *
(C) Access establishment and
modification (Addressable). Implement
policies and procedures that, based
upon the covered entity’s or the
business associate’s access authorization
policies, establish, document, review,
and modify a user’s right of access to a
workstation, transaction, program, or
process.
*
*
*
*
*
(6) * * *
(ii) Implementation specification:
Response and reporting (Required).
Identify and respond to suspected or
known security incidents; mitigate, to
the extent practicable, harmful effects of
security incidents that are known to the
covered entity or business associate; and
document security incidents and their
outcomes.
*
*
*
*
*
(8) Standard: Evaluation. Perform a
periodic technical and nontechnical
evaluation, based initially upon the
standards implemented under this rule
and, subsequently, in response to
environmental or operational changes
affecting the security of electronic
protected health information, that
establishes the extent to which a
covered entity’s or business associate’s
security policies and procedures meet
the requirements of this subpart.
(b)(1) Business associate contracts
and other arrangements. A covered
entity may permit a business associate
to create, receive, maintain, or transmit
electronic protected health information
on the covered entity’s behalf only if the
covered entity obtains satisfactory
assurances, in accordance with
§ 164.314(a), that the business associate
will appropriately safeguard the
information. A covered entity is not
required to obtain such satisfactory
assurances from a business associate
that is a subcontractor.
(2) A business associate may permit a
business associate that is a
E:\FR\FM\14JYP2.SGM
14JYP2
40918
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
subcontractor to create, receive,
maintain, or transmit electronic
protected health information on its
behalf only if the business associate
obtains satisfactory assurances, in
accordance with § 164.314(a), that the
subcontractor will appropriately
safeguard the information.
(3) Implementation specifications:
Written contract or other arrangement
(Required). Document the satisfactory
assurances required by paragraph (b)(1)
or (b)(2) of this section through a written
contract or other arrangement with the
business associate that meets the
applicable requirements of § 164.314(a).
34. Revise the introductory text of
§ 164.310 to read as follows:
§ 164.310
Physical safeguards.
A covered entity or business associate
must, in accordance with § 164.306:
*
*
*
*
*
35. Revise the introductory text of
§ 164.312 to read as follows:
§ 164.312
Technical safeguards.
A covered entity or business associate
must, in accordance with § 164.306:
*
*
*
*
*
36. Amend § 164.314 by revising
paragraphs (a) and (b)(2)(iii) to read as
follows:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 164.314
Organizational requirements.
(a)(1) Standard: Business associate
contracts or other arrangements. The
contract or other arrangement required
by § 164.308(b)(4) must meet the
requirements of paragraph (a)(2)(i),
(a)(2)(ii), or (a)(2)(iii) of this section, as
applicable.
(2) Implementation specifications
(Required).
(i) Business associate contracts. The
contract must provide that the business
associate will—
(A) Comply with the applicable
requirements of this subpart;
(B) In accordance with
§ 164.308(b)(2), ensure that any
subcontractors that create, receive,
maintain, or transmit electronic
protected health information on behalf
of the business associate agree to
comply with the applicable
requirements of this subpart by entering
into a contract or other arrangement that
complies with this section; and
(C) Report to the covered entity any
security incident of which it becomes
aware, including breaches of unsecured
protected health information as required
by § 164.410.
(ii) Other arrangements. The covered
entity is in compliance with paragraph
(a)(1) of this section if it has another
arrangement in place that meets the
requirements of § 164.504(e)(3).
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
(iii) Business associate contracts with
subcontractors. The requirements of
paragraphs (a)(2)(i) and (a)(2)(ii) of this
section apply to the contract or other
arrangement between a business
associate and a subcontractor required
by § 164.308(b)(4) in the same manner
as such requirements apply to contracts
or other arrangements between a
covered entity and business associate.
(b) * * *
(2) * * *
(iii) Ensure that any agent to whom it
provides this information agrees to
implement reasonable and appropriate
security measures to protect the
information; and
*
*
*
*
*
37. Revise the introductory text of
§ 164.316 and the third sentence of
paragraph (a) to read as follows:
§ 164.316 Policies and procedures and
documentation requirements.
A covered entity or business associate
must, in accordance with § 164.306:
(a) * * * A covered entity or business
associate may change its policies and
procedures at any time, provided that
the changes are documented and are
implemented in accordance with this
subpart.
*
*
*
*
*
38. The authority citation for subpart
E of part 164 is revised to read as
follows:
Authority: 42 U.S.C. 1320d–2 and 1320d–
4; sec. 264 of Pub. L. 104–191, 110 Stat.
2033–2034 (42 U.S.C. 1320d–2 (note)); and
secs. 13400–13424, Pub. L. 111–5, 123 Stat.
258–279.
39. In § 164.500, redesignate
paragraph (c) as paragraph (d) and add
new paragraph (c) to read as follows:
§ 164.500
Applicability.
*
*
*
*
*
(c) Where provided, the standards,
requirements, and implementation
specifications adopted under this
subpart apply to a business associate
with respect to the protected health
information of a covered entity.
*
*
*
*
*
40. Amend § 164.501 as follows:
a. Revise paragraph (1) of the
definition of ‘‘health care operations’’;
and
b. Revise the definition of
‘‘marketing’’.
The revisions read as follows:
§ 164.501
Definitions.
*
*
*
*
*
Health care operations * * *
(1) Conducting quality assessment
and improvement activities, including
outcomes evaluation and development
of clinical guidelines, provided that the
PO 00000
Frm 00052
Fmt 4701
Sfmt 4702
obtaining of generalizable knowledge is
not the primary purpose of any studies
resulting from such activities; patient
safety activities (as defined in 42 CFR
3.20); population-based activities
relating to improving health or reducing
health care costs, protocol development,
case management and care coordination,
contacting of health care providers and
patients with information about
treatment alternatives; and related
functions that do not include treatment;
*
*
*
*
*
Marketing: (1) Except as provided in
paragraph (2) of this definition,
marketing means to make a
communication about a product or
service that encourages recipients of the
communication to purchase or use the
product or service.
(2) Marketing does not include a
communication made:
(i) For treatment of an individual by
a health care provider, including case
management or care coordination for the
individual, or to direct or recommend
alternative treatments, therapies, health
care providers, or settings of care to the
individual, provided, however, that if
the communication is in writing and the
health care provider receives financial
remuneration in exchange for making
the communication, the requirements of
§ 164.514(f)(2) are met.
(ii) To provide refill reminders or
otherwise communicate about a drug or
biologic that is currently being
prescribed for the individual, only if
any financial remuneration received by
the covered entity in exchange for
making the communication is
reasonably related to the covered
entity’s cost of making the
communication.
(iii) For the following health care
operations activities, except where the
covered entity receives financial
remuneration in exchange for making
the communication:
(A) To describe a health-related
product or service (or payment for such
product or service) that is provided by,
or included in a plan of benefits of, the
covered entity making the
communication, including
communications about: The entities
participating in a health care provider
network or health plan network;
replacement of, or enhancements to, a
health plan; and health-related products
or services available only to a health
plan enrollee that add value to, but are
not part of, a plan of benefits; or
(B) For case management or care
coordination, contacting of individuals
with information about treatment
alternatives, and related functions to the
extent these activities do not fall within
the definition of treatment.
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
(3) Financial remuneration means
direct or indirect payment from or on
behalf of a third party whose product or
service is being described. Direct or
indirect payment does not include any
payment for treatment of an individual.
*
*
*
*
*
41. In § 164.502, revise paragraphs (a),
(b)(1), (e), and (f) to read as follows:
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 164.502 Uses and disclosures of
protected health information: General rules.
(a) Standard. A covered entity or
business associate may not use or
disclose protected health information,
except as permitted or required by this
subpart or by subpart C of part 160 of
this subchapter.
(1) Covered entities: Permitted uses
and disclosures. A covered entity is
permitted to use or disclose protected
health information as follows:
(i) To the individual;
(ii) For treatment, payment, or health
care operations, as permitted by and in
compliance with § 164.506;
(iii) Incident to a use or disclosure
otherwise permitted or required by this
subpart, provided that the covered
entity has complied with the applicable
requirements of §§ 164.502(b),
164.514(d), and 164.530(c) with respect
to such otherwise permitted or required
use or disclosure;
(iv) Pursuant to and in compliance
with a valid authorization under
§ 164.508;
(v) Pursuant to an agreement under, or
as otherwise permitted by, § 164.510;
and
(vi) As permitted by and in
compliance with this section, § 164.512,
§ 164.514(e), (f), or (g).
(2) Covered entities: Required
disclosures. A covered entity is required
to disclose protected health information:
(i) To an individual, when requested
under, and required by § 164.524 or
§ 164.528; and
(ii) When required by the Secretary
under subpart C of part 160 of this
subchapter to investigate or determine
the covered entity’s compliance with
this subchapter.
(3) [Reserved]
(4) Business associates: Permitted
uses and disclosures. (i) A business
associate may use or disclose protected
health information only as permitted or
required by its business associate
contract or other arrangement pursuant
to § 164.504(e), or as required by law.
The business associate may not use or
disclose protected health information in
a manner that would violate the
requirements of this subpart, if done by
the covered entity, except for the
purposes specified under
§ 164.504(e)(2)(i)(A) or (B) if such uses
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
or disclosures are permitted by its
contract or other arrangement.
(5) Business associates: Required uses
and disclosures. A business associate is
required to disclose protected health
information:
(i) When required by the Secretary
under subpart C of part 160 of this
subchapter to investigate or determine
the business associate’s compliance
with this subchapter.
(ii) To the covered entity, individual,
or individual’s designee, as necessary to
satisfy a covered entity’s obligations
under § 164.524(c)(2)(ii) and (3)(ii) with
respect to an individual’s request for an
electronic copy of protected health
information.
(b) * * * (1) Minimum necessary
applies. When using or disclosing
protected health information or when
requesting protected health information
from another covered entity, a covered
entity or business associate must make
reasonable efforts to limit protected
health information to the minimum
necessary to accomplish the intended
purpose of the use, disclosure, or
request.
*
*
*
*
*
(e)(1) Standard: Disclosures to
business associates. (i) A covered entity
may disclose protected health
information to a business associate and
may allow a business associate to create
or receive protected health information
on its behalf, if the covered entity
obtains satisfactory assurance that the
business associate will appropriately
safeguard the information. A covered
entity is not required to obtain such
satisfactory assurances from a business
associate that is a subcontractor.
(ii) A business associate may disclose
protected health information to a
business associate that is a
subcontractor and may allow the
subcontractor to create or receive
protected health information on its
behalf, if the business associate obtains
satisfactory assurances, in accordance
with § 164.504(e)(1)(i), that the
subcontractor will appropriately
safeguard the information.
(2) Implementation specification:
Documentation. The satisfactory
assurances required by paragraph (e)(1)
of this section must be documented
through a written contract or other
written agreement or arrangement with
the business associate that meets the
applicable requirements of § 164.504(e).
(f) Standard: Deceased individuals. A
covered entity must comply with the
requirements of this subpart with
respect to the protected health
information of a deceased individual for
PO 00000
Frm 00053
Fmt 4701
Sfmt 4702
40919
a period of 50 years following the death
of the individual.
*
*
*
*
*
42. In § 164.504, revise paragraphs (e)
and (f)(2)(ii)(B) to read as follows:
§ 164.504 Uses and disclosures:
Organizational requirements.
*
*
*
*
*
(e)(1) Standard: Business associate
contracts. (i) The contract or other
arrangement required by § 164.502(e)(2)
must meet the requirements of
paragraph (e)(2), (e)(3), or (e)(5) of this
section, as applicable.
(ii) A covered entity is not in
compliance with the standards in
§ 164.502(e) and this paragraph, if the
covered entity knew of a pattern of
activity or practice of the business
associate that constituted a material
breach or violation of the business
associate’s obligation under the contract
or other arrangement, unless the
covered entity took reasonable steps to
cure the breach or end the violation, as
applicable, and, if such steps were
unsuccessful, terminated the contract or
arrangement, if feasible.
(iii) A business associate is not in
compliance with the standards in
§ 164.502(e) and this paragraph, if the
business associate knew of a pattern of
activity or practice of a subcontractor
that constituted a material breach or
violation of the subcontractor’s
obligation under the contract or other
arrangement, unless the business
associate took reasonable steps to cure
the breach or end the violation, as
applicable, and, if such steps were
unsuccessful, terminated the contract or
arrangement, if feasible.
(2) Implementation specifications:
Business associate contracts. A contract
between the covered entity and a
business associate must:
(i) Establish the permitted and
required uses and disclosures of
protected health information by the
business associate. The contract may not
authorize the business associate to use
or further disclose the information in a
manner that would violate the
requirements of this subpart, if done by
the covered entity, except that:
(A) The contract may permit the
business associate to use and disclose
protected health information for the
proper management and administration
of the business associate, as provided in
paragraph (e)(4) of this section; and
(B) The contract may permit the
business associate to provide data
aggregation services relating to the
health care operations of the covered
entity.
(ii) Provide that the business associate
will:
E:\FR\FM\14JYP2.SGM
14JYP2
srobinson on DSKHWCL6B1PROD with PROPOSALS2
40920
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
(A) Not use or further disclose the
information other than as permitted or
required by the contract or as required
by law;
(B) Use appropriate safeguards and
comply, where applicable, with subpart
C of this part with respect to electronic
protected health information, to prevent
use or disclosure of the information
other than as provided for by its
contract;
(C) Report to the covered entity any
use or disclosure of the information not
provided for by its contract of which it
becomes aware, including breaches of
unsecured protected health information
as required by § 164.410;
(D) In accordance with
§ 164.502(e)(1)(ii), ensure that any
subcontractors that create or receive
protected health information on behalf
of the business associate agree to the
same restrictions and conditions that
apply to the business associate with
respect to such information;
(E) Make available protected health
information in accordance with
§ 164.524;
(F) Make available protected health
information for amendment and
incorporate any amendments to
protected health information in
accordance with § 164.526;
(G) Make available the information
required to provide an accounting of
disclosures in accordance with
§ 164.528;
(H) To the extent the business
associate is to carry out a covered
entity’s obligation under this subpart,
comply with the requirements of this
subpart that apply to the covered entity
in the performance of such obligation.
(I) Make its internal practices, books,
and records relating to the use and
disclosure of protected health
information received from, or created or
received by the business associate on
behalf of, the covered entity available to
the Secretary for purposes of
determining the covered entity’s
compliance with this subpart; and
(J) At termination of the contract, if
feasible, return or destroy all protected
health information received from, or
created or received by the business
associate on behalf of, the covered entity
that the business associate still
maintains in any form and retain no
copies of such information or, if such
return or destruction is not feasible,
extend the protections of the contract to
the information and limit further uses
and disclosures to those purposes that
make the return or destruction of the
information infeasible.
(iii) Authorize termination of the
contract by the covered entity, if the
covered entity determines that the
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
business associate has violated a
material term of the contract.
(3) Implementation specifications:
Other arrangements. (i) If a covered
entity and its business associate are both
governmental entities:
(A) The covered entity may comply
with this paragraph and § 164.314(a)(1),
if applicable, by entering into a
memorandum of understanding with the
business associate that contains terms
that accomplish the objectives of
paragraph (e)(2) of this section and
§ 164.314(a)(2), if applicable.
(B) The covered entity may comply
with this paragraph and § 164.314(a)(1),
if applicable, if other law (including
regulations adopted by the covered
entity or its business associate) contains
requirements applicable to the business
associate that accomplish the objectives
of paragraph (e)(2) of this section and
§ 164.314(a)(2), if applicable.
(ii) If a business associate is required
by law to perform a function or activity
on behalf of a covered entity or to
provide a service described in the
definition of business associate in
§ 160.103 of this subchapter to a covered
entity, such covered entity may disclose
protected health information to the
business associate to the extent
necessary to comply with the legal
mandate without meeting the
requirements of this paragraph and
§ 164.314(a)(1), if applicable, provided
that the covered entity attempts in good
faith to obtain satisfactory assurances as
required by paragraph (e)(2) of this
section and § 164.314(a)(1), if
applicable, and, if such attempt fails,
documents the attempt and the reasons
that such assurances cannot be
obtained.
(iii) The covered entity may omit from
its other arrangements the termination
authorization required by paragraph
(e)(2)(iii) of this section, if such
authorization is inconsistent with the
statutory obligations of the covered
entity or its business associate.
(4) Implementation specifications:
Other requirements for contracts and
other arrangements. (i) The contract or
other arrangement between the covered
entity and the business associate may
permit the business associate to use the
protected health information received
by the business associate in its capacity
as a business associate to the covered
entity, if necessary:
(A) For the proper management and
administration of the business associate;
or
(B) To carry out the legal
responsibilities of the business
associate.
(ii) The contract or other arrangement
between the covered entity and the
PO 00000
Frm 00054
Fmt 4701
Sfmt 4702
business associate may permit the
business associate to disclose the
protected health information received
by the business associate in its capacity
as a business associate for the purposes
described in paragraph (e)(4)(i) of this
section, if:
(A) The disclosure is required by law;
or
(B)(1) The business associate obtains
reasonable assurances from the person
to whom the information is disclosed
that it will be held confidentially and
used or further disclosed only as
required by law or for the purposes for
which it was disclosed to the person;
and
(2) The person notifies the business
associate of any instances of which it is
aware in which the confidentiality of
the information has been breached.
(5) Implementation specifications:
Business associate contracts with
subcontractors. The requirements of
§ 164.504(e)(2) through (e)(4) apply to
the contract or other arrangement
required by § 164.502(e)(1)(ii) between a
business associate and a business
associate that is a subcontractor in the
same manner as such requirements
apply to contracts or other arrangements
between a covered entity and business
associate.
(f) * * *
(2) * * *
(ii) * * *
(B) Ensure that any agents to whom it
provides protected health information
received from the group health plan
agree to the same restrictions and
conditions that apply to the plan
sponsor with respect to such
information;
*
*
*
*
*
43. Revise § 164.506(c)(5) to read as
follows:
§ 164.506 Uses and disclosures to carry
out treatment, payment, or health care
operations.
*
*
*
*
*
(c) * * *
(5) A covered entity that participates
in an organized health care arrangement
may disclose protected health
information about an individual to other
participants in the organized health care
arrangement for any health care
operations activities of the organized
health care arrangement.
44. Amend § 164.508 as follows:
a. Revise the headings of paragraphs
(a), (a)(1), and (a)(2);
b. Revise paragraph (a)(3)(ii);
c. Add new paragraph (a)(4); and
d. Revise paragraphs (b)(1)(i), and
(b)(3).
The revisions and additions read as
follows:
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
srobinson on DSKHWCL6B1PROD with PROPOSALS2
§ 164.508 Uses and disclosures for which
an authorization is required.
(a) Standard: Authorizations for uses
and disclosures—(1) Authorization
required: General rule. * * *
(2) Authorization required:
Psychotherapy notes. * * *
(3) * * *
(ii) If the marketing involves direct or
indirect financial remuneration, as
defined in paragraph (3) of the
definition of marketing at § 164.501, to
the covered entity from a third party,
the authorization must state that such
remuneration is involved.
(4) Authorization required: Sale of
protected health information. (i)
Notwithstanding any provision of this
subpart, a covered entity must obtain an
authorization for any disclosure of
protected health information for which
the disclosure is in exchange for direct
or indirect remuneration from or on
behalf of the recipient of the protected
health information. Such authorization
must state that the disclosure will result
in remuneration to the covered entity.
(ii) Paragraph (a)(4)(i) of this section
does not apply to disclosures of
protected health information:
(A) For public health purposes
pursuant to § 164.512(b) or § 164.514(e);
(B) For research purposes pursuant to
§ 164.512(i) or § 164.514(e), where the
only remuneration received by the
covered entity is a reasonable cost-based
fee to cover the cost to prepare and
transmit the protected health
information for such purposes;
(C) For treatment and payment
purposes pursuant to § 164.506(a);
(D) For the sale, transfer, merger, or
consolidation of all or part of the
covered entity and for related due
diligence as described in paragraph
(6)(iv) of the definition of health care
operations and pursuant to § 164.506(a);
(E) To or by a business associate for
activities that the business associate
undertakes on behalf of a covered entity
pursuant to §§ 164.502(e) and
164.504(e), and the only remuneration
provided is by the covered entity to the
business associate for the performance
of such activities;
(F) To an individual, when requested
under § 164.524 or § 164.528;
(G) Required by law as permitted
under § 164.512(a); and
(H) Permitted by and in accordance
with the applicable requirements of this
subpart, where the only remuneration
received by the covered entity is a
reasonable, cost-based fee to cover the
cost to prepare and transmit the
protected health information for such
purpose or a fee otherwise expressly
permitted by other law.
(b) * * *
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
(1) * * *
(i) A valid authorization is a
document that meets the requirements
in paragraphs (a)(3)(ii), (a)(4)(i), (c)(1),
and (c)(2) of this section, as applicable.
*
*
*
*
*
(3) Compound authorizations. An
authorization for use or disclosure of
protected health information may not be
combined with any other document to
create a compound authorization,
except as follows:
(i) An authorization for the use or
disclosure of protected health
information for a research study may be
combined with any other type of written
permission for the same or another
research study. This exception includes
combining an authorization for the use
or disclosure of protected health
information for a research study with
another authorization for the same
research study, with an authorization
for the creation or maintenance of a
research database or repository, or with
a consent to participate in research.
Where a covered health care provider
has conditioned the provision of
research-related treatment on the
provision of one of the authorizations,
as permitted under paragraph (b)(4)(i) of
this section, any compound
authorization created under this
paragraph must clearly differentiate
between the conditioned and
unconditioned components and provide
the individual with an opportunity to
opt in to the research activities
described in the unconditioned
authorization.
(ii) An authorization for a use or
disclosure of psychotherapy notes may
only be combined with another
authorization for a use or disclosure of
psychotherapy notes.
(iii) An authorization under this
section, other than an authorization for
a use or disclosure of psychotherapy
notes, may be combined with any other
such authorization under this section,
except when a covered entity has
conditioned the provision of treatment,
payment, enrollment in the health plan,
or eligibility for benefits under
paragraph (b)(4) of this section on the
provision of one of the authorizations.
The prohibition in this paragraph on
combining authorizations where one
authorization conditions the provision
of treatment, payment, enrollment in a
health plan, or eligibility for benefits
under paragraph (b)(4) of this section
does not apply to a compound
authorization created in accordance
with paragraph (b)(3)(i) of this section.
*
*
*
*
*
45. Amend § 164.510 as follows:
PO 00000
Frm 00055
Fmt 4701
Sfmt 4702
40921
a. Revise paragraph (a)(1)(ii)
introductory text;
b. Revise paragraph (b)(1)(i), the
second sentence of paragraph (b)(1)(ii),
paragraph (b)(2)(iii), the first sentence of
paragraph (b)(3), and paragraph (b)(4);
and
c. Add new paragraph (b)(5).
The revisions and additions read as
follows:
§ 164.510 Uses and disclosures requiring
an opportunity for the individual to agree or
to object.
*
*
*
*
*
(a) * * *
(1) * * *
(ii) Use or disclose for directory
purposes such information:
*
*
*
*
*
(b) * * *
(1) * * *
(i) A covered entity may, in
accordance with paragraphs (b)(2),
(b)(3), or (b)(5) of this section, disclose
to a family member, other relative, or a
close personal friend of the individual,
or any other person identified by the
individual, the protected health
information directly relevant to such
person’s involvement with the
individual’s health care or payment
related to the individual’s health care.
(ii) * * * Any such use or disclosure
of protected health information for such
notification purposes must be in
accordance with paragraphs (b)(2),
(b)(3), (b)(4), or (b)(5) of this section, as
applicable.
*
*
*
*
*
(2) * * *
(iii) Reasonably infers from the
circumstances, based on the exercise of
professional judgment, that the
individual does not object to the
disclosure.
(3) * * * If the individual is not
present, or the opportunity to agree or
object to the use or disclosure cannot
practicably be provided because of the
individual’s incapacity or an emergency
circumstance, the covered entity may, in
the exercise of professional judgment,
determine whether the disclosure is in
the best interests of the individual and,
if so, disclose only the protected health
information that is directly relevant to
the person’s involvement with the
individual’s care or payment related to
the individual’s health care or needed
for notification purposes. * * *
(4) Uses and disclosures for disaster
relief purposes. A covered entity may
use or disclose protected health
information to a public or private entity
authorized by law or by its charter to
assist in disaster relief efforts, for the
purpose of coordinating with such
entities the uses or disclosures
E:\FR\FM\14JYP2.SGM
14JYP2
40922
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
permitted by paragraph (b)(1)(ii) of this
section. The requirements in paragraphs
(b)(2), (b)(3), or (b)(5) of this section
apply to such uses and disclosures to
the extent that the covered entity, in the
exercise of professional judgment,
determines that the requirements do not
interfere with the ability to respond to
the emergency circumstances.
(5) Uses and disclosures when the
individual is deceased. If the individual
is deceased, a covered entity may
disclose protected health information of
the individual to a family member, or
other persons identified in paragraph
(b)(1) of this section who were involved
in the individual’s care or payment for
health care prior to the individual’s
death, unless doing so is inconsistent
with any prior expressed preference of
the individual that is known to the
covered entity.
46. Amend § 164.512 as follows:
a. Revise the introductory text of
paragraph (b)(1) and the introductory
text of paragraph (b)(1)(v)(A);
b. Add new paragraph (b)(1)(vi);
c. Revise the introductory text of
paragraph (e)(1)(iii) and paragraph
(e)(1)(vi);
d. Revise paragraph (i)(2)(iii); and
e. Revise paragraphs (k)(1)(ii), (k)(3),
and (k)(5)(i)(E).
The revisions and additions read as
follows:
§ 164.512 Uses and disclosures for which
an authorization or opportunity to agree or
object is not required.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
*
*
*
*
*
(b) Standard: Uses and disclosures for
public health activities.
(1) Permitted uses and disclosures. A
covered entity may use or disclose
protected health information for the
public health activities and purposes
described in this paragraph to:
*
*
*
*
*
(v) * * *
(A) The covered entity is a covered
health care provider who provides
health care to the individual at the
request of the employer:
*
*
*
*
*
(vi) A school, about an individual
who is a student or prospective student
of the school, if:
(A) The protected health information
that is disclosed is limited to proof of
immunization;
(B) The school is required by State or
other law to have such proof of
immunization prior to admitting the
individual; and
(C) The covered entity obtains the
agreement to the disclosure from either:
(1) A parent, guardian, or other person
acting in loco parentis of the individual,
if the individual is an unemancipated
minor; or
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
(2) The individual, if the individual is
an adult or emancipated minor.
*
*
*
*
*
(e) * * *
(1) * * *
(iii) For the purposes of paragraph
(e)(1)(ii)(A) of this section, a covered
entity receives satisfactory assurances
from a party seeking protected health
information if the covered entity
receives from such party a written
statement and accompanying
documentation demonstrating that:
* * *
*
*
*
*
*
(vi) Notwithstanding paragraph
(e)(1)(ii) of this section, a covered entity
may disclose protected health
information in response to lawful
process described in paragraph (e)(1)(ii)
of this section without receiving
satisfactory assurance under paragraph
(e)(1)(ii)(A) or (B) of this section, if the
covered entity makes reasonable efforts
to provide notice to the individual
sufficient to meet the requirements of
paragraph (e)(1)(iii) of this section or to
seek a qualified protective order
sufficient to meet the requirements of
paragraph (e)(1)(v) of this section.
*
*
*
*
*
(i) * * *
(2) * * *
(iii) Protected health information
needed. A brief description of the
protected health information for which
use or access has been determined to be
necessary by the IRB or privacy board,
pursuant to paragraph (i)(2)(ii)(C) of this
section;
*
*
*
*
*
(k) * * *
(1) * * *
(ii) Separation or discharge from
military service. A covered entity that is
a component of the Departments of
Defense or Homeland Security may
disclose to the Department of Veterans
Affairs (DVA) the protected health
information of an individual who is a
member of the Armed Forces upon the
separation or discharge of the individual
from military service for the purpose of
a determination by DVA of the
individual’s eligibility for or entitlement
to benefits under laws administered by
the Secretary of Veterans Affairs.
*
*
*
*
*
(3) Protective services for the
President and others. A covered entity
may disclose protected health
information to authorized Federal
officials for the provision of protective
services to the President or other
persons authorized by 18 U.S.C. 3056 or
to foreign heads of state or other persons
authorized by 22 U.S.C. 2709(a)(3), or
PO 00000
Frm 00056
Fmt 4701
Sfmt 4702
for the conduct of investigations
authorized by 18 U.S.C. 871 and 879.
*
*
*
*
*
(5) * * *
(i) * * *
(E) Law enforcement on the premises
of the correctional institution; or
*
*
*
*
*
47. In § 164.514, revise paragraphs
(e)(4)(ii)(C)(4) and (f) to read as follows:
§ 164.514 Other requirements relating to
uses and disclosures of protected health
information.
*
*
*
*
*
(e) * * *
(4) * * *
(ii) * * *
(C) * * *
(4) Ensure that any agents to whom it
provides the limited data set agrees to
the same restrictions and conditions
that apply to the limited data set
recipient with respect to such
information; and
*
*
*
*
*
(f) Fundraising and remunerated
treatment communications.
(1)(i) Standard: Uses and disclosures
for fundraising. Subject to the
conditions of paragraph (f)(1)(ii) of this
section, a covered entity may use, or
disclose to a business associate or to an
institutionally related foundation, the
following protected health information
for the purpose of raising funds for its
own benefit, without an authorization
meeting the requirements of § 164.508:
(A) Demographic information relating
to an individual; and
(B) Dates of health care provided to an
individual.
(ii) Implementation specifications:
Fundraising requirements. (A) A
covered entity may not use or disclose
protected health information for
fundraising purposes as otherwise
permitted by paragraph (f)(1)(i) of this
section unless a statement required by
§ 164.520(b)(1)(iii)(B) is included in the
covered entity’s notice of privacy
practices.
(B) With each fundraising
communication sent to an individual
under this paragraph, a covered entity
must provide the individual with a clear
and conspicuous opportunity to elect
not to receive any further fundraising
communications. The method for an
individual to elect not to receive further
fundraising communications may not
cause the individual to incur an undue
burden or more than a nominal cost.
(C) A covered entity may not
condition treatment or payment on the
individual’s choice with respect to the
receipt of fundraising communications.
(D) A covered entity may not send
fundraising communications to an
E:\FR\FM\14JYP2.SGM
14JYP2
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
individual under this paragraph where
the individual has elected not to receive
such communications under paragraph
(f)(1)(ii)(B) of this section.
(2) Standard: Uses and disclosures for
remunerated treatment
communications. Where a covered
health care provider receives financial
remuneration, as defined in paragraph
(3) of the definition of marketing at
§ 164.501, in exchange for making a
treatment communication to an
individual about a health-related
product or service, such communication
is not marketing and does not require an
authorization meeting the requirements
of § 164.508, only if the following
requirements are met:
(i) The covered health care provider
has included the information required
by § 164.520(b)(1)(iii)(A) in its notice of
privacy practices; and
(ii) The communication discloses the
fact that the covered health care
provider is receiving financial
remuneration in exchange for making
the communication and provides the
individual with a clear and conspicuous
opportunity to elect not to receive any
further such communications. The
method for an individual to elect not to
receive further such communications
may not cause the individual to incur an
undue burden or more than a nominal
cost.
*
*
*
*
*
48. In § 164.520, revise paragraphs
(b)(1)(ii)(E), (b)(1)(iii), and (b)(1)(iv)(A)
to read as follows:
§ 164.520 Notice of privacy practices for
protected health information.
srobinson on DSKHWCL6B1PROD with PROPOSALS2
*
*
*
*
*
(b) * * *
(1) * * *
(ii) * * *
(E) A description of the types of uses
and disclosures that require an
authorization under § 164.508(a)(2)–
(a)(4), a statement that other uses and
disclosures not described in the notice
will be made only with the individual’s
written authorization, and a statement
that the individual may revoke an
authorization as provided by
§ 164.508(b)(5).
(iii) Separate statements for certain
uses or disclosures. If the covered entity
intends to engage in any of the
following activities, the description
required by paragraph (b)(1)(ii)(A) of
this section must include a separate
statement informing the individual of
such activities, as applicable:
(A) In accordance with § 164.514(f)(2),
the covered health care provider may
send treatment communications to the
individual concerning treatment
alternatives or other health-related
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
products or services where the provider
receives financial remuneration, as
defined in paragraph (3) of the
definition of marketing at § 164.501, in
exchange for making the
communications, and the individual has
a right to opt out of receiving such
communications;
(B) In accordance with § 164.514(f)(1),
the covered entity may contact the
individual to raise funds for the covered
entity and the individual has a right to
opt out of receiving such
communications; or
(C) In accordance with § 164.504(f),
the group health plan, or a health
insurance issuer or HMO with respect to
a group health plan, may disclose
protected health information to the
sponsor of the plan.
(iv) * * *
(A) The right to request restrictions on
certain uses and disclosures of protected
health information as provided by
§ 164.522(a), including a statement that
the covered entity is not required to
agree to a requested restriction, except
in case of a disclosure restricted under
§ 164.522(a)(1)(vi);
*
*
*
*
*
49. Amend § 164.522 as follows:
a. Revise paragraph (a)(1)(ii);
b. Add new paragraph (a)(1)(vi); and
c. Revise the introductory text of
paragraph (a)(2), and paragraphs
(a)(2)(iii), and paragraph (a)(3).
The revisions and additions read as
follows:
§ 164.522 Rights to request privacy
protection for protected health information.
(a)(1) * * *
(ii) Except as provided in paragraph
(a)(1)(vi) of this section, a covered entity
is not required to agree to a restriction.
*
*
*
*
*
(vi) A covered entity must agree to the
request of an individual to restrict
disclosure of protected health
information about the individual to a
health plan if:
(A) The disclosure is for the purpose
of carrying out payment or health care
operations and is not otherwise required
by law; and
(B) The protected health information
pertains solely to a health care item or
service for which the individual, or
person other than the health plan on
behalf of the individual, has paid the
covered entity in full.
(2) Implementation specifications:
Terminating a restriction. A covered
entity may terminate a restriction, if:
*
*
*
*
*
(iii) The covered entity informs the
individual that it is terminating its
agreement to a restriction, except that
such termination is:
PO 00000
Frm 00057
Fmt 4701
Sfmt 4702
40923
(A) Not effective for protected health
information restricted under paragraph
(a)(1)(vi) of this section; and
(B) Only effective with respect to
protected health information created or
received after it has so informed the
individual.
(3) Implementation specification:
Documentation. A covered entity must
document a restriction in accordance
with § 160.530(j) of this subchapter.
*
*
*
*
*
50. Amend § 164.524 as follows:
a. Revise paragraph (c)(2)(i);
b. Redesignate paragraph (c)(2)(ii) as
paragraph (c)(2)(iii);
c. Add new paragraph (c)(2)(ii);
d. Revise paragraphs (c)(3) and
(c)(4)(i);
e. Redesignate paragraphs (c)(4)(ii)
and (c)(4)(iii) as paragraphs (c)(4)(iii)
and (c)(4)(iv), respectively; and
f. Add new paragraph (c)(4)(ii).
The revisions and additions read as
follows:
§ 164.524 Access of individuals to
protected health information.
*
*
*
*
*
(c) * * *
(2) Form of access requested. (i) The
covered entity must provide the
individual with access to the protected
health information in the form and
format requested by the individual, if it
is readily producible in such form and
format; or, if not, in a readable hard
copy form or such other form and
format as agreed to by the covered entity
and the individual.
(ii) Notwithstanding paragraph
(c)(2)(i) of this section, if the protected
health information that is the subject of
a request for access is maintained in one
or more designated record sets
electronically and if the individual
requests an electronic copy of such
information, the covered entity must
provide the individual with access to
the protected health information in the
electronic form and format requested by
the individual, if it is readily producible
in such form and format; or, if not, in
a readable electronic form and format as
agreed to by the covered entity and the
individual.
*
*
*
*
*
(3) Time and manner of access. (i)
The covered entity must provide the
access as requested by the individual in
a timely manner as required by
paragraph (b)(2) of this section,
including arranging with the individual
for a convenient time and place to
inspect or obtain a copy of the protected
health information, or mailing the copy
of the protected health information at
the individual’s request. The covered
entity may discuss the scope, format,
E:\FR\FM\14JYP2.SGM
14JYP2
40924
Federal Register / Vol. 75, No. 134 / Wednesday, July 14, 2010 / Proposed Rules
and other aspects of the request for
access with the individual as necessary
to facilitate the timely provision of
access.
(ii) If an individual’s request for
access directs the covered entity to
transmit the copy of protected health
information directly to another person
designated by the individual, the
covered entity must provide the copy to
the person designated by the individual.
The individual’s request must be in
writing, signed by the individual, and
clearly identify the designated person
and where to send the copy of protected
health information.
(4) * * *
(i) Labor for copying the protected
health information requested by the
individual, whether in paper or
electronic form;
(ii) Supplies for creating the paper
copy or electronic media if the
individual requests that the electronic
copy be provided on portable media;
*
*
*
*
*
51. In § 164.532, revise paragraphs (d),
(e)(1) and (e)(2) to read as follows:
§ 164.532
Transition provisions.
*
*
*
*
(d) Standard: Effect of prior contracts
or other arrangements with business
associates. Notwithstanding any other
provisions of this part, a covered entity,
or business associate with respect to a
srobinson on DSKHWCL6B1PROD with PROPOSALS2
*
VerDate Mar<15>2010
15:51 Jul 13, 2010
Jkt 220001
subcontractor, may disclose protected
health information to a business
associate and may allow a business
associate to create, receive, or use
protected health information on its
behalf pursuant to a written contract or
other written arrangement with such
business associate that does not comply
with §§ 164.308(b), 164.314(a),
164.502(e), and 164.504(e), only in
accordance with paragraph (e) of this
section.
(e) Implementation specification:
Deemed compliance. (1) Qualification.
Notwithstanding other sections of this
part, a covered entity, or business
associate with respect to a
subcontractor, is deemed to be in
compliance with the documentation and
contract requirements of §§ 164.308(b),
164.314(a), 164.502(e), and 164.504(e),
with respect to a particular business
associate relationship, for the time
period set forth in paragraph (e)(2) of
this section, if:
(i) Prior to [DATE OF PUBLICATION
OF THE FINAL RULE IN THE FEDERAL
REGISTER], such covered entity, or
business associate with respect to a
subcontractor, has entered into and is
operating pursuant to a written contract
or other written arrangement with the
business associate that complies with
the applicable provisions of
§§ 164.314(a) or 164.504(e) that were in
effect on such date; and
PO 00000
Frm 00058
Fmt 4701
Sfmt 9990
(ii) The contract or other arrangement
is not renewed or modified from [DATE
THAT IS 60 DAYS AFTER DATE OF
PUBLICATION OF THE FINAL RULE
IN THE FEDERAL REGISTER], until
[DATE THAT IS 240 DAYS AFTER
DATE OF PUBLICATION OF THE
FINAL RULE IN THE FEDERAL
REGISTER].
(2) Limited deemed compliance
period. A prior contract or other
arrangement that meets the qualification
requirements in paragraph (e) of this
section shall be deemed compliant until
the earlier of:
(i) The date such contract or other
arrangement is renewed or modified on
or after [DATE THAT IS 240 DAYS
AFTER DATE OF PUBLICATION OF
THE FINAL RULE IN THE FEDERAL
REGISTER]; or
(ii) [DATE THAT IS ONE YEAR AND
240 DAYS AFTER DATE OF
PUBLICATION OF THE FINAL RULE
IN THE FEDERAL REGISTER].
*
*
*
*
*
Dated: April 9, 2010.
Kathleen Sebelius,
Secretary.
Editorial Note: This document was
received in the Office of the Federal Register
on July 2, 2010.
[FR Doc. 2010–16718 Filed 7–8–10; 8:45 am]
BILLING CODE 4153–01–P
E:\FR\FM\14JYP2.SGM
14JYP2
Agencies
[Federal Register Volume 75, Number 134 (Wednesday, July 14, 2010)]
[Proposed Rules]
[Pages 40868-40924]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-16718]
[[Page 40867]]
-----------------------------------------------------------------------
Part II
Department of Health and Human Services
-----------------------------------------------------------------------
45 CFR Parts 160 and 164
Modifications to the HIPAA Privacy, Security, and Enforcement Rules
Under the Health Information Technology for Economic and Clinical
Health Act; Proposed Rule
Federal Register / Vol. 75 , No. 134 / Wednesday, July 14, 2010 /
Proposed Rules
[[Page 40868]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
45 CFR Parts 160 and 164
RIN: 0991-AB57
Modifications to the HIPAA Privacy, Security, and Enforcement
Rules Under the Health Information Technology for Economic and Clinical
Health Act
AGENCY: Office for Civil Rights, Department of Health and Human
Services.
ACTION: Notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS or ``the
Department'') is issuing this notice of proposed rulemaking to modify
the Standards for Privacy of Individually Identifiable Health
Information (Privacy Rule), the Security Standards for the Protection
of Electronic Protected Health Information (Security Rule), and the
rules pertaining to Compliance and Investigations, Imposition of Civil
Money Penalties, and Procedures for Hearings (Enforcement Rule) issued
under the Health Insurance Portability and Accountability Act of 1996
(HIPAA). The purpose of these modifications is to implement recent
statutory amendments under the Health Information Technology for
Economic and Clinical Health Act (``the HITECH Act'' or ``the Act''),
to strengthen the privacy and security protection of health
information, and to improve the workability and effectiveness of these
HIPAA Rules.
DATES: Submit comments on or before September 13, 2010.
ADDRESSES: You may submit comments, identified by RIN 0991-AB57, by any
of the following methods (please do not submit duplicate comments):
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Attachments should be
in Microsoft Word, WordPerfect, or Excel; however, we prefer Microsoft
Word.
Regular, Express, or Overnight Mail: U.S. Department of
Health and Human Services, Office for Civil Rights, Attention: HITECH
Privacy and Security Rule Modifications, Hubert H. Humphrey Building,
Room 509F, 200 Independence Avenue, SW., Washington, DC 20201. Please
submit one original and two copies.
Hand Delivery or Courier: Office for Civil Rights,
Attention: HITECH Privacy and Security Rule Modifications, Hubert H.
Humphrey Building, Room 509F, 200 Independence Avenue, SW., Washington,
DC 20201. Please submit one original and two copies. (Because access to
the interior of the Hubert H. Humphrey Building is not readily
available to persons without Federal government identification,
commenters are encouraged to leave their comments in the mail drop
slots located in the main lobby of the building.)
Inspection of Public Comments: All comments received before the
close of the comment period will be available for public inspection,
including any personally identifiable or confidential business
information that is included in a comment. We will post all comments
received before the close of the comment period at https://www.regulations.gov. Because comments will be made public, they should
not include any sensitive personal information, such as a person's
social security number; date of birth; driver's license number, State
identification number or foreign country equivalent; passport number;
financial account number; or credit or debit card number. Comments also
should not include any sensitive health information, such as medical
records or other individually identifiable health information, or any
non-public corporate or trade association information, such as trade
secrets or other proprietary information.
FOR FURTHER INFORMATION CONTACT: Andra Wicks, 202-205-2292.
SUPPLEMENTARY INFORMATION:
The discussion below includes a description of the statutory and
regulatory background of the proposed rules, a section-by-section
description of the proposed modifications, and the impact statement and
other required regulatory analyses. We solicit public comment on the
proposed rules. Persons interested in commenting on the provisions of
the proposed rules can assist us by preceding discussion of any
particular provision or topic with a citation to the section of the
proposed rule being discussed.
I. Statutory and Regulatory Background
The regulatory modifications proposed below concern several sets of
rules that implement the Administrative Simplification provisions of
title II, subtitle F, of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA) (Pub. L. 104-191), which added a new
part C to title XI of the Social Security Act (sections 1171-1179 of
the Social Security Act, 42 U.S.C. 1320d-1320d-8). The Health
Information Technology for Economic and Clinical Health (HITECH) Act,
which was enacted as title XIII of division A and title IV of division
B of the American Recovery and Reinvestment Act of 2009 (ARRA), Public
Law 111-5, modifies certain provisions of the Social Security Act
pertaining to the Administrative Simplification Rules (HIPAA Rules) and
requires certain modifications to the HIPAA Rules themselves.
A. HIPAA Administrative Simplification--Statutory Background
The Administrative Simplification provisions of HIPAA provided for
the establishment of national standards for the electronic transmission
of certain health information, such as standards for certain health
care transactions conducted electronically and code sets and unique
health care identifiers for health care providers and employers. The
Administrative Simplification provisions of HIPAA also required the
establishment of national standards to protect the privacy and security
of personal health information and established civil money and criminal
penalties for violations of the Administrative Simplification
provisions. The Administrative Simplification provisions of HIPAA apply
to three types of entities, which are known as ``covered entities'':
health care providers who conduct covered health care transactions
electronically, health plans, and health care clearinghouses.
B. HIPAA Administrative Simplification--Regulatory Background
The rules proposed below concern the privacy and security standards
issued pursuant to HIPAA, as well as the enforcement rules that
implement HIPAA's civil money penalty authority. The Standards for
Privacy of Individually Identifiable Health Information, known as the
``Privacy Rule,'' were issued on December 28, 2000, and amended on
August 14, 2002. See 65 FR 82462, as amended at 67 FR 53182. The
Security Standards for the Protection of Electronic Protected Health
Information, known as the ``Security Rule,'' were issued on February
20, 2003. See 68 FR 8334. The Compliance and Investigations, Imposition
of Civil Money Penalties, and Procedures for Hearings regulations,
collectively known as the ``Enforcement Rule,'' were issued as an
interim final rule on April 17, 2003 (68 FR 18895), and revised and
issued as a final rule, following rulemaking, on February 16, 2006 (71
FR 8390).
The Privacy Rule protects individuals' medical records and other
individually
[[Page 40869]]
identifiable health information created or received by or on behalf of
covered entities, known as ``protected health information.'' The
Privacy Rule protects individuals' health information by regulating the
circumstances under which covered entities may use and disclose
protected health information and by requiring covered entities to have
safeguards in place to protect the privacy of the information. As part
of these protections, covered entities are required to have contracts
or other arrangements in place with business associates that perform
functions for or provide services to the covered entity and that
require access to protected health information to ensure that these
business associates likewise protect the privacy of the health
information. The Privacy Rule also gives individuals rights with
respect to their protected health information, including rights to
examine and obtain a copy of their health records and to request
corrections.
The Security Rule, which applies only to protected health
information in electronic form, requires covered entities to implement
certain administrative, physical, and technical safeguards to protect
this electronic information. As with the Privacy Rule, the Security
Rule requires covered entities to have contracts or other arrangements
in place with their business associates that provide satisfactory
assurances that the business associates will appropriately safeguard
the electronic protected health information they receive, create,
maintain, or transmit on behalf of the covered entities.
The Enforcement Rule establishes rules governing the compliance
responsibilities of covered entities with respect to cooperation in the
enforcement process. It also provides rules governing the investigation
by the Department of compliance by covered entities, both through the
investigation of complaints and the conduct of compliance reviews. It
establishes rules governing the process and grounds for establishing
the amount of a civil money penalty where the Department has determined
a covered entity has violated a requirement of a HIPAA Rule. Finally,
the Enforcement Rule establishes rules governing the procedures for
hearings and appeals where the covered entity challenges a violation
determination.
C. The HITECH Act--Statutory Background
The HITECH Act, enacted on February 17, 2009, is designed to
promote the widespread adoption and standardization of health
information technology. Subtitle D of title XIII, entitled ``Privacy,''
supports this goal by adopting amendments designed to strengthen the
privacy and security protections of health information established by
HIPAA. These provisions include extending the applicability of certain
of the Privacy and Security Rules' requirements to the business
associates of covered entities; requiring HIPAA covered entities and
business associates to provide for notification of breaches of
``unsecured protected health information''; establishing new
limitations on the use and disclosure of protected health information
for marketing and fundraising purposes; prohibiting the sale of
protected health information; requiring the consideration of a limited
data set as the minimum necessary amount of information; and expanding
individuals' rights to access and receive an accounting of disclosures
of their protected health information, and to obtain restrictions on
certain disclosures of protected health information to health plans. In
addition, subtitle D adopts provisions designed to strengthen and
expand HIPAA's enforcement provisions. We provide a brief overview of
the relevant statutory provisions below.
In the area of business associates, the Act makes a number of
changes. First, section 13401 of the Act applies certain provisions of
the Security Rule that apply to covered entities directly to their
business associates and makes business associates liable for civil and
criminal penalties for the failure to comply with these provisions.
Similarly, section 13404 makes business associates of covered entities
civilly and criminally liable under the Privacy Rule for making uses
and disclosures of protected health information that do not comply with
the terms of their business associate contracts. The Act also provides
that the additional privacy and security requirements of subtitle D of
the Act are applicable to business associates and that such
requirements shall be incorporated into business associate contracts.
Finally, section 13408 of the Act requires that organizations that
provide data transmission of protected health information to a covered
entity or business associate and that require routine access to such
information, such as Health Information Exchange Organizations,
Regional Health Information Organizations, and E-prescribing Gateways,
as well as vendors that contract with covered entities to offer
personal health records to patients as part of the covered entities'
electronic health records, shall be treated as business associates for
purposes of the HITECH Act and the HIPAA Privacy and Security Rules and
required to enter into business associate contracts.
Section 13402 of the Act sets forth the breach notification
provisions, requiring covered entities and business associates to
provide notification following discovery of a breach of unsecured
protected health information. Additionally, section 13407 of the Act,
enforced by the Federal Trade Commission (FTC), applies similar breach
notification provisions to vendors of personal health records and their
third party service providers.
Section 13405 of the Act requires the Department to modify certain
Privacy Rule provisions. In particular, section 13405 sets forth
certain circumstances in which covered entities must comply with an
individual's request for restriction of disclosure of his or her
protected health information, provides for covered entities to consider
a limited data set as the minimum necessary for a particular use,
disclosure, or request of protected health information, and requires
the Secretary to issue guidance to address what constitutes minimum
necessary under the Privacy Rule. Section 13405 also requires the
Department to modify the Privacy Rule to require covered entities that
use or maintain electronic health records to provide individuals, upon
request, with an accounting of disclosures of protected health
information through an electronic health record for treatment, payment,
or health care operations; generally prohibits the sale of protected
health information without a valid authorization from the individual;
and strengthens an individual's right to an electronic copy of their
protected health information, where a covered entity uses or maintains
an electronic health record.
Section 13406 of the Act requires the Department to modify the
marketing and fundraising provisions of the Privacy Rule. With respect
to marketing, the Act requires authorizations for certain health-
related communications, which are currently exempted from the
definition of marketing, if the covered entity receives remuneration in
exchange for making the communication. The Act also strengthens an
individual's right under the Privacy Rule to opt out of fundraising
communications by requiring the Department to modify the Privacy Rule
so that covered entities must provide individuals with a clear and
conspicuous opportunity to opt out of receiving fundraising
[[Page 40870]]
communications and by requiring that an opt out be treated as a
revocation of authorization under the Privacy Rule.
Section 13410 of the Act addresses enforcement in a number of ways.
First, section 13410(a) provides that the Secretary's authority to
impose a civil money penalty will only be barred to the extent a
criminal penalty has been imposed, rather than in cases in which the
offense in question merely constitutes an offense criminally
punishable. In addition, section 13410(a) of the Act requires the
Secretary to formally investigate any complaint where a preliminary
investigation of the facts indicates a possible violation due to
willful neglect and to impose a penalty where a violation is found in
such cases. Section 13410(c) of the Act provides, for purposes of
enforcement, for the transfer to the HHS Office for Civil Rights of any
civil money penalty or monetary settlement collected under the Privacy
and Security Rules and also requires the Department to establish by
regulation a methodology for distributing to harmed individuals a
percentage of the civil money penalties and monetary settlements
collected under the Privacy and Security Rules. Effective as of
February 18, 2009, section 13410(d) of the Act also modified the civil
money penalty structure for violations of the HIPAA Rules by
implementing a tiered increase in the amount of penalties based on
culpability. In addition, as of February 18, 2009, section 13410(e) of
the Act also granted State Attorneys General the authority to enforce
the HIPAA Rules by bringing civil actions on behalf of State residents
in court.
Section 13421 states that HIPAA's State preemption provisions at 42
U.S.C. 1320d-7 shall apply to the provisions of subtitle D of the
HITECH Act in the same manner as they do to HIPAA's provisions.\1\
Section 13423 of the Act provides a general effective date of February
18, 2010, for most of its provisions, except where a different
effective date is otherwise provided.
---------------------------------------------------------------------------
\1\ We note that section 13421 of the HITECH Act and HIPAA's
State preemption provisions do not affect the applicability of other
Federal law, such as the Confidentiality of Alcohol and Drug Abuse
Patient Records Regulation at 42 CFR Part 2, to a covered entity's
use or disclosure of health information.
---------------------------------------------------------------------------
The Act also provides for the development of guidance, reports, and
studies in a number of areas, including guidance on appropriate
technical safeguards to implement the HIPAA Security Rule (section
13401(c)); for purposes of breach notification, guidance on the methods
and technologies for rendering protected health information unusable,
unreadable, or indecipherable to unauthorized individuals (section
13402(h)); guidance on what constitutes the minimum necessary amount of
information for purposes of the Privacy Rule (section 13405(b)); a
report by the Government Accountability Office (GAO) regarding
recommendations for a methodology under which harmed individuals may
receive a percentage of civil money penalties and monetary settlements
under the HIPAA Privacy and Security Rules (section 13410(c)); a report
to Congress on HIPAA Privacy and Security enforcement (section
13424(a)); a study and report on the application of privacy and
security requirements to non-HIPAA covered entities (section 13424(b));
guidance on de-identification (section 13424(c)); and a study on the
Privacy Rule's definition of ``psychotherapy notes'' at 45 CFR 164.501,
with regard to including test data that is related to direct responses,
scores, items, forms, protocols, manuals, or other materials that are
part of a mental health evaluation (section 13424(f)).
Finally, the Act includes provisions for education by HHS on health
information privacy and for periodic audits by the Secretary. Section
13403(a) provides for the Secretary to designate HHS regional office
privacy advisors to offer guidance and education to covered entities,
business associates, and individuals on their rights and
responsibilities related to Federal privacy and security requirements
for protected health information. Section 13403(b) requires the HHS
Office for Civil Rights, not later than 12 months after enactment, to
develop and maintain a multi-faceted national education initiative to
enhance public transparency regarding the uses of protected health
information, including programs to educate individuals about potential
uses of their protected health information, the effects of such uses,
and the rights of individuals with respect to such uses. Section 13411
requires the Secretary to provide for periodic audits to ensure covered
entities and business associates comply with the applicable
requirements of the HIPAA Privacy and Security Rules.
We discuss many of the Act's statutory provisions in more detail
below where we describe section-by-section how these proposed
regulations would implement those provisions of the Act. However, we do
not discuss in detail the breach notification provisions in sections
13402 of the Act or the modified civil money penalty structure in
section 13410(d) of the Act, which as explained below, have been the
subject of previous rulemakings. In addition, we do not address in this
rulemaking the accounting for disclosures requirement in section 13405
of the Act, which is tied to the adoption of a standard under the
HITECH Act at subtitle A of title XIII of ARRA, or the penalty
distribution methodology requirement in section 13410(c) of the Act,
which is to be based on the recommendations noted above to be developed
at a later date by the GAO. These provisions will be the subject of
future rulemakings. Further, we clarify that we are not issuing
regulations with respect to the new authority of the State Attorneys
General to enforce the HIPAA Rules. Finally, other than the guidance
required by section 13405(b) of the Act with respect to what
constitutes minimum necessary, this proposed rule does not address the
studies, reports, guidance, audits, or education efforts required by
the HITECH Act.
D. The HITECH Act--Regulatory Background
As noted above, certain of the HITECH Act's privacy and security
provisions have already been the subject of rulemakings and related
actions. In particular, the Department published interim final
regulations to implement the breach notification provisions at section
13402 of the Act for HIPAA covered entities and business associates in
the Federal Register on August 24, 2009 (74 FR 42740), effective
September 23, 2009. Similarly, the FTC published final regulations
implementing the breach notification provisions at section 13407 for
personal health record vendors and their third party service providers
on August 25, 2009 (74 FR 42962), effective September 24, 2009. For
purposes of determining to what information the HHS and FTC breach
notification regulations apply, the Department also issued, first on
April 17, 2009 (published in the Federal Register on April 27, 2009, 74
FR 19006), and then later with its interim final rule, the guidance
required by the HITECH Act under 13402(h) specifying the technologies
and methodologies that render protected health information unusable,
unreadable, or indecipherable to unauthorized individuals. In addition,
to conform the provisions of the Enforcement Rule to the new tiered and
increased civil money penalty structure made effective by the HITECH
Act on the day after enactment, or February 18, 2009, the Department
published an interim final rule on October 30, 2009 (74 FR 56123),
effective November 30, 2009.
[[Page 40871]]
II. General Issues
A. Effective and Compliance Dates
As noted above, section 13423 of the Act provides that the
provisions in subtitle D took effect one year after enactment, i.e., on
February 18, 2010, except as specified otherwise. There are a number of
exceptions to this general rule. Some provisions were effective the day
after enactment, i.e., February 18, 2009. For example, the tiered and
increased civil money penalty provisions of section 13410(d) were
effective for violations occurring after the date of enactment.
Sections 13402 and 13407 of the Act regarding breach notification
required interim final rules within 180 days of enactment, with
effective dates 30 days after the publication of such rules. Other
provisions of the Act have later effective dates. For example, the
provision at section 13410(a)(1) of the Act providing that the
Secretary's authority to impose a civil money penalty will only be
barred to the extent a criminal penalty has been imposed, rather than
in cases in which the offense in question merely constitutes an offense
that is criminally punishable, becomes effective for violations
occurring on or after February 18, 2011. The rules proposed below
generally pertain to the statutory provisions that became effective on
February 18, 2010, or, in a few cases, on a later date.
We note that the final rule will not take effect until after most
of the provisions of the HITECH Act became effective on February 18,
2010. We recognize that it will be difficult for covered entities and
business associates to comply with the statutory provisions until after
we have finalized our changes to the HIPAA Rules. In addition, we
recognize that covered entities and business associates will need some
time beyond the effective date of the final rule to come into
compliance with the final rule's provisions. In light of these
considerations, we intend to provide covered entities and business
associates with 180 days beyond the effective date of the final rule to
come into compliance with most of the rule's provisions. We believe
that providing a 180-day compliance period best comports with section
1175(b)(2) of the Social Security Act, 42 U.S.C. 1320d-4, and our
implementing provision at 45 CFR 160.104(c)(1), which require the
Secretary to provide at least a 180-day period for covered entities to
comply with modifications to standards and implementation
specifications in the HIPAA Rules. While the Social Security Act and
the HIPAA Rules permit the Secretary to further delay the compliance
date for small health plans, we do not believe that it is necessary to
do so for this rule both because most of the changes being proposed are
discrete modifications to existing requirements of the HIPAA Rules, as
well as because the Department is proposing an additional one-year
transition period to modify certain business associate agreements,
which should provide sufficient relief to all covered entities,
including small health plans. The Department welcomes comment on the
assumption that it is not necessary to extend the compliance date for
small health plans.
We also expect that for future modifications to the HIPAA Rules, in
most cases, a 180-day compliance period will suffice. Accordingly, we
propose to add a provision at Sec. 160.105 to address the compliance
date generally for implementation of new or modified standards in the
HIPAA Rules. Proposed Sec. 160.105 would provide that with respect to
new standards or implementation specifications or modifications to
standards or implementation specifications in the HIPAA Rules, except
as otherwise provided, covered entities and business associates must
comply with the applicable new standards or implementation
specifications or modifications to standards or implementation
specifications no later than 180 days from the effective date of any
such change. Where future modifications to the HIPAA Rules necessitate
a longer compliance period, we would provide so accordingly in the
regulatory text. We propose to retain the compliance date provisions at
Sec. Sec. 164.534 and 164.318, which provide the compliance dates of
April 14, 2003, and April 20, 2005, for initial implementation of the
HIPAA Privacy and Security Rules, respectively, for historical purposes
only.
We note that proposed Sec. 160.105 regarding the compliance date
of new or modified standards or implementation specifications would not
apply to modifications to the provisions of the HIPAA Enforcement Rule
because such provisions are not standards or implementation
specifications (as the terms are defined at Sec. 160.103). Such
provisions are in effect and apply at the time the final rule becomes
effective or as otherwise specifically provided. We also note that our
proposed general rule for a 180-day compliance period for new or
modified standards would not apply where we expressly provide a
different compliance period in the regulation for one or more
provisions. For purposes of this proposed rule, this would mean that
the 180-day compliance period would not govern the time period required
to modify those business associate agreements that qualify for the
longer transition period proposed in Sec. 164.532. We seek comments on
any potential unintended consequences of establishing a 180-day
compliance date as a regulatory default, with the noted exceptions.
B. Other Proposed Changes
While passage of the HITECH Act necessitates much of the rulemaking
below, it does not account for all of the proposed changes to the HIPAA
Privacy, Security, and Enforcement Rules encompassed in this
rulemaking. The Department is taking this opportunity to improve the
workability and effectiveness of all three sets of HIPAA Rules. The
Privacy Rule has not been amended since 2002, and the Security Rule has
not been amended since 2003. While the Enforcement Rule was amended in
the October 30, 2009, interim final rule to incorporate the
enforcement-related HITECH statutory changes that are already
effective, it has not been otherwise substantively amended since 2006.
In the intervening years, HHS has accumulated a wealth of experience
with these rules, both from public contact in various forums and
through the process of enforcing the rules. In addition, we have
identified a number of needed technical corrections to the rules.
Accordingly, we propose a number of modifications that we believe will
eliminate ambiguities in the rules and/or make them more workable and
effective. Further, we propose a few modifications to conform the HIPAA
Privacy Rule to provisions in the Patient Safety and Quality
Improvement Act of 2005 (PSQIA). We address the substantive proposed
changes in the section-by-section description of the proposed rule
below. Technical corrections are discussed at the end of the section-
by-section description of the other proposed amendments to the rules.
III. Section-by-Section Description of the Proposed Amendments to
Subparts A and B of Part 160
Subpart A of part 160 of the HIPAA Rules contains general
provisions that apply to all of the HIPAA Rules. Subpart B of part 160
contains the regulatory provisions implementing HIPAA's preemption
provisions. We propose to amend a number of these provisions. Some of
the proposed changes are necessitated by the statutory changes made by
the HITECH Act, while others are of a technical or conforming nature.
[[Page 40872]]
A. Subpart A--General Provisions, Section 160.101--Statutory Basis and
Purpose
This section sets out the statutory basis and purpose of the HIPAA
Rules. We propose a technical change to include a reference to the
provisions of the HITECH Act upon which most of the regulatory changes
proposed below are based.
B. Subpart A--General Provisions, Section 160.102--Applicability
This section sets out to whom the HIPAA Rules apply. We propose to
add a new paragraph (b) to make clear, consistent with the provisions
of the HITECH Act that are discussed more fully below, that the
standards, requirements, and implementation specifications of the
subchapter apply to business associates, where so provided.
C. Subpart A--General Provisions, Section 160.103--Definitions
Section 160.103 contains definitions of terms that appear
throughout the HIPAA Rules. For ease of reference, we propose to move
several definitions currently found at Sec. 160.302 to Sec. 160.103
without substantive change to the definitions themselves. This category
includes definitions of the following terms: ``ALJ,'' ``civil money
penalty,'' and ``violation or violate.'' As the removal of these
definitions, along with the removal of other definitions discussed
below (e.g., ``administrative simplification provision'' and
``respondent''), would leave Sec. 160.302 unpopulated, we propose to
reserve that section. We also propose to remove a comma from the
definition of ``disclosure'' inadvertently inserted into the definition
in a prior rulemaking, which is not intended as a substantive change to
the definition. In addition, we propose to replace the term
``individually identifiable health information'' with ``protected
health information'' in the definition of ``standard'' to better
reflect the scope of the Privacy and Security Rules. Further, we
propose the following definitional changes:
1. Definition of ``Administrative Simplification Provision''
This definition is currently located in the definitions section of
subpart C of part 160 of the HIPAA Enforcement Rule. We propose to
remove the definition of this term from Sec. 160.302 and move it to
the definitions section located at Sec. 160.103 for clarity and
convenience, as the term is used repeatedly throughout the entire part
160. We also propose to add to the definition a reference to sections
13400-13424 of the HITECH Act.
2. Definition of ``Business Associate''
Sections 164.308(b) of the Security Rule and 164.502(e) of the
Privacy Rule require a covered entity to enter into a contract or other
written agreement or arrangement with its business associates. The
purpose of these contracts or other arrangements, generally known as
business associate agreements, is to provide some legal protection when
protected health information is being handled by another person (a
natural person or legal entity) on behalf of a covered entity. The
HIPAA Rules define ``business associate'' generally to mean a person
who performs functions or activities on behalf of, or certain services
for, a covered entity that involve the use or disclosure of protected
health information. Examples of business associates include third party
administrators or pharmacy benefit managers for health plans, claims
processing or billing companies, transcription companies, and persons
who perform legal, actuarial, accounting, management, or administrative
services for covered entities and who require access to protected
health information. We propose a number of modifications to the
definition of ``business associate.'' In particular, we propose to
modify the definition to conform the term to the statutory provisions
of PSQIA, 42 U.S.C. 299b-21, et seq., and the HITECH Act. Additional
modifications are made for the purpose of clarifying circumstances when
a business associate relationship exists and for general clarification
of the definition.
a. Inclusion of Patient Safety Organizations
We propose to add patient safety activities to the list of
functions and activities a person may undertake on behalf of a covered
entity that give rise to a business associate relationship. PSQIA, at
42 U.S.C. 299b-22(i)(1), provides that Patient Safety Organizations
(PSOs) must be treated as business associates when applying the Privacy
Rule. PSQIA provides for the establishment of PSOs to receive reports
of patient safety events or concerns from providers and provide
analyses of events to reporting providers. A reporting provider may be
a HIPAA covered entity and, thus, information reported to a PSO may
include protected health information that the PSO may analyze on behalf
of the covered provider. The analysis of such information is a patient
safety activity for purposes of PSQIA and the Patient Safety Rule, 42
CFR 3.10, et seq. While the HIPAA Rules as written would encompass a
PSO as a business associate when the PSO was performing quality
analyses and other activities on behalf of a covered health care
provider, we propose this change to the definition of business
associate to more clearly align the HIPAA and Patient Safety Rules.
We note that in some cases a covered health care provider, such as
a public or private hospital, may have a component PSO that performs
patient safety activities on behalf of the health care provider. See 42
CFR 3.20. In such cases, the component PSO would not be a business
associate of the covered entity but rather the persons performing
patient safety activities would be workforce members of the covered
entity. However, if the component PSO contracts out some of its patient
safety activities to a third party, the third party would be a business
associate of the covered entity. In addition, if a component PSO of one
covered entity performs patient safety activities for another covered
entity, such component PSO would be a business associate of the other
covered entity.
b. Inclusion of Health Information Organizations (HIO), E-Prescribing
Gateways, and Other Persons That Facilitate Data Transmission; as Well
as Vendors of Personal Health Records
Section 13408 of the HITECH Act, which became effective on February
18, 2010, provides that an organization, such as a Health Information
Exchange Organization, E-prescribing Gateway, or Regional Health
Information Organization, that provides data transmission of protected
health information to a covered entity (or its business associate) and
that requires access on a routine basis to such protected health
information must be treated as a business associate for purposes of the
Act and the HIPAA Privacy and Security Rules. Section 13408 also
provides that a vendor that contracts with a covered entity to allow
the covered entity to offer a personal health record to patients as
part of the covered entity's electronic health record shall be treated
as a business associate. Section 13408 requires that such organizations
and vendors enter into a written business associate contract or other
arrangement with the covered entity in accordance with the HIPAA Rules.
In accordance with the Act, we propose to modify the definition of
``business associate'' to explicitly designate these persons as
business
[[Page 40873]]
associates. Under proposed paragraphs (3)(i) and (ii) of the
definition, the term ``business associate'' would include: (1) A Health
Information Organization, E-prescribing Gateway, or other person that
provides data transmission services with respect to protected health
information to a covered entity and that requires routine access to
such protected health information; and (2) a person who offers a
personal health record to one or more individuals on behalf of a
covered entity.
Section 13408 of the Act makes reference to Health Information
Exchange Organizations; however, we instead include in the proposed
definition the term ``Health Information Organization'' because it is
our understanding that ``Health Information Organization'' is the more
widely recognized and accepted term to describe an organization that
oversees and governs the exchange of health-related information among
organizations.\2\ Section 13408 of the Act also specifically refers to
Regional Health Information Organizations. However, we do not believe
the inclusion of the term in the definition of ``business associate''
is necessary as a Regional Health Information Organization is simply a
Health Information Organization that governs health information
exchange among organizations within a defined geographic area.\3\
Further, the specific terms of ``Health Information Organization'' and
``E-prescribing Gateway'' are merely illustrative of the types of
organizations that would fall within this paragraph of the definition
of ``business associate.'' We request comment on the use of these terms
within the definition and whether additional clarifications or
additions are necessary.
---------------------------------------------------------------------------
\2\ Department of Health and Human Services, Office of the
National Coordinator for Health Information Technology, The National
Alliance for Health Information Technology Report to the Office of
the National Coordinator For Health Information Technology: Defining
Key Health Information Terms, Pg. 24 (2008).
\3\ Id. at 25.
---------------------------------------------------------------------------
Section 13408 also provides that the data transmission
organizations that the Act requires to be treated as business
associates are those that require access to protected health
information on a routine basis. Conversely, data transmission
organizations that do not require access to protected health
information on a routine basis would not be treated as business
associates. This is consistent with our prior interpretation of the
definition of ``business associate,'' through which we have indicated
that entities that act as mere conduits for the transport of protected
health information but do not access the information other than on a
random or infrequent basis are not business associates. See https://www.hhs.gov/ocr/privacy/hipaa/faq/providers/business/245.html. In
contrast, however, entities that manage the exchange of protected
health information through a network, including providing patient
locator services and performing various oversight and governance
functions for electronic health information exchange, have more than
``random'' access to protected health information and thus, would fall
within the definition of ``business associate.''
c. Inclusion of Subcontractors
We propose to add language in paragraph (3)(iii) of the definition
of ``business associate'' to provide that subcontractors of a covered
entity--i.e., those persons that perform functions for or provide
services to a business associate, other than in the capacity as a
member of the business associate's workforce, are also business
associates to the extent that they require access to protected health
information. We also propose to include a definition of
``subcontractor'' in Sec. 160.103 to make clear that a subcontractor
is a person who acts on behalf of a business associate, other than in
the capacity of a member of the workforce of such business associate.
Even though we use the term ``subcontractor,'' which implies there is a
contract in place between the parties, we note that the definition
would apply to an agent or other person who acts on behalf of the
business associate, even if the business associate has failed to enter
into a business associate contract with the person. We request comment
on the use of the term ``subcontractor'' and its proposed definition.
The proposed modifications are similar in structure and effect to
the Privacy Rule's initial extension of privacy protections from
covered entities to business associates through contract requirements
to protect downstream protected health information. The proposed
provisions avoid having privacy and security protections for protected
health information lapse merely because a function is performed by an
entity that is a subcontractor rather than an entity with a direct
relationship with a covered entity. Allowing such a lapse in privacy
and security protections may allow business associates to avoid
liability imposed upon them by sections 13401 and 13404 of the Act,
thus circumventing the congressional intent underlying these
provisions. The proposed definition of ``subcontractor'' also is
consistent with Congress' overall concern that the privacy and security
protections of the HIPAA Rules extend beyond covered entities to those
entities that create or receive protected health information in order
for the covered entity to perform its health care functions. For
example, as discussed above, section 13408 makes explicit that certain
types of entities providing services to covered entities--e.g., vendors
of personal health records--shall be considered business associates.
Therefore, consistent with Congress' intent in sections 13401 and 13404
of the Act, as well as its overall concern that the HIPAA Rules extent
beyond covered entities to those entities that create or receive
protected health information, we propose that downstream entities that
work at the direction of or on behalf of a business associate and
handle protected health information would also be required to comply
with the applicable Privacy and Security Rule provisions in the same
manner as the primary business associate, and likewise would incur
liability for acts of noncompliance. We note, and further explain
below, that this proposed modification would not require the covered
entity to have a contract with the subcontractor; rather, the
obligation would remain on each business associate to obtain
satisfactory assurances in the form of a written contract or other
arrangement that a subcontractor will appropriately safeguard protected
health information. For example, under this proposal, if a business
associate, such as a third party administrator, hires a company to
handle document and media shredding to securely dispose of paper and
electronic protected health information, then the shredding company
would be directly required to comply with the applicable requirements
of the HIPAA Security Rule (e.g., with respect to proper disposal of
electronic media) and the Privacy Rule (e.g., with respect to limiting
its uses and disclosures of the protected health information in
accordance with its contract with the business associate).
d. Exceptions to Business Associate
We also propose to move the provisions at Sec. Sec. 164.308(b)(2)
and 164.502(e)(1)(ii) to the definition of business associate. These
provisions provide that in certain circumstances, such as when a
covered entity discloses protected health information to a health care
provider concerning the treatment of an individual, a covered entity is
not required to enter into a business
[[Page 40874]]
associate contract or other arrangement with the recipient of the
protected health information. While we do not change the meaning of
these provisions, we believe these limitations on the scope of
``business associate'' are more appropriately placed in the definition
as exceptions to the term to make clear that the Department does not
consider the recipients of the protected health information in these
circumstances to be business associates. The movement of these
exceptions and refinement of the definition of ``business associate''
also would help clarify that a person is a business associate if it
meets the definition of ``business associate,'' even if a covered
entity, or business associate with respect to a subcontractor, fails to
enter into the required contract with the business associate.
e. Technical Changes to the Definition
For clarity and consistency, we also propose to change the term
``individually identifiable health information'' in the current
definition of ``business associate'' to ``protected health
information,'' since a business associate has no obligations under the
HIPAA Rules with respect to individually identifiable health
information that is not protected health information.
3. Definition of ``Compliance Date''
The term ``compliance date'' currently refers only to covered
entities. We propose a technical change to include business associates
in the term, in light of the HITECH Act amendments, which apply certain
provisions of the HIPAA Rules to business associates.
4. Definition of ``Electronic Media''
The term ``electronic media'' was originally defined in the
Transactions and Code Sets Rule issued on August 17, 2000 (65 FR 50312)
and was included in the definitions at Sec. 162.103. That definition
was subsequently revised and moved to Sec. 160.103. The purpose of the
revision was to clarify that--
the physical movement of electronic media from place to place is
not limited to magnetic tape, disk, or compact disk. This
clarification removes a restriction as to what is considered to be
physical electronic media, thereby allowing for future technological
innovation. We further clarified that transmission of information
not in electronic form before the transmission, for example, paper
or voice, is not covered by this definition.
68 FR 8339, Feb. 20, 2003.
We propose to revise the definition of ``electronic media'' in the
following ways. First, we would revise paragraph (1) of the definition
to conform it to current usage, as set forth in ``Guidelines for Media
Sanitization'' (Definition of Medium, NIST SP 800-88, Glossary B, p. 27
(2006)). The NIST definition, which was updated subsequent to the
issuance of the Privacy and Security Rules, was developed in
recognition of the likelihood that the evolution of development of new
technology would make use of the term ``electronic storage media''
obsolete in that there may be ``storage material'' other than ``media''
that house electronic data. Second, we would add to paragraph (2) of
the definition of ``electronic media'' a reference to intranets, to
clarify that intranets come within the definition. Third, we propose to
change the word ``because'' to ``if'' in the final sentence of
paragraph (2) of the definition of ``electronic media.'' The definition
assumed that no transmissions made by voice via telephone existed in
electronic form before transmission; the evolution of technology has
made this assumption obsolete. This modification would extend the
policy described in the preamble discussion quoted above, but correct
its application to current technology, where some voice technology is
digitally produced from an information system and transmitted by phone.
5. Definition of ``Protected Health Information''
We propose to modify the definition of ``protected health
information'' at Sec. 160.103 to provide that the Privacy and Security
Rules do not protect the individually identifiable health information
of persons who have been deceased for more than 50 years. This proposed
modification is explained more fully below in Section VI.E. of the
preamble where we discuss the proposed changes to the Privacy Rule
related to the protected health information of decedents.
6. Definition of ``Respondent''
The definition of the term ``Respondent,'' which is currently in
Sec. 160.302, would be moved to Sec. 160.103. A reference to
``business associate'' would be added following the reference to
``covered entity'' in recognition of the potential liability imposed on
business associates for violations of certain provisions of the Privacy
and Security Rules by sections 13401 and 13404 of the Act.
7. Definition of ``State''
The HITECH Act at section 13400, which became effective February
18, 2010, includes a definition of ``State'' to mean ``each of the
several States, the District of Columbia, Puerto Rico, the Virgin
Islands, Guam, American Samoa, and the Northern Mariana Islands.'' This
definition varies from paragraph (2) of the HIPAA definition of
``State'' at Sec. 160.103, which does not include reference to
American Samoa and the Northern Mariana Islands. Thus, for consistency
with the definition applied to the HIPAA Rules by the HITECH Act, we
propose to add reference to American Samoa and the Commonwealth of the
Northern Mariana Islands in paragraph (2) of the definition of
``State'' at Sec. 160.103.
8. Definition of ``Workforce''
The HITECH Act is directly applicable to business associates and
has extended liability for compliance with certain provisions of the
Privacy and Security Rules to business associates. Because some
provisions of the Act and the Privacy and Security Rules place
obligations on the business associate with respect to workforce
members, we propose to revise the definition of ``workforce member'' in
Sec. 160.103 to make clear that such term includes the employees,
volunteers, trainees, and other persons whose conduct, in the
performance of work for a business associate, is under the direct
control of the business associate.
D. Subpart B--Preemption of State Law, Section 160.201--Statutory Basis
We propose to modify Sec. 160.201 regarding the statutory basis
for the preemption of State law provisions to add a reference to
section 264(c) of HIPAA, which contains the statutory basis for the
exception to preemption at Sec. 160.203(b) for State laws that are
more stringent than the HIPAA Privacy Rule. We also propose to add a
reference to section 13421(a) of the HITECH Act, which applies HIPAA's
preemption rules to the HITECH Act's privacy and security provisions.
Finally, we propose to re-title the provision to read ``Statutory
basis'' instead of ``Applicability.''
We also take this opportunity to make clear that section 264(c)(2)
of HIPAA and Sec. 160.203(b) do not create a Federal evidentiary
privilege. Additionally, we take this opportunity to make clear that
neither the HIPAA statute nor its implementing regulations give effect
to State physician-patient privilege laws or provisions of State law
relating to the privacy of individually identifiable health information
for use in Federal court proceedings. Therefore, consistent with the
Supremacy Clause, any State law that was preempted prior to HIPAA
because of conflicts with a Federal law would continue to be preempted.
Nothing in HIPAA or its implementing regulations is intended to expand
the
[[Page 40875]]
scope of State laws, regardless of whether they are more or less
stringent than Federal law.
E. Subpart B--Preemption of State Law, Section 160.202--Definitions.
1. Definition of ``Contrary''
The term ``contrary'' is currently defined in Sec. 160.202 to make
clear when the preemption provisions of HIPAA apply to State law.
Consistent with the limited application of the HIPAA provisions to
covered entities only, the current definition of the term ``contrary''
does not include reference to business associates. However, section
13421(a) of the HITECH Act provides that the HIPAA preemption provision
(section 1178 of the Social Security Act) applies to the provisions and
requirements under the HITECH Act ``in the same manner'' as it would
apply under the HIPAA provisions. Thus, the preemption provisions would
apply to business associates, who are now, by virtue of the HITECH Act,
required to comply with certain provisions of the HIPAA Rules and are
subject to penalties for noncompliance, as discussed elsewhere. Thus,
we propose to amend the definition of ``contrary'' by inserting
references to business associates in paragraph (1) of the definition.
We also expand the reference to the HITECH statutory provisions in
paragraph (2) of the definition to encompass all of the sections of
subtitle D of the HITECH Act, rather than merely to section 13402,
which was added by the breach notifications regulations. These changes
would give effect to section 13421(a).
2. Definition of ``More Stringent''
The term ``more stringent'' is part of the statutory preemption
language under HIPAA. HIPAA preempts State law that is contrary to a
HIPAA privacy standard unless, among other exceptions, the State law is
more stringent than the contrary HIPAA privacy standard. The current
regulatory definition of ``more stringent'' does not include business
associates. We propose to amend the definition to add a reference to
business associates, for the reasons set out in the preceding
discussion.
IV. Section-by-Section Description of the Proposed Amendments to the
Enforcement Rule--Subparts C and D of Part 160
Section 13410 of the HITECH Act made several amendments that
directly impact the Enforcement Rule, which applies to the Secretary's
enforcement of all of the HIPAA Administrative Simplification Rules, as
well as the recently promulgated Breach Notification Rule. We issued an
interim final rule on October 30, 2009, 74 FR 56123, to address the
HITECH Act amendments impacting the Enforcement Rule that became
effective on February 18, 2009. For context, we describe those
modifications to the Enforcement Rule briefly below. We then provide a
section-by-section description of the other section 13410 amendments
that are part of this proposed rule.
In addition, sections 13401 and 13404 of the HITECH Act impose
direct civil money penalty liability on business associates for
violations of the HITECH Act and certain Privacy and Security Rule
provisions. In doing so, sections 13401(b) and 13404(c) of the Act
provide that section 1176 of the Social Security Act shall apply to a
violation by a business associate ``in the same manner'' as it would
apply to a covered entity with respect to such a violation. Both
provisions are, by virtue of section 13423, effective February 18,
2010.
The provisions of subparts C and D of part 160 currently apply by
their terms solely to covered entities. Accordingly, to implement
sections 13401(b) and 13404(c) of the Act, we propose to revise a
number of provisions in both subparts to reflect this statutory change
by adding the term ``business associate'' where appropriate, following
a reference to ``covered entity.'' For ease, we list the sections in
which the term ``business associate'' is added here rather than repeat
the change in each discussion of the sections below: Sec. Sec.
160.300; 160.304; 160.306(a) and (c); 160.308; 160.310; 160.312;
160.316; 160.401; 160.402; 160.404(b); 160.406; 160.408(c) and (d); and
160.410(a) and (c).
In addition to these references, we propose to add a paragraph in
Sec. 160.402(c)(2) to describe a business associate's liability for
the actions of its agents, in accordance with the Federal common law of
agency. This proposed modification is discussed more fully below in the
discussion of Sec. 160.402(c).
As noted above, the Department issued an interim final rule (IFR)
on October 30, 2009, revising the Enforcement Rule to incorporate the
provisions required by section 13410(d) of the HITECH Act that
immediately took effect: Four categories of violations that reflect
increasing levels of culpability, the corresponding tiers of civil
money penalty amounts, and the revised limitations placed on the
Secretary's authority to impose penalties. More specifically, the IFR
revised subpart D of the Enforcement Rule to transfer the definitions
of ``reasonable cause,'' ``reasonable diligence,'' and ``willful
neglect'' from Sec. 160.410(a) to a new definitions section at Sec.
160.401. The IFR revised Sec. 160.404 to incorporate, for violations
occurring on or after February 18, 2009, the new penalty scheme
required by section 13410(d), as follows: For violations in which it is
established that the covered entity did not know and, by exercising
reasonable diligence, would not have known that the covered entity
violated a provision, an amount not less than $100 or more than $50,000
for each violation; for a violation in which it is established that the
violation was due to reasonable cause and not to willful neglect, an
amount not less than $1000 or more than $50,000 for each violation; for
a violation in which it is established that the violation was due to
willful neglect and was timely corrected, an amount not less than
$10,000 or more than $50,000 for each violation; and for a violation in
which it is established that the violation was due to willful neglect
and was not timely corrected, an amount not less than $50,000 for each
violation; except that a penalty for violations of the same requirement
or prohibition under any of these categories may not exceed $1,500,000
in a calendar year. It also revised the affirmative defenses in Sec.
160.410 for violations occurring on or after February 18, 2009, to
remove a covered entity's lack of knowledge as an affirmative defense
and to provide an affirmative defense when violations not due to
willful neglect are corrected within 30 days. Finally, the IFR added a
requirement that a notice of proposed determination pursuant to Sec.
160.420 also reference the applicable category of violation. Readers
are encouraged to refer to the IFR for a more detailed discussion of
these topics as well as the Enforcement Rule's statutory and regulatory
background. See 74 FR 56123, 56124, Oct. 30, 2009.
The rules proposed below would revise many provisions of subparts C
and D of part 160. However, the Department's current interpretations of
the regulatory provisions at subparts C and D continue unchanged,
except to the extent they are inconsistent with the changes to those
provisions, as indicated below.
A. Subpart C--Compliance and Investigations, Section 160.304--
Principles for Achieving Compliance
Section 160.304 identifies cooperation and assistance as two
overarching principles for achieving compliance. The principle of
cooperation, in Sec. 160.304(a), states that ``[t]he Secretary will,
to the extent practicable, seek the cooperation of covered entities in
[[Page 40876]]
obtaining compliance with the applicable administrative simplification
provisions.''
Section 13410(a) of the HITECH Act adds a new subsection (c) to
section 1176 of the Social Security Act:
(c) NONCOMPLIANCE DUE TO WILLFUL NEGLECT.--
(1) IN GENERAL.--A violation of a provision of this part due to
willful neglect is a violation for which the Secretary is required
to impose a penalty under subsection (a)(1).
(2) REQUIRED INVESTIGATION.--For purposes of paragraph (1), the
Secretary shall formally investigate any complaint of a violation of
a provision of this part if a preliminary investigation of the facts
of the complaint indicate such a possible violation due to willful
neglect.
Section 13410(b)(1) makes the provisions of section 13410(a) effective
February 18, 2011.
Under section 1176(c), HHS is required to impose a civil money
penalty for violations due to willful neglect. Accordingly, although
the Secretary often will still seek to correct indications of
noncompliance through voluntary corrective action, there may be
circumstances (such as circumstances indicating willful neglect), where
the Secretary may seek to proceed directly to formal enforcement. As a
conforming amendment, HHS proposes to add the phrase, ``and consistent
with the provisions of this subpart,'' to Sec. 160.304(a) to recognize
the statutory revision.
B. Subpart C--Compliance and Investigations, Section 160.306(c)--
Complaints to the Secretary
Section 160.306(c) of the Enforcement Rule currently provides the
Secretary with discretion to investigate HIPAA complaints, through use
of the word ``may.'' The new willful neglect provisions, at section
1176(c)(2) of the Social Security Act, will require HHS to investigate
``any complaint of a violation of a provision of this part if a
preliminary investigation of the facts of the complaint indicates * * *
a possible violation due to willful neglect.''
HHS proposes to implement section 1176(c)(2) by adding a new
paragraph (1) at Sec. 160.306(c) to provide that the Secretary will
investigate any complaint filed under this section when a preliminary
review of the facts indicates a possible violation due to willful
neglect. As a practical matter, HHS currently conducts a preliminary
review of every complaint received and proceeds with the investigation
in every eligible case where its preliminary review of the facts
indicate a possible violation of the HIPAA Rules. Nevertheless, we
propose this addition to Sec. 160.306 to make clear our intention to
pursue an investigation where a preliminary review of the facts
indicates a possible violation due to willful neglect.
HHS proposes to conform the remainder of Sec. 160.306(c)
accordingly. The new Sec. 160.306(c)(2) (presently, the initial
sentence of Sec. 160.306(c)) would be revised by replacing
``complaints'' with ``any other complaint'' to distinguish the
Secretary's discretion with respect to complaints for which HHS's
preliminary review of the facts does not indicate a possible violation
due to willful neglect from the statutory requirement to investigate
all complaints for which HHS's preliminary review of the facts
indicates a possible violation due to willful neglect, as set out in
the new Sec. 160.306(c)(1). The current second sentence of Sec.
160.306(c), which addresses the content of an investigation, would be
renumbered as Sec. 160.306(c)(3) and amended by changing the first
word of the sentence from ``such'' to ``an,'' to signal the provision's
application to any investigation, regardless of whether a preliminary
review of the facts indicates a possible violation due to willful
neglect.
C. Subpart C--Compliance and Investigations, Section 160.308--
Compliance Reviews
Section 160.308 provides that the Secretary may conduct compliance
reviews. Use of the word ``may'' in this section makes clear that this
is a discretionary activity. While complaints and not compliance
reviews are specifically mentioned in the statutory language of section
13410(a)(1)(B) of the Act